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Abstract 
Methods for on-farm extraction of low-concentration (minor) proteins from raw whole 
bovine milk directly after milking were explored. These minor proteins have high 
commercial value. Lactoferrin (LF) and lactoperoxidase (LP) were used as model proteins 
for extraction using cation exchange chromatography. 
Laboratory fractionations showed that milk could be processed by conventional column 
chromatography without excessive column backpressures if resin with large particles sizes 
were used and the temperature was high enough so fat in the milk was malleable; ideally 
the milk should be near the secretion temperature of 37oC. Processing parameters such as 
equilibrium and dynamic capacities were determined for SP Sepharose™ (GE Healthcare 
Technologies) and Bio Rex 70 (BioRad Laboratories) resins. SP Sepharose Big Beads (SP 
BB) were found to be more suitable than BR 70, for raw whole milk processing due to the 
larger size (200 µm).  
Design considerations showed that column chromatography was not the most practical 
method for on-farm processing of fresh, raw whole milk. Trials with a single-stage stirred 
tank showed that SP BB resin could extract up to 65% of LF (initial LF concentration of 
0.5 mg/mL) with a 10-minute adsorption time. The composite non-linear (CNL) model of 
Rowe et al. (1999) was used to describe LF uptake by SP BB resin in raw whole milk with 
initial LF concentrations of 0 to 1.0 mg/mL and resin:milk volume ratios of 0.010, 0.012, 
0.017 and 0.024 over 45-minute contact times. The CNL model could be used to predict LF 
yields if initial feed concentration, milk and resin volumes, and contact times were known. 
Laboratory extractions showed that processing did not significantly affect bulk milk 
composition (fat, protein, lactose and total solids), indicating that the milk could be used 
for conventional processing after the minor proteins had been extracted. 
Resin cleaning and regeneration studies, using a procedure similar to that recommended by 
the resin supplier, showed that the Sepharose resin had not degraded and there was no 
significant decrease in binding capacity after 50 extraction cycles. 
A Protein Fractionation Robot (PFR) prototype based on a single-stage stirred tank and the 
operating parameters obtained from the laboratory trials was designed, assembled and 
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coupled to an Automated Milking System (AMS) to process fresh, raw whole milk from 
individual cows immediately after milking. The LF and LP extracted from the milk from 16 
individual cows were 19.7 - 55.2% (35.6 ± 10.2%) and 21.2 - 99.5% (87.1 ± 12.0%) 
respectively. Generally, higher extraction levels were obtained at higher resin:milk ratios. 
The amount of LF extracted on-farm agreed within 14.1 ± 9.8% of those predicted by the 
CNL model, with predicted values generally being higher. The experimental on-farm 
adsorption values were calculated using data of LF recovered after elution, so differences 
between actual and predicted values may be due to losses during post-adsorption 
processing. 
Economic feasibility studies, based on experimental data from the PFR and realistic 
wholesale prices for LF and LP ($400 and $150/kg respectively) showed that PFR-based 
processing is economically viable if the farmer is paid for the LF and LP produced as well 
as the bulk milk. This system would have a payback period of approximately five years and 
an internal rate of return of 14.5%. Further case studies determined the sensitivity of the 
economics to various operating parameters and value/cost assumptions, including 
producing recombinant human protein from transgenic bovine milk. These studies showed 
that the higher the value of the processed raw milk, the higher the absorptive capacity of 
the resin, and the higher the value of the extracted protein, the more favourable the 
economics. In the extreme case of producing a very high value therapeutic protein (e.g. $20 
000), the payback period could be as low as 0.3 years, with an internal rate of return of 
818%. 
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Preface 
The development of Automated Milking Systems (AMS) and associated technology as a 
future for milk harvesting in New Zealand has generated considerable commercial interest. 
It has the potential to address a lot of labour and productivity issues facing the dairying 
industry in New Zealand today. However, the uptake of the technology is low with the 
costs and economics of switching to such a high technology option still a concern for the 
farmers. The AMS is a shift in the way milk has been traditionally harvested. The concept 
for on-farm fractionation was looked at by DEC International Limited in mid 1990s. 
However, a feasibility study based on the dynamics of New Zealand dairy and market for 
bioactives in 1996 showed that it was not a viable technology for the market. Since then, 
the functional food market and the perception of dairy specialty foods have changed 
dramatically. Also with the introduction of the first AMS to New Zealand in 2001, an 
opportunity was presented to explore the practicality of this on-farm technology so this 
project was initiated in 2003 through this PhD project. The on-farm project’s overall aim 
was to develop a platform technology to extract high-values proteins on-farm, in-line from 
freshly harvested, raw whole milk. 
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 1 Introduction 
1.1 Background 
Bovine milk has been used as a food source for many centuries. More recently, the 
minor milk components have been identified as important for human health and 
nutrition, with both nutraceutical and therapeutic applications. Examples include 
lactoferrin (LF) used in infant formulae, lactoperoxidase (LP) used as a natural 
preservative, and whey protein isolates used in sports and nutritional supplements.  
Minor milk proteins are typically produced from dairy waste steams, particularly 
whey. Processing whey has evolved mainly to improve revenue while reducing the 
amount of waste produced (Smithers et al. 1996). High-value milk proteins such as 
LF and LP have also been extracted from skim (non-fat) milk.  
Economy of scale drives production of commodities such as milk powder, casein, 
cheese and butterfat, leading to centralised processing in large factories (Figure 1-1). 
Currently, all milk fractionation is performed on bulk milk streams at the dairy 
processing plant, so farms that produce milk with particularly high concentrations of 
high-value minor components do not directly benefit. This lack of return on 
investment to the farmer has restricted the development of processes that can capture 
such benefits at the farm. 
There are large variations in milk composition, both between cows and between 
milkings of individual cows. Farm management practices such as selective breeding, 
supplementary feeding, etc, can produce milk with different fat, proteins and lactose 
content. These differences, however, are minimised when milk from different 
suppliers is amalgamated into large silos before centralised processing.  
Industrial milk processing involves many unit operations before the separation 
processes to extract valuable functional proteins (Figure 1-1). Such extensive 
processing may affect proteins yield and activity. 
 
  
1-2 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1-1: Commercial milk processing in a centralised facility. 
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Proteins are delicate molecules where structure and function are intertwined. It is a 
truism in the biotechnology industry that proteins should be processed as quickly as 
possible and in as few steps as possible because yields (Figure 1-2) and bioactivity 
are directly related to efficient and effective processing (Ladisch 2001; Harrison et 
al. 2003). 
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Figure 1-2: The effect of number of processing steps on yields. 
Pre-treating milk before adsorption processes to capture proteins is universal 
(Humphrey and Newsome 1984, Andrews et al. 1985, Yoshida 1988). The current 
processes for functional dairy proteins use pharmaceutical protein separation and 
purification techniques (mainly ion exchange chromatography together with 
ultrafiltration) to produce proteins, whey proteins, whey protein isolates, 
immunoglobulins etc from filtered skim milk and whey. 
An Automated Milking System (AMS) with a high degree of automation, herd 
management capability, and control and traceability has been demonstrated on a 
commercial farm (Dexcel and Sensortec Limited, Hamilton, New Zealand) 
(Woolford et al. 2003). This presents an opportunity to couple the AMS and protein 
fractionation for extracting thermally labile and unstable proteins from raw whole 
milk on-farm at the point of secretion. This process has the potential to increase 
product yield and activity. 
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The LF, LP, and other minor components of milk have high value. On-farm 
extraction creates the opportunity for individual farmers to improve their returns if 
they use practices that increase the concentrations of these components in their 
animals’ milk. The concept of on-farm fractionation from fresh raw whole milk had 
not been previously attempted. It is generally accepted that fat fouls adsorbents and 
therefore must be removed before milk is further processed. Little or no information 
is available on processes about on-farm milk processing and/or from processing 
fresh, raw whole milk. This project was designed to explore the technical challenges 
of processing raw whole milk and develop a functional system suitable for on-farm 
operation. 
1.2 Objectives 
The primary goal of this thesis was to demonstrate the feasibility of on-farm 
fractionation of milk proteins from fresh, raw whole milk. A further goal was to 
couple a robotic fractionation system to the AMS.  
The specific objectives for the project were to: 
• investigate milk processing technologies for extracting high-value, 
specialty minor components 
• explore chromatographic extraction of proteins from raw whole milk and 
determine adsorption capacities, kinetics and pressure-flow relationships 
of suitable adsorbents 
• evaluate techniques and materials for extracting components from milk 
for their suitability for on-farm use 
• develop an automatic fractionation platform that can be coupled to an 
AMS to extract components of interest 
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1.3 Thesis organisation 
A general review on milk, its components, their extraction and separation 
technologies is presented in Chapter 2. In particular, LF and LP purification is 
reviewed with the aim of developing a process to extract them from raw whole milk. 
Laboratory methods and small scale fractionation experiments are described in 
Chapter 3 and the results and discussion are presented in Chapter 4. In Chapter 5, 
batch chromatography adsorption kinetics are explored using the new composite 
non-linear (CNL) model of Rowe et al. (1999). Data from both laboratory and on-
farm adsorption experiments are fitted with the CNL model and used to explore the 
effects of operating parameters on yields. Chapter 6 describes the design of an 
extraction robot and the methodology used for on-farm experiments. Results from 
on-farm experiments are presented in Chapter 7. Chapter 8 contains an economic 
feasibility study based on the data for LF and LP extraction obtained with the robot 
and in the laboratory. Conclusions and recommendations for future work are 
presented in Chapter 9. 
 
 2 Literature Review 
2.1 Introduction 
Extracting proteins from dairy fluids using ion exchange chromatography has been 
extensively studied for many years. It is almost exclusively carried out on ‘skim’ 
(defatted) milk and/or whey (de-caseinated or cheese milk). The basis for on-farm 
extraction (‘harvesting’) of minor proteins from milk is protein purification 
chromatography (that is, selective adsorption of target proteins). This chapter 
reviews preparative chromatography techniques for extracting proteins from milk, 
although most analytical separations are generally not relevant to large-scale 
extraction of individual proteins. Before reviewing literature on industrial protein 
chromatography in general and milk protein purification in particular, a description 
of milk properties and its components is given, followed by a description of unit 
operations commonly used in dairy protein processing. The extraction/purification 
techniques of the two minor milk proteins LF and LP are described in detail because 
these were the model proteins used for on-farm capture. Chromatographic 
fractionation of raw whole milk is not described in the literature so this review 
discusses purification techniques for pre-treated milk such as skim and whey. The 
most suitable techniques for extracting proteins from raw whole milk are then 
discussed. 
The composition of raw milk from individual cows can vary widely but milk 
processed in factories has a much more uniform composition and particle size. Since 
the protein fractionating system to be developed has to function with an AMS, some 
aspects of farming and harvesting milk are described. 
2.2 Milk and its components 
Milk is the first food of the neonate. Milk from domestic animals has been used for 
food for hundreds of years and it has been studied scientifically for well over 100 
years. Hence it possibly is the best characterized of our major foods. 
Total annual world production of milk is ~560 x 106 tonnes (85% cattle, 11% 
buffalo, 2% each sheep and goats). Other milking species such as camel, yak, horse 
and reindeer, are insignificant, although important in some regions (Fox 2001).  
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Milk is a complex colloidal dispersion of fat globules and various proteins in an 
aqueous solution of lactose, minerals and other minor components. Normal milk is 
approximately 87.4% water and 12.6% milk solids (3.7% fat, 8.9% milk solids non-
fat; consisting of 3.4% protein, 4.8% lactose and 0.7% minerals and other minor 
components). Bovine, buffalo, ovine and caprine milk contain 3.4, 4.5, 5.5 and 3.0% 
weight percent protein respectively (Table 2-1) so ~20 x 106 tonnes of milk proteins 
are produced annually (Fox, 2001). 
Table 2-1: Approximate composition of milk (g/L) (Playne et al. 2003).  
Component Cow Human Buffalo Goat Sheep 
Total solids 125 129 171 130 163 
Proteins 34 10 38 29 55 
Casein proteins 28 4 -- 23 -- 
Whey proteins 6 5.5 -- 6 -- 
LF (mg/L) 10-50 2000 -- -- -- 
Fat 31 38 75 45 53 
Lactose 48 71 49 41 46 
Oligosaccharides 0.03-0.06 3.8 -- -- -- 
Riboflavin (mg/L) 1.57 0.43 1.02 1.14 4.36 
Minerals 
Ash 7 2 8 8 9 
Calcium 1.14 0.34 1.85 1.30 1.93 
Phosphorous 0.93 0.14 1.25 1.06 0.99 
Milk proteins can be broadly classified as caseins or whey proteins. The five bovine 
casein proteins (α-s1, α-s2, β, γ, and κ) are very well-characterized and have 
substantially different properties. Their molecular weights are between 20-25 kDa, 
they are phosphorylated, and display polymorphism (Fox 2001). The whey protein 
fraction of bovine milk contains four main proteins: β-lactoglobulin (β-Lg), α-
lactalbumin (α-La), bovine serum albumin (BSA) and immunoglobulins (mainly 
IgG1, with lesser amounts of IgG2, IgA and IgM) (Table 2-2). Human milk contains 
no β-Lg and the principal immunoglobulin is IgA.  
2.2.1 Factors affecting milk composition 
On-farm practices such as breed, genetic selection, diet, and health can influence 
functionality of bovine milk (Auldist et al. 2000; Yang et al. 2000). For example, 
milk with softer fat (soft milk fat) can be obtained by grain feeding; and selective 
breeding can increase concentrations of special proteins such as α-casein and other 
minor milk components that have bioactive properties.  
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Table 2-2: Bovine milk proteins and their molecular weights (Varman and 
Sutherland 1994; Bylund and TetraPak 2003; Etzel 2004). 
 Concentration  % of total Mr of  pI 
 (g/kg) protein monomer (kDa) 
Casein  
α-s1-casein 10.0 30.6 23 4.9/5.3 
α-s2-casein 2.6 8.0 25 4.9/5.3 
β-casein 10.1 30.8 24 5.2 
κ-casein 3.3 10.1 2 5.8 
Total casein 26.0 79.5 
Whey proteins 
α-La 1.2 3.7 14 4.4 
β-Lg 3.2 9.8 18.3 5.4 
BSA 0.4 1.2 67 5.1 
Immunoglobulins 0.7 2.1 up to 1000 5-8 
Miscellaneous (including  
 proteose-peptone) 0.8 2.4 
LF 0.1  77 7.9 
LP 0.03  78 9.6 
Total whey proteins 6.3 19.3 
Fat globule membrane proteins 0.4 1.2 
Total protein 32.7 100 
Glycomacropeptide 1.5  8.6 <3.8 
Mr  molecular weight 
Supplementary feeding, breed effects, stage of lactation and seasonal changes 
influence milk composition (Coulon et al. 1994; 1998; Mackle et al. 1999; 2000; 
Nicholas et al. 2002; Turner et al. 2003a; 2003b; Auldist et al. 2004). Milking 
frequency also affects milk composition. For example, LF concentrations in cows 
milked once daily were higher than those milked twice daily (Farr et al. 2002). The 
LF levels in colostrum of Holstein-Friesian and Jersey (dairy breeds) is higher than 
in Japanese Black and Brown (beef breeds), being 2 mg/mL and 0.5 mg/mL 
respectively (Tsuji et al. 1990).  
Functionality of milk components is also affected by post farm-gate practices such as 
storage conditions, pre-treatment, processing steps and product storage. Harvesting 
(milking) and post- harvest storage can affect milk quality and also enhance post-
harvest deterioration during storage such as lipolysis, creaming, rancidity (off-
flavours), denaturation and hydrolysis, which affect the factory processing 
characteristics of milk (Roupas 2001). 
 
  
2-4 
2.2.2 Milk harvesting  
In New Zealand, milk is generally harvested twice daily (morning and afternoon). 
Effective farm layouts and dairy parlours minimize worker effort. Rotary machines 
on large revolving platforms can accommodate 60 or more cows, with automatic 
positioning and exit of cows. Labour-saving devices such as automatic gate openers, 
in-line milk metering and sampling, teat washing and cup removers have also been 
developed. Dairy farm staffing levels are between one person per 100 to 200 cows 
milked according to time spent milking and dairy parlour design. Hogeveen and 
Ouweltjes (2003) note two trends in developing high-tech milking equipment that 
may break the labour barriers to expansion: high-capacity milking parlours with high 
throughput of cows per person per hour and automatic milking systems where 
manual labour is replaced by a milking robot. 
AMSs are generally used for housed cows (Fisher et al. 2004). Adoption of the AMS 
was slow initially, but by 2002 over 1000 herds (Figure 2-1) were being milked by 
AMS, with at least seven equipment suppliers offering such systems (Hillerton 1997; 
de Koning and van de Vorst 2002). The New Zealand dairying industry is 
predominantly pasture based; housed herds are limited, mainly due to the high cost 
of supplementary (grain) feeding. The AMS has been adapted to pasture-based 
dairying and systems exist in Ireland, Australia and New Zealand. Reported benefits 
of AMS are labour savings (Hayashi and Kawamura 2002; Fisher et al. 2004) and 
improved yields (Fisher et al. 2004). 
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Figure 2-1: Number of farms with automatic milking systems in Europe (de Koning 
and van de Vorst 2002). 
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Currently the AMS cannot keep pace with high throughput dairies (e.g. 200-1000 
cows being milked twice per day) because it is based on distributed milking with 
continuous cow traffic over 24 hours. Cost is also a deterrent being $250,000-
$300,000 per robotic station that can handle 160 milkings in 24 hours (Dexcel 2006). 
2.2.3 Milk as a source for transgenic proteins  
Transgenic animals with foreign genes able to express specific proteins in their milk 
are used as sources of therapeutic proteins. Milk from transgenic dairy animals can 
be a viable, ample and specific pathogen-free source of recombinant and natural 
proteins to augment therapeutics derived from sources such as human plasma. 
Transgenic manufacture using animals or plants can be up to 20 g/L (Werner 1999) 
compared with production in bioreactors of 500-800 mg/L, making transgenic cattle 
an attractive vehicle for large-scale production of biopharmaceuticals (Owen and 
Chase 1997; van Berkel et al. 2002). It has been used for producing recombinant 
human LF (rhLF) and other examples using milk as a source of therapeutics have 
been reported (Denman et al. 1991; Ebert et al. 1991; Wright et al. 1991; Wolf et al. 
1997; Degener et al. 1998; Pollock et al. 1999; Wright and Noble 1999; Andrews et 
al. 2000; Konrad et al. 2000; Fulton 2001; Baruah et al. 2003; Lindsay et al. 2004; 
Nikolov and Woodard 2004; Parker et al. 2004; Capezio et al. 2005). These natural 
and recombinant sources of therapeutic proteins generate the need for economic, 
high-resolution purification technologies. 
2.2.4 Nutraceutical and functional foods 
Functional foods (also referred to as physiologically functional foods, nutraceuticals, 
designer foods or pharmafoods) provide the consumer with an identified health 
benefit over basic nutritional value. More refined methods of fractionation and 
analysis of proteins has renewed interest in minor milk proteins. The new tools of 
biotechnology make it possible to take different approaches to studying components 
of milk. The current focus on milk protein components is based mostly on the 
physiological effects and hence their commercial value. It is now widely accepted 
that milk proteins demonstrate multiple functions such as bioactivity (Table 2-3) as 
well as being a high-grade source of dietary nitrogen in human nutrition (Tome and 
Debabbi 1998; Parodi 1999; Tsuda et al. 2000; Korhonen et al. 2001; Korhonen and 
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Pihlanto-Leppälä 2001; Meisel 2001; Parodi 2001; Steijns 2001; Kilara and Panyam 
2003; Ohashi et al. 2003; Seifu et al. 2005; Severin and Xia 2005; Walsh and 
FitzGerald 2005). 
The global functional food and nutraceutical market was worth US$50-63bn in 2004 
(AROQ Limited 2004) and is expected to grow to US$167bn by 2010 (14% 
annually). Dairy foods represent a significant proportion of this market (Tome and 
Debabbi 1998; AROQ Limited 2004). Dairy constituents, notably the proteins and 
peptides, with multi-functional components, provide desirable features such as 
physical functional traits, nutritional qualities and an increasing array of 
substantiated bioactivities (Playne et al. 2003). 
Table 2-3: Milk-derived components as possible ingredients of functional foods. 
Components Source 
Antimicrobial and anti-inflammatory substances Cheese, whey, colostral whey, fat globule  
 membranes 
Bioactive peptides Caseins, whey proteins, fermented 
 cheeses, fermented milks 
Antibodies (immunoglobulins) Colostral and cheese whey, fat free milk 
Whey proteins and their hydrolylates Cheese whey, acid whey, whey powder 
Lactose and its derivatives Milk, cheese whey 
Growth factors, cytokines Colostral whey 
Conjugated linoleic acid (CLA) Milk fat 
Minerals (calcium salts) Acid whey, fermented milks, cheeses 
Organic acids and their salts Cheese whey 
The worldwide market for both consumer products and ingredients from milk will 
continue to grow, with technology often preceding market demand (Huffman and 
Harper 1999). The challenge for science and technology is to isolate these 
ingredients in a cost-effective manner while maintaining their inherent functional and 
nutritional traits. The approach to functional foods needs to be considered not only 
from a processing point of view but as a business model. Aspects such as market, 
consumer perceptions, food safety issues, value chain and regulatory issues need to 
be considered. Niche markets are valuable but usually difficult and costly to 
establish. Furthermore, palatable foods such as high-protein beverages must be 
developed to provide attractive routes for consumption (Etzel et al. 2006). 
Technologies needed to harness the health and well-being potential of milk and milk 
products include analytical capability to determine the levels of components such as 
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peptides and surface proteins present in milk, bioactivity determinations and 
isolation/concentration processes (Marshall and Fenwick 1998). A review of 
chromatographic phases for process development by Bensch et al. (2005) highlighted 
the need to be “first to market” and to cut production costs to obtain fast process 
development while optimising processing parameters. 
2.3 Protein purification  
Laboratory-scale separation techniques for isolating proteins by salt or solvent 
precipitation, ion exchange chromatography and/or crystallization have been 
available for a long time. The processes available for commercial-scale production 
especially milk proteins, fall into three main categories: selective adsorption; 
membrane filtration based on different size and charge; and selective precipitation by 
adjusting physical properties of the solution. 
These processes are used either individually or in combination followed by recovery 
using selective elution, filtration, etc. Various modes of purification exist. Column 
chromatography is widely used for selective adsorption and elution (Chisti and Moo-
Young 1990; Strange et al. 1992), membrane filtrations using discs, filter cartridges 
and hollow fibres (Zydney 1998; Demmer and Nussbaumer 1999; Gosh 2002) and 
stirred tank systems in continuous and batch modes.  
The highly specific and mild conditions needed to separate proteins and peptides 
from complex mixtures make separation difficult. Most separation schemes are 
scaled-up laboratory procedures (Korhonen et al. 1998) usually involving scaling 
chromatographic methods by adapting large-scale equipment. 
It is essential to use or develop technologies that retain or enhance bioactivity of the 
desired component (Korhonen et al. 1998). Technologies that target protein 
functionality are already emerging. These include ultra pressure processing (DeSilva 
et al. 2003), membrane adsorbers (Splitt et al. 1996; Zydney 1998; Gosh 2002), 
crossflow filtration (Ulber et al. 2001), pulsed electric field processing (Bendicho et 
al. 2002), super-paramagnetic anion-exchangers in high-gradient magnetic fishing 
(Heebøll-Nielsen et al. 2004), colloidal gas aphrons generated for selective 
adsorption using surfactants (Fuda et al. 2004), and supercritical fluid or high 
pressure carbon dioxide extractions (Tomasula et al. 1997). 
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2.4 Chromatography 
Chromatography can be operated in batch or continuous modes in packed columns, 
expanded (or fluidised) beds and stirred (suspended) tanks. The versatility of 
chromatography is due to the affinity of components for a sorbent phase based on 
size, charge, or hydrophobicity. This can often be modulated by adding solvents 
(reverse phase chromatography) or salts (ion exchange or hydrophobic interaction 
chromatography). Specialist sorbents (resins) are available for particular 
biomolecules (Hedhammer and Hober 2005). 
2.4.1 Affinity chromatography 
Affinity chromatography uses protein-protein interactions for selective extraction 
(Przybycien 1998). Specialist affinity media that target and capture a particular 
species in milk whilst leaving the rest of the milk for further processing can be 
formulated. However, toxic materials leaching from the media into the milk could be 
an issue and requires further work. 
2.4.2 Ion exchange chromatography 
Ion exchange chromatography is the most common type of adsorption 
chromatography. Ion exchange involves selectivity for cationic or anionic interaction 
with the target species. Anion exchange with diethlyaminoethyl (DEAE) moieties 
covalently attached to the adsorption matrix is more commonly used at pH 6-8 whilst 
cationic exchange is more commonly used at pH 4.5-6.0. Several factors can 
influence adsorption but two most important are pH and salt (ionic concentration). 
Once the target protein is adsorbed to the matrix, varying the salt concentration 
elutes both the target protein and background proteins. Typical protein binding is 
about 20-40 mg total protein per ml of matrix. 
2.4.3 Column-based chromatography 
Packed bed column chromatography offers high surface areas, giving high capacities 
and hence yields or recoveries if operated at optimum linear velocities (Chisti and 
Moo-Young 1990). This process is used extensively for biopharmaceuticals and on a 
very large industrial scale for whey fractionation and cation exchange capture of LF 
and LP from whey and skim milk feeds.  
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The media (resin) is packed into a column and solution passes though the bed. 
Columns are usually wide and short to minimize pressure drop and maximize flow 
rate. Industrial columns usually have beds 20 cm high and diameters up to 2.0 m, 
(total volume of 628 L) and operate at flow rates of 21 L/s. Media such as SP BB 
resin can minimize column clogging. On-line monitoring can be done using 
conductivity, flow rate, temperature, pH and UV (usually at 280 nm) detectors.  
2.4.4 Batch (stirred tank) chromatography 
Although batch procedures are less efficient than column techniques, they offer 
advantages, especially where very large sample volumes with a low protein 
concentration have to be processed. General practice is to allow an hour for 
adsorption and at least 30 minutes for desorption. Batch chromatography is very 
useful when concentrating dilute solutions or separating the target protein from gross 
contaminants during initial stages of a purification scheme. 
Batch stirred-tank chromatography can be used to extract protein from complex 
mixtures and may be useful for on-farm separations because of the variable and, at 
times, high (up to 10% w/v) fat content in an individual cow’s milk 
Batch stirred-tank separation can be a rapid technique with minimal technical 
difficulties due to resin swelling or shrinking. Stirrer speed is important as fines are 
generated if the resin is stirred too vigorously. Fines can increase filtration time. 
Stirring speeds of 150 rpm (Rowe et al. 1999) and 200 rpm (Morison and Joyce 
2005) have been used without damaging the resin. 
2.4.5 Fluidised or expanded bed chromatography 
In fluidised or expanded bed (EBA) adsorption, resin is suspended (fluidised) and the 
desired species are adsorbed from the feed stream flowing by. Column washing and 
elutions are done while the resin is suspended. A fluidised bed reduces problems 
associated with column clogging but adsorption and desorption times are longer than 
in column chromatography. 
2.5 Selective precipitation 
Selective precipitation involves adjusting physical properties of solution by adding 
organic solvents, enzymes or salts, pH changes and/or heating to promote selective 
insolubility. For example selective precipitaton is used to obtain caseins from milk 
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for making cheese (Pearce 1983; Uchida et al. 1996; Gesan-Guiziou et al. 1999). 
Crystallization can be used to recover milk components. For example, Harju and 
Heikkil (1989) recovered lactose by concentrating cheese whey to crystallize the 
lactose. 
2.6 Membrane processing technologies 
The dairy industry uses membrane processes such as cross-flow microfiltration 
(CFM), ultrafiltration (UF), microfiltration (MF), reverse osmosis (RO), dynamic 
membrane filtration (DMF), electro ultrafiltration (EU), and nano-filtration (NF) 
extensively for standardization of many products and protein concentration (Brans et 
al. 2004). Each process operates over a different particle size range (Figure 2-2). 
Ultrafiltration with polymeric or ceramic membranes completely retains whey 
proteins and produces retentate with lactose and minerals that can be further 
processed by evaporation and spray drying (Zydney 1998). Diafiltration can be used 
to further reduce lactose and minerals content in whey. There are many reviews on 
membrane filtration in the dairy industry (Marshall et al. 1993; Rosenberg 1995; 
Zydney 1998; Demmer and Nussbaumer 1999; Ghosh 2002). 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2-2. Membrane processes for separating milk components (Brans et al. 2004). 
 
2.7 Overview of dairy protein fractionation 
There are two main classes of dairy proteins. Traditionally, caseins have been 
extracted as cheese or dried as casein powder, leaving whey as a by-product. Whilst 
10 µm 
 
1 µm 
 
100 nm 
 
10 nm 
1 nm 
Microfiltration 
 
 
 
Ultrafiltration 
 
Nanofiltration 
 
Reverse osmosis 
Somatic cells 
Fat globules 
Bacteria and spores 
Casein micelles 
Casein sub micelles 
Serum proteins Lactose 
  
2-11 
butterfat and anhydrous butter fat have been traded as bulk products alongside milk 
powder, whey has been a waste product, often creating disposal issues. Membrane 
and gel filtration techniques developed in the 1970s allowed large-scale 
concentration of whey and manufacture of whey protein concentrates and isolates 
(Jelen 1983; Maubois et al. 1987; Jelen 1991; Hobman 1992). Large quantities of 
whey are produced. For example, Durham et al. (2003) reported that the Australian 
cheese industry produced 3.4 million tonnes of whey protein in 2001, which 
contained 160 000 tonnes of whey proteins but only 50 000 tonnes of whey was 
recovered. The low recovery, together with the associated effluent problems for 
disposing of the whey poses environmental risks. Other cheese producing countries 
have had similar issues. For example Germany produced 10 million tonnes of whey 
in 1996 as a by-product of cheese making (Ulber et al. 2001). 
Issues with waste disposal led to innovations to recover and use the components in 
whey, firstly as whey protein concentrates and later as individual proteins and lactose 
fractions. 
2.8 Properties of whey proteins and their extractions 
The protein product, whey protein isolate (WPI), produced by single-stage batch 
anion exchange of waste from cheese production, is a crude mixture of acidic whey 
proteins and contains mainly α-La, β-Lg, BSA and immunoglobulins (mainly 
immunoglobulin G or IgG). Two whey proteins not captured by anion exchange 
chromatography because of their high isoelectric points are LF and LP. These basic 
proteins are extracted from whey or skim milk by cation exchange chromatography 
and sold as specialty ingredients.  
The low total solids in whey (63 g/L) are mainly lactose (50 g/L) and proteins (6 g/L) 
(Doultani et al. 2004) of various molecular weights and isoelectric points (Table 2-
2). 
The LF and LP may be extracted from skim (non fat) milk or, more commonly, from 
whey produced as permeate during membrane concentration of milk or after 
precipitating out the caseins in cheese production (Zydney 1998; Tomita et al. 2002). 
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The literature reports many efficient protocols to fractionate milk (Mirabel 1978; 
Henricus 1983; Smithers et al. 1996) and for isolating natural milk components such 
as LF and LP (Kawakami et al. 1988; Burling 1989; Yoshida and Xiuyun 1991b; 
Kussendrager et al. 1994). Fat and caseins are normally removed before extracting 
recombinant proteins from the milk of transgenic animals (van Berkel et al. 2002). 
Many authors have examined capture and analysis of whey proteins by 
chromatography (Lonnerdal and Carlsson 1977; Humphrey and Newsome 1984; 
Andrews et al. 1985; Chaplin 1986; Al-Mashikhi and Nakai 1987; Al-Mashikhi et al. 
1988; Yoshida and Xiuyun 1988; Donnelly 1991; Visser et al. 1991; de Frutos et al. 
1992; Morr and Ha 1993; Konecny et al. 1994; Francis et al. 1995; Torre and Cohen 
1996; Felipe and Law 1997; Geberding and Byers 1998; Hahn et al. 1998; Noppe et 
al. 1999; Elgar et al. 2000; Xu et al. 2000; Ye et al. 2000c; Doultani et al. 2004). 
The milk and whey is usually extensively pre-treated before ion exchange capture of 
proteins in the laboratory. The following describes some recent examples of typical 
pre-treatments in laboratory studies. 
• Hahn et al. (1998) examined the performance of several commercially available 
pharmaceutical grade cation exchangers (S-HyperD-F, Fractogel EMD 650(S), 
SP FF, Macro Prep High S) to extract protein from acid whey. Milk was first 
centrifuged at 4420×g for 30 min to remove fat, then acidified to precipitate 
casein and centrifuged at 17,700×g for 30 min, diluted with distilled water and 
then filtered through a 0.45-µm filter before being applied to the column. 
• Bounous (1990) produced biologically active whey proteins by cooling milk to 
4oC immediately after milking then precipitating the caseins by reducing pH to 
4.6 with lactic acid. Rennet was added and the temperature raised to 30.5oC with 
low speed agitation. Whey was ultrafiltered with 10 000 and 17 000 molecular 
weight cut-off membranes, retaining α-La and whey protein concentrate. 
• Doultani et al. (2004) used cation exchange chromatography to produce several 
protein products from mozzarella cheese whey. The pH was adjusted with H2SO4 
and then whey was filtered through Whatman No.5 filter paper before being 
applied to a column packed with SP BB. 
• Ye et al. (2000b) used both anion and cation exchange chromatography to isolate 
α-La, β-Lg, LF and LP from rennet whey produced from skim milk that had first 
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been defatted by centrifugation. After 1-hr incubation with rennet, the caseins 
were separated by filtration and the whey was then centrifuged at 10,000×g for 
25 min before being applied to the column. 
• Lyndsay et al. (2004) purified recombinant DNA-derived factor IX from milk of 
transgenic pigs. They removed fat by centrifugation and used EDTA to dissolve 
the casein micelles. The resultant fluid was diluted 5-fold in heparin loading 
buffer before being loaded onto a heparin-Sepharose Fast Flow column. 
There is, therefore, a wide difference between the normal practices of dairy 
production processes and the usual requirement of protein purification processes to 
minimise the number of steps and to process quickly. The resulting loss in yield can 
be significant. Korhonen et al. (1998, 1991) lists deleterious effects of various 
process operations such as heat treatment, pH modification and storage on proteins 
and amino acids. 
2.9 Properties and applications of LF and LP 
2.9.1 LF  
LF is a single-chain glycoprotein. The non-glycosylated form has a molecular weight 
of 80 kDa and pI 8 to 9 (Naidu 2002). It is a versatile, bioactive milk protein that 
plays an important role in immune response and helps protect the body against 
infections. Scientific studies show that LF also prevents growth of pathogens, has 
antibacterial and antiviral properties, controls cell and tissue damage caused by 
oxidation, and facilitates iron transport (Brock 2002). 
Human milk has the highest LF concentrations (1.4 to 2.0 mg/mL) of the mammalian 
milks (Playne et al. 2003) compared with the average LF concentration in bovine 
milk of 0.1 mg/mL (Reiter 1985; Barth and Schlimme 1988; Renner 1989; 
Kawakami et al. 1990; IDF Bulletins 1991; Yamauchi 1991; Satue´-Gracia et al. 
2000). There are large variations in LF concentrations (0.06 to 1.0 mg/mL) of milk 
from individual cows (Indyk and Filonzi (2005), which are similar to those observed 
in this study (0.08-1.13 mg/mL, section 7.3). Whey or skim milk (Table 2-4) is the 
normal source for LF used in product formulations. Highly purified bovine LF is 
used in nutritional formulations (especially infant formula), adult health products, 
medical nutritionals, cosmetics, health foods, beverages and animal feeds, shelf-life 
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extension of natural products such as meat (Taylor et al. 2004); its potential 
applications are extensive. 
If LF could be captured from the milk of high LF-producing cows immediately after 
the cow is milked, both LF yields and bioactivity could be maximised. This also 
creates the opportunity to selectively extract LF from high-LF producing animals. 
Table 2-4: The LF in various bovine milk fractions measured by reverse phase-high 
pressure liquid chromatography (Palmano and Elgar 2002). 
 Type of feed Concentration (mg/mL) 
Cheese (dried whey protein concentrate)  0.30 (% powder mass) 
Acid (liquid whey protein concentrate) 0.99 
Lactic (whey protein concentrate) 0.78 
Basic fraction 0.40 
Skim milk whey 0.15 
2.9.2 LP 
LP is present in most mammalian milks (FSANZ 2002; Naidu 2002) and has a 
molecular weight of 78 kDa and pI of 9.6 (Sievers 1981; Watanbe et al. 2000). It is 
one of the most abundant and active enzymes in bovine milk and catalyses the 
inactivation of a wide range of micro-organisms (Claeys et al. 2002). Hence, it acts 
as a natural preservative in milk. The LP-systems, which are harmless to mammalian 
cells, have been identified in the natural anti-microbial systems of human secretions 
such as saliva, tear-fluid and milk (Ekstrand and Bjorck 1986; Ekstrand 1989; Elgar 
et al. 2000; Palmano and Elgar 2002). 
Concentrations of LP in raw whole milk are influenced by factors such as breed, 
stage of lactation, time of year, health status of animals etc. Values of 38 mg/L (Seifu 
et al. 2005) and 30 mg/L (Seifu et al. 2005) have been reported. LP is used in 
healthcare, animal feeds and food applications. A commercial application of LP is as 
coatings, especially in meat. LP is used  to increase shelf life of milk by activation of 
LP-system in milk where refrigeration is unavailable (Seifu et al. 2005). 
2.10 Unit operations used in dairy processing 
Liquid milk products contain proteins, fats and sugars. Many processes are used to 
make commercial products such as milk powders, cheese, fats, and protein products. 
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Fat products include anhydrous milk fat (AMF or ghee) or butter. Powder products 
include whole milk powder, skim (no fat) milk powder and protein powders (whey 
protein isolates, caseinates) and individual protein powders. These products are used 
in many dairy products and other food formulations. Numerous unit operations are 
involved in processing them to a stable form. 
Milk processing starts on farm with milk harvesting (using semi-automated processes 
involving pulsators that generate vacuum to aid milking). The harvested milk is 
immediately cooled and stored at 4-8oC under gentle stirring before collection (1-2 
day interval) by tankers (ambient temperatures) and transported to a centralized 
facility (factory) for processing. At the factory, milk is pumped into large silos and 
stored at 4-8oC. Processing begins with centrifugation (removal of fat as cream) 
followed by pasteurization (variable heat treatment e.g. 72oC for 15 seconds). 
Subsequent processing depends on the end use of the product, but can involve many 
filtration steps such as reverse osmosis and UF for concentration. Most liquid milk in 
New Zealand is either processed into various milk powders or used for cheese-
making. The main unit operations involved (including fractionation of proteins) are 
evaporation and drying, centrifugation, crystallization, chromatography, ion 
exchange, electrodialysis, membrane processes and absorption (e.g. activated carbon 
or colour removal). 
Many unit operations occur before LF and LP are captured using ion exchange 
chromatography (Figure 1-1). This scheme does not show all the chemical balancing 
operations, desalting, pumping cycles, mixing, screening, washing, etc. 
2.11 LF and LP purification techniques 
Johanson (1960) was one of the first to isolate LF from human milk using a calcium 
phosphate matrix. The process was based on a physico-chemical interaction between 
protein and the solid matrix. Other solid supports such as cellulose phosphate, silica, 
diatomaceous earths, or bentonite have also been used for LF adsorption (Spring and 
Peyrouset 1982; Foley and Bates 1987). 
Fractionating LF and LP from cheese whey, skim milk and colostral whey has been 
demonstrated on a laboratory scale (Spring and Peyrouset 1982; Foley and Bates 
1987; Burling 1989; Uchida et al. 1996) and on an industrial scale from whey, whey 
  
2-16 
protein concentrate, or skim milk using cation exchange resin. Ion exchange 
membranes have also been used to fractionate LF and LP (Chiu and Etzel 1997; 
Zydney 1998; Ghosh and Cui 2000; Ghosh 2002). 
High purity LF, LP and secretory compounds have been separated from milk and 
whey using cross-linked polysaccharide, cellulose or acrylamide cation exchange 
resins with carboxyl, sulphonic acid or phosphoric acid functional groups (Uchida et 
al. 2003). The LP was eluted in buffer (0.2-0.5 ionic strength), secretory component 
(0.1-0.5 ionic strength) and LF (≥ 0.5 ionic strength). Uchida and coworkers used 
SP-Toyopearl, SP FF, sulfonated Chitopearl, and CM-Cellulofine with cheese whey 
that was desalted using UF before ion exchange from skim milk. Contacting was 
done in a stirred tank and the resin was retrieved and packed in column for washing 
and eluting the LF, LP and secretary components with NaCl. Because whey protein 
concentrates and individual whey proteins have commercial value, processing 
technologies have been patented for purifying LF and LP (Uchida et al. 1996) and 
whey proteins (Jensen and Larsen 1995).  
Pre-treating milk prior to chromatographic capture of proteins is virtually universal 
(Lonnerdal and Carlsson 1977; Humphrey and Newsome 1984; Andrews et al. 1985; 
Chaplin 1986; Al-Mashikhi and Nakai 1987; Al-Mashikhi et al. 1988; Yoshida and 
Xiuyun 1988; Donnelly 1991; Visser et al. 1991; Yoshida and Xiuyun 1991a; de 
Frutos et al. 1992; Morr and Ha 1993; Konecny et al. 1994; Francis et al. 1995; 
Torre and Cohen 1996; Felipe and Law 1997; Etzel et al. 1998; Geberding and Byers 
1998; Hahn et al. 1998; Noppe et al. 1999; Elgar et al. 2000; Xu et al. 2000; Ye et 
al. 2000a; Ye et al. 2000c; Ye and Ng 2000; Doultani et al. 2004). A review of 
downstream processing of recombinant proteins from transgenic feedstock identifies 
removal of fat globules and casein micelles from milk by centrifugation, acid 
precipitation, and/or membrane filtration as critical for reducing fouling in 
subsequent purification steps (Nikolov and Woodard 2004). 
Pre-treatment by centrifugation, precipitation, Ca2+ chelation and/or filtration 
methods are done to remove fat and caseins before LF and LP are extracted. 
Chromatography especially ion exchange but to a lesser extent affinity, chelation, gel 
filtration and hydrophobic interaction based chromatography is used exclusively for 
extracting LF and LP from whey or defatted milk (Table 2-5). Batch foaming and 
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reverse micellar techniques are emerging for extracting LF and LP (Saleh and 
Hossain 2001; Fuda et al. 2004; Noh et al. 2005). 
Table 2-5: LF and LP extractions. 
Separation/purification technique Target protein/compound Reference 
IEX chromatography (CM-Sepahdex-C50) LF from human milk (Johanson (1960)  
IEX chromatography (DEAE cellulose) LF from milk (Goves (1965) 
Metal-chelate affinity chromatography LF from human milk (Lonnerdal & Carlsson 1977) 
Single chromatographic step affinity LF from human whey  (Blackberg & Hernell (1979) 
chromatography (Heparin Sepharose) 
Affinity chromatography LF from human whey  (Bezwooda & Mansoor (1986) 
IEX (Fast protein liquid chromatography)  LP, LF and lysozyme (Ekstrand and Bjorck 1986) 
Gel filtration chromatography Immunoglobulins, (Al-Mashikhi and Nakai 1987)  
 LF from whey 
Batch extraction (cellulose phosphate)  LF from human whey 
(80% yield, 96% purity)  (Foley and Bates 1987) 
Immobilised monoclononal antibodies   
(specialised affinity chromatography) LF (Kawakami et al. 1987) 
Gel filtration chromatography LF from whey (Al-Mashikhi and Nakai 1987) 
Extraction using sulphate compound LF from defatted milk (Kawakami et al. 1988) 
Chelating chromatography Immunoglobulins,  (Al-Mashikhi et al. 1988) 
 LF from whey 
IEX chromatography  LF  (Okonogi et al. 1988) 
IEX chromatography  LP, globulin (Yoshida 1988) 
IEX chromatography LP, LF from whey (Burling 1989) 
Hydrophobic interaction chromatography LF (Yoshida 1989) 
Affinity chromatography  Human LF (Ena et al. 1990) 
(insolubilized bovine β-Lg)   
Microfiltration and affinity chromatography LF, IgG from cheese whey (Chen and Wang 1991) 
Batch ion exchange (80% LP and LP, LF from whey (Dionysius et al. 1991) 
90% LP yields -60 min adsorptions) 
IEX chromatography LF from whey (Yoshida and Xiuyun 1991a) 
(carboxymethyl cation) LP 
IEX chromatography (sulphopropyl cation) LP, LF from whey (Yoshida and Xiuyun 1991b) 
Process (patent) LF, LP from milk  (Kussendrager et al. 1994) 
 and milk products  
IEX chromatography LF, LP, secretory component (Uchida et al. 1996) 
(cation exchange resin)  
IEX chromatography LF, LP from whey (Chiu and Etzel 1997) 
(cation exchange membrane)    
IEX- column and LF from skim milk (Etzel et al. 1998) 
expanded bed chromatography 
IEX chromatography (cation) LF, LP, IgG, BSA  (Hahn et al. 1998) 
evaluation of resins   
LF isolation from milk  LF from milk (Nuyens and Van Veen 1999) 
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Table 2 continued 
IEX chromatography LP, LF, α-La, β-Lg A and B  (Ye et al. 2000b) 
(DEAE and sulphopropyl) from whey  
IEX chromatography LF A and B from colostrum  (Yoshida et al. 2000) 
Foam fractionation BSA, α-La and LF (Saleh and Hossain 2001) 
(semi-batch foaming process)   
Expanded-bed column chromatography LF from skim milk (Shiozawa et al. 2001) 
(Streamline SP as adsorbent, 90% yield)   
CFF, cation exchange membranes (IEX) LF from whey (Ulber et al. 2001) 
Transferrins, semi-large scale with HIC LF from skim milk (Tomita et al. 2002) 
IEX chromatography (S Sepharose),  Recombinant human LF in (van Berkel et al. 2002 
and Marco Prep skim milk (transgenic cows)  (van Berkel et al. 2002) 
IEX chromatography (SP-Sepharose cation) LF from colostrum (Zhang et al. 2002) 
IEX chromatography (sulphate-linked IEX) LF, LP, secretory component (Uchida et al. 2003) 
IEX chromatography LF, LP from raw whole milk  (Chand and Fee 2004) 
IEX chromatography Whey proteins: WPI, α-lac,  (Doultani et al. 2004) 
(SP BB) β-Lg, IgG GMP, LF and LP  
Colloidal gas aphrons (CGAs)  LF, LP from whey (Fuda et al. 2004) 
generated from anionic surfactant, AOT   
Superparamagnetic anion- and cation  LF, LP, immuno- (Heebøll-Nielsen et al. 2004) 
exchangers (high-gradient magnetic fishing) globulins from whey  
IEX - Batch chromatography  LP from acid whey (Samsam and Naieri 2004) 
(cation-exchange phosphocellulose)    
IEX - chromatography (cation) LF, LP from raw whole milk (Fee and Chand 2005) 
Reverse micelles formed LF (Noh et al. 2005) 
by cationic surfactants  
Affinity chromatography LF from skim milk (Noppe et al. 2006) 
Immobilised peptide as affinity ligands 
IEX – ion exchange chromatography; HIC – hydrophobic interaction chromatography, GMP glycomacropeptide 
2.11.1 Chelation chromatography 
Chelate-interaction-chromatography has been used to isolate immunoglobulins, LF 
and LP on non-sterilised skim milk (Vervaeck et al. 1992; Nikolov and Woodard 
2004). Al-Mashiki and Li-Chan (1988) used a similar chelating technique using 
transition metals to isolate immunoglobulins and LF. Lonnerdal and Carlsson (1977) 
used metal chelate affinity chromatography to extract LF from human whey. 
2.11.2 Affinity chromatography 
Affinity chromatography has been described (Blackberg and Hernell 1979; 
Kawakami et al. 1988; Rejman et al. 1989; Chen and Wang 1991; Blomkalns and 
Gomez 1997). Some researchers used heparin immobilized on agarose and Sepharose 
to purify LF and immunoglobulins from whey. The heparin interaction is believed to 
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be by ion exchange of sulphate groups present in the glucosaminoglycan. Kawakami 
et al. (1988) used monoclonal LF antibodies to extract LF from human and bovine 
milks. 
Single step affinity chromatography with heparin Sepharose was used to extract LF 
from cultured yeast (Paramasivam et al. 2002). Affinity chromatography combined 
with large scale ion-exchange (heparin chitosan bed, Sulphonated Chitopearl 3L) 
chromatography was used to isolate LF, LP and secretory compound from whey 
(Uchida et al. 2003). The LF and LP were eluted using citric buffer (pH 4.0) with 0.5 
M NaCl, tightly bound-LF was eluted with 10 mM hydrogen carbonate (pH 7.6) with 
0.7-1.0 M NaCl, and secretory compound was eluted at pH 6.0. 
Grasselli and Cascone (1996) investigated the effects of pH (5, 7 and 9) and eight 
triazinic dyes using affinity chromatography to purify LF from rennet whey. 
Optimum conditions using Red HE-3B at pH 7.0 in a batch extraction gave a yield of 
82% and a purity of 98%. Noppe et al. (2006) used selected phage clones expressing 
a peptide with high binding affinity coupled to macroporous 
poly(dimethylacrylamide) monolithic column to extract LF from skim milk. Bound 
LF of >95% purity was eluted using 1 M NaCl. 
2.11.3 Hydrophobic interaction chromatography 
Yoshida (1988) isolated globulin and LP from neutralized bovine milk acid whey 
using UF and hydrophobic interaction chromatography with Toyopearl 650M to 
extract LF. The LF was eluted with 0.25 M acetic acid. Tomita et al. (2002) used 
semi large-scale hydrophobic interaction chromatography to extract LF from cheese 
whey or skim milk. 
2.11.4 Ion exchange chromatography 
Extracting LF and LP using carboxymethyl ion exchange chromatography, as 
described by Johanson (1960), albeit other media, is still one of the most effective 
methods. Okonogoi et al. (1988) used a cation exchanger with carboxymethyl 
groups, which had with haemoglobin adsorption properties to extract LF from skim 
milk or whey. After desorption using salts, yields were >80%. 
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Ulber et al. (2001) used continuous crossflow filtration steps to remove particulate 
matter from whey before using an ion exchange membrane adsorber with a dynamic 
binding capacity of 0.2 mg/cm2 to extract the LF. The process extracted 8 g of LF 
(feed 0.1 g/L) from two cycles in an hour (2 L/min), with 66% yields. 
Dionysius et al. (1991) used CM Sephadex in a stirred tank to investigate the binding 
characteristics of LF and LP from cheese, acid and rennet whey. The LF recovery 
was not affected by whey type. The maximum binding capacity occurred with cheese 
whey at pH 7.0. More than 90% of the original amount of LF in the whey was 
recovered for a 60-minute contact time. 
Heebøll-Nielson et al. (2004) used superparamagnetic anion- and cation-exchangers 
to fractionate bovine whey proteins as a model study for high-gradient magnetic 
fishing. The immunoglobulins were separated from other proteins by desorption with 
low concentration NaCl (0.4 M). The LF and LP were co-eluted to give 28-fold 
purification of LP over the starting material. 
Chiu and Etzel (1997) used 3-5 µm cross-linked regenerated cellulose membranes 
with immobilized sulfonic moieties to extract LF and LP from whey. The reactor had 
790 cm2 of membrane in a 16-mL bed volume. After 12 cycles, the LF and LP were 
eluted with 0.9 and 0.3 M NaCl to give 50 and 72% recovery respectively. 
Hahn et al. (1998) reported that SP FF, S-Hyper D-F and Fractogel EMD SO 650 (S) 
resins were suitable for large-scale purification of bovine whey proteins. The lower 
binding capacities (ca. 3.2-3.3 mg IgG per mL of gel) of the resins used were thought 
to be due to the low pH of the whey. 
Gerberding and Byers (1998) describe a preparative ion exchange process for 
separating and recovering α-La, β-Lg, BSA, IgG and lactose from whey feed of pH 
between 5.5 and 5.8, using Q- and SP BB resins. The α-La and BSA were extracted 
with both anion and cation exchange resins and β-Lg with the anion exchange resin. 
The BSA, IgG and lactose were extracted mainly with cation exchange resin with 
varying degrees of recoveries (Table 2-6).  
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Table 2-6: Compositions of serum streams using anion and cation exchange columns 
for one CV (Gerberding and Byers, 1994). 
 α-La β-Lg BSA IgG Lactose 
Anion exchange 
Feed (% w/w) 1.68 7.31 0.40 0.82 9.72 
Breakthrough (%) 63.6 6.1 78.8 94.2 100 
Peak 1 fraction (%) 36.43 0.49 2.20 5.80 0 
Peak 2 fraction (%) - 93.4 19.0 - - 
 
Cation exchange 
Feed (%w/w) 1.12 0.46 0.42 0.82 57.99 
Breakthrough (%) 61.8 97.3 42.3 83.1 14.3 
Peak 1 fraction (%) 38.2 2.7 57.7 16.9 85.7 
Foley and Bates (1987) extracted LF from human whey using cellulose phosphate in 
a batch stirred tank system with a rapid, two-step procedure and obtained average 
yields of 80% and 96% purity. 
Etzel (2004) used a prototype column chromatography to fractionate acid whey that 
had first been microfiltered (1.4 µm). The reported flow rates were low, giving long 
loading times (Burling 1989; Chiu and Etzel 1997; Etzel et al. 1998; Etzel 2004). 
2.11.5 Gel filtration chromatography 
Gel filtration has not been extensively used to separate LF and LP from milk and 
whey although Al-Mashiki and Nakai, (1987) used this method to separate LF and 
immunoglobulins from whey. 
2.11.6 Other non chromatographic methods 
Saleh and Hossain (2001) describe a semi-batch foaming process using a 530-mm 
long glass column fitted with a stainless steel sparger to generate bubbles. A yield of 
87% was obtained from a mix of BSA, α-Lg and LF. Noh et al. (2005) selectively 
extracted LF from other whey proteins using reverse micelles formed by cationic 
surfactant, cetyldimethyl ammonium bromide in 50 mM berate buffer (pH 9).  
Bargeman et al. (2002) isolated bioactive peptides from a s2-casein hydrolysate 
using electro-membrane filtration (EMF). They believed EMF to be more selective 
than membrane filtration, less costly than chromatography and an alternative for 
isolating bioactive proteins and peptides, especially those that carry strong charged 
components. 
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2.12 Other milk protein purifications 
Milk proteins, other than LF and LP that could be of interest and possible targets for 
on-farm extractions exist. Although most of the literature discusses purification from 
skim milk and whey, direct purification from raw whole milk was demonstrated 
during this study (Chand and Fee 2004; Fee and Chand 2005). 
There is interest in industrial-scale fractionation of casein for special applications. 
For example, β-casein has very high surface activity and could be used as a high-
quality emulsifier or foaming agent. Human milk contains β- and κ-caseins but no 
αs-caseins, so β-casein from bovine milk could be an attractive ingredient for bovine 
milk-based infant formulae. Ion exchange resins are effective for preparing high-
quality casein and whey protein products with high purities (Mulvihill 1992). 
Igarashi (1995) used differences in solubilities to fractionate milk proteins. Skim 
milk was first treated with 50% (v/v) ethanol containing 0.4 M NaSCN and 0.15 M 
CaCl2. Both the precipitate and the supernatant containing the γ-caseins and α-La 
were further fractionated using an urea-Ca phosphate system to yield κ-casein and β-
Lg and an insoluble fraction of calcium-sensitive proteins (αs1-casein, αs2-casein and 
β-caseins). Tomasula et al. (1997) used high pressure CO2 to isolate good quality 
casein from milk in two different reactors: a spray reactor where milk was sprayed 
into CO2 and a tubular reactor to feed CO2 into the milk. 
Neystani et al. (2003) isolated -La, -Lg, and BSA from bovine whey by firstly 
removing casein from defatted milk using HCl. The globulins were then precipitated 
from the whey by half-saturated ammonium sulphate and -Lg was purified further 
using Sephadex G-50 gel filtration. Dubois (1990) used UF with 40-kDa cut off 
membranes to produce retentates enriched in whey proteins.  
Ye and Ng, (2000) isolated glycolactin from bovine acid whey, which had been 
obtained by precipitating out the casein (1.8 M (NH4)2SO4), followed by 
centrifugation (10,000xg for 20 minutes at 4oC). After dialysis, the whey was loaded 
onto CM-Sepharose cation exchange column at pH 7.7. A linear gradient elution (0-
0.5 M NaCl) in phosphate buffer was used. Fractions were collected, lyophilized and 
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reconstituted in 50 mM phosphate buffer and then applied to Mono S HR 5/5 column 
and eluted under a linear gradient (0-0.5 M NaCl, 20 minute at 1 mL/min). 
Caseins are usually isolated by isoelectric precipitation using lactic acid-producing 
bacteria or acidifying to pH 4.6 using mineral acids such as HCl or H2SO4. For 
example, Pearce (1999) adjusted whey to pH 4.2 and then heated it to denature, 
aggregate and precipitate α-La. Bounous (1994) produced un-denatured whey 
protein concentrate with at least 10% serum albumin content using MF to remove 
bacteria and UF to separate the casein proteins. Cheang and Zydney (2004) separated 
-La and -Lg from whey protein isolate using a two-stage membrane system (30 
and 100 kDa) with recoveries of 70-95% for different setups. Vivekanand et al. 
(2004) showed that casein and whey proteins can be fractionated from skim milk 
using 0.1-µm MF membranes. This provided a non-thermal processing alternative to 
the more traditional coagulation operations for casein separation. 
Pedersen et al. (2003) used whey proteins as a model system for chromatographic 
separations of proteins. They evaluated the anion exchangers Q-Sepharose XL, 
Source 30Q, Ceramic Q Hyper-D F, and Fractogel EMD 650 (S). After adsorption 
onto the anion exchangers, α-La, β-Lgs A and B, and BSA were eluted at pH 6 to 9 
with various NaCl concentrations. 
Avramescu et al. (2003) used different types of Lewatit ion exchange resins 
incorporated into a random copolymer of ethylene and vinyl alcohol as porous, 
mixed-matrix membranes to separate BSA and bovine haemoglobulin. Affinity 
cross-flow filtration, a technique that combines affinity adsorption and MF was used 
to isolate BSA from a mixture of IgG and serum albumin using Cibracron Blue with 
sodium octanoate as a desorber (Borneman et al. 2002). Gambero et al. (1997) used 
affinity chromatography in a packed column silica modified with β-diketoamine 
groups chelated with copper ions to separate α-La from whey. The single-step 
purification gave 66% α-La. Punidadas and Rizvi (1998) separated partially defatted 
skim milk into casein and whey-rich fractions using 0.05-µm ceramic membranes 
that retained the caseins and allowed α-La and β-Lg to pass through. Dimmer and 
Nussbaumer (1999) demonstrated that membranes could be added in parallel to 
increase flux and scaled the 21-m2 pilot plant to 100-m2 membrane surface for 
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separating haemoglobulin. Affinity-based MF membranes have been used to extract 
BSA (Avramesu et al. 2003) and have potential for other protein extractions by 
modifying the affinity ligands but the major limiting factor in most stages of milk 
fractionation is fouling (Brans et al. 2004). 
Other components present in milk and colostrum such as such as hormones, growth 
factors (prolactin PRL, IGF-1), prosaposin (Craddock 2001), glycomacropeptide (Xu 
et al. 2000), casein glycomacropeptide (Nakano et al. 2002) and analogs such as 
glycolactin (Ye and Ng 2000), CD36 surface membrane protein (Wilcox et al. 2002), 
lysozyme (Owen and Chase 1997), milk-clotting enzyme (Iannucci et al. 2003), and 
whey growth factor extract (Colby et al. 1996) have also been extracted successfully 
in laboratory experiments (Pakkamen and Aalto 1997). 
2.13 Large scale applications 
Many reviews discuss processing technologies useful for the dairy and 
biopharmaceutical industry such as membrane adsorbers (Rosenberg 1995; 
Meindersma and Kuczynski 1996; Splitt et al. 1996; Zydney 1998; Demmer and 
Nussbaumer 1999; Kawai et al. 2003; Brans et al. 2004), and analytical and 
preparative chromatographic, and electrophoretic methods (Chisti and Moo-Young 
1990; Wheelwright 1991; Strange et al. 1992; Levison 2003). 
Treloar et al. (2000) used a whey feed stream and an already-published laboratory 
method to scale-up production of FBP (folate binding proteins). They report that 
although the laboratory-scale procedure was well documented, they had to optimize 
the process to scale to pilot plant operation. Liquid whey had various particulates that 
sometimes caused column blockages. They extracted 0.7 g of FBP per batch with an 
average yield of 40% and >90% purity. 
Durham et al. (2003; 2004) patented a fractionation process based on ion exchange 
and NF to concentrate whey and recover mono ions which were then used to 
regenerate the ion exchange column. They reported 90% yield of high purity lactose. 
Konecny et al. (1994) purified IgG from whey using thiophilic T-gel 
chromatography and found the process suitable for large scale isolation of IgG. 
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Colby et al. (1996) used LF and LP as model proteins to investigate the effects of 
compression on scaling SP BB resin in a commercially packed column and reported 
that compression was not an important factor in scale-up. 
Cheng and Zydney (2003) reported on several methods that have been studied for 
whey protein fractionation including ion exchange chromatography (Uchida et al. 
1996; Hahn et al. 1998) affinity binding (Bezwooda and Mansoor 1986; Kawakami 
et al. 1987; Chen and Wang 1991), and selective precipitation using salts, pH, and/or 
heating (Pearce 1983; Gesan-Guiziou et al. 1999). None of these processes or 
techniques has been effectively implemented on a large commercial scale due to 
inadequate yield/purification and/or poor overall economics. 
Anon. (2003) reports of a prototype whey refinery process at Wisconsin University 
that uses milk as a starting material and uses MF to retain and concentrate the casein 
fraction. Membranes were used to separate α-La and ion exchange chromatography 
to separate α-, β- and κ-caseins. 
Ion exchange chromatography has been developed and used successfully to separate 
whey proteins on a commercial scale. In a study of commercial extraction of LF from 
(defatted) milk, Buchanan (1994) evaluated several cation exchangers (not 
identified) and SP FF resin using column chromatography. Capacities ranged from 
1.6 to 9.3 mg LF per mL of resin at pH 6.7 compared with 33 mg LF per mL of SP 
Sepharose FF resin. The high capacity cellulose-based resins were unsuitable for 
industrial applications due to their high compressibility. As a result of Buchannan’s 
study, the industrial scale ion exchanger was replaced with one of the resins studied. 
The Vistec process used by Davisco Co. (LeSuer, MN, U.S.A.) uses a cellulose-
based exchanger in a stirred tank reactor. Whey pH is adjusted, lactose and the 
proteins are eluted. UF, evaporation and spray drying are used to give a whey protein 
concentrate with 95% w/w protein content. Tatua Dairy Co-operative (Tatanui, 
Morrinsville, New Zealand) uses cation exchanger column chromatography to 
extract LF, LP and other basic proteins from skim milk. Further ion exchange 
purifications give high purity LF, LP and other protein fractions. Details on the 
exchanger resin and the process are unavailable because the process is proprietary. 
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2.14 Effect of pre-processing on yield and activity of proteins 
Proteins should be separated from a source material as fast and in as few steps as 
possible to minimise loss of activity and yield (Ladisch 2001; Harrison et al. 2003). 
Losses in individual steps and complex separation sequences can be large. For 
example, Nuyens and Van Veen (1999) report that acid precipitation of casein 
resulted in 4-8 times more LF entrapped in the casein pellet than in the whey 
fraction. Denman et al. (1991) lost 50% of the human tissue-type activator protein 
produced in transgenic goats milk in the acid precipitation step, and obtained an 
overall yield of only 25%. 
Fast processing reduces proteolytic degradation of proteins (Jungbauer et al. 1988; 
Korhonen et al. 1998). Proteolysis increases heterogeneity of all species because 
milk contains a broad spectrum of proteins (Orthner et al. 1989). 
High-temperature processing disrupts non-covalent bonds in macromolecules such as 
proteins and polysaccharides causing denaturation and gelling of milk components 
(Datta and Deeth 1999). Ultra heat temperature (UHT) pasteurization of skim milk 
causes interaction between casein and whey proteins, reduces solubility of casein at 
neutral pH or below, decreases chemically-available lysine in whey protein and 
causes a 56% denaturation of whey protein in the skim milk but no denaturation in 
the raw milk (Douglas et al. 1981). 
2.15 Options for on-farm processing of milk proteins from 
raw whole milk 
Chromatographic fractionation of proteins from milk at a commercial scale is quite 
different from analytical scale chromatography. For instance: 
• all buffers must be food grade and inexpensive 
• relative flow rates in column volumes must be 10-20 times greater than 
laboratory scale for economic viability 
• columns must be 20,000 to 30,000 times larger in volume 
• recovery must be >90% 
• the column must operate for many cycles without loss in capacity before it 
needs to be cleaned. 
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The high solids content and fat globules with diameters up to 10 µm, and caseins 
present as a colloidal suspension of particles with diameters up to 0.1 µm (Bylund 
and TetraPak 2003) make raw whole milk a challenging matrix to process. 
2.15.1 Membrane filtrations and adsorptive membranes 
Large scale membrane processes have been successfully used in the dairy industry to 
remove bacteria and to control the fat and lactose content of various products 
(Zydney 1998). UF is the most widely-used commercial method to concentrate whey. 
However, it has the disadvantages of high capital and operating costs, membrane 
fouling, and low-molecular-mass solutes not being completely removed. In-place 
cleaning and sanitation are required to minimize microbial contamination. Also, 
large volumes of low protein content permeates are produced (Geberding and Byers 
1998). The LF (80 kDa) and LP (77.8 kDa) have very similar molecular weights 
(which infers similar molecular size in MF), so membrane separation based on size is 
not possible. 
Some researchers have used ion exchange membrane to selectively capture LF (Chen 
and Wang 1991; Chiu and Etzel 1997; Ulber et al. 2001). Whey was first clarified 
using MF before membrane adsorption. Chiu and Etzel (1997) recovered 72 and 50% 
of the LP and LF respectively, after repeated cycles using ion exchange membrane. 
Burling (1989) reported that the industrial processing of LF from whey in packed bed 
chromatography was only possible after MF (1.4 µm) and the flow rates were low 
(1.25 bed volumes/min) resulting in long loading time of 16.7 hours. 
Etzel (2004) evaluated large-scale commercial whey refining and noted membrane 
filtration is not ideal for capturing individual whey fractions, especially LF, because 
membrane filtration capacity is mainly dictated by the volume of whey processed, 
whereas capacity of process chromatography is set mainly by the mass of LF 
recovered, making membrane processing (a volume dependant separation process) 
not economic. Mass transfer limitations using ion exchange membranes have also 
been reported (Sarfert and Etzel 1997). 
There are many studies on membrane fouling and effective cleaning mechanisms 
(Brink et al. 1993; Chilukuri et al. 2001; James et al. 2003; Arguello et al. 2005). 
Chilukuri et al. (2001) used sodium dodecyl sulphate to reduce fouling during cross 
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flow-filtration of LF solutions and report that the protein aggregates play an 
important role in fouling. Significant fouling of the membranes with 0.2% (w/v) LF 
occurred at high flux (200 L/m2 hr). 
Ion exchange membranes are a promising new technology that could overcome some 
of the difficulties encountered during ion exchange chromatography in packed beds 
and stirred tank systems. The interest in adsorptive membranes and their 
effectiveness for extracting LF and LP from whey, skim milk or reconstituted 
solutions shows that this emerging technology has potential and may be suitable for 
on-farm applications. The current prices of the adsorptive membranes make the 
process expensive, but this could change as more units are sold and the costs of 
disposable technology decreases. 
2.15.2 Expanded bed adsorption chromatography 
EBA chromatography has been demonstrated for biomolecules but current process 
times are too long. For example, two or more days can be required to process 250 L 
of mammalian cell culture broth (Wright et al. 1999). Process streams frequently 
encountered in biological applications of fluidized bed adsorptions often have 
viscosities of 1-2 cp (mammalian cell culture broths) and 10 cp or higher 
(Escherichia coli and Pischia pastoris broths). Most chromatographic resins suitable 
for product adsorption have low densities and unacceptably low settling velocities in 
this viscosity range. The viscosity of milk, which is temperature dependant, is 
usually 3 cp (25oC), but the fat content in raw whole milk may cause fouling in EBA 
chromatography. 
Etzel et al. (1998) used EBA to capture proteins from skim milk and demonstrated 
that crude feedstock can be processed in a fluidised bed. However, there were mass 
transfer limitations, which increased processing time. This would make EBA 
chromatography unsuitable for milk processing. Also, the long processing time may 
compromise milk quality by allowing microbial growth and/or protein degradation. 
Houwing et al. (2003) found that mass-transfer effects also limited the performance 
of the simulated moving bed (SMB) chromatography during experimental 
fractionation of BSA and myoglobin on SP BB resin. The resin particle size selected 
for SMB was a compromise between productivity and mass transfer. 
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Noppe et al. (1999) recovered α-La from skim milk using hydrophobic Streamline 
Phenyl gel in EBA chromatography to avoid column clogging. They used defatted 
milk so the expanded bed would not be saturated with fat globules. Owen and Chase 
(1997) used continuous counter-current EBA chromatography to extract lysozyme 
from lysozyme-enriched fat-free milk and obtained 66% yields. The adsorbent was 
perfluorocarbon matrix coated with poly(vinyl alcohol) with triazine dye Procion 
Red HE-7B. 
2.15.3 Ion exchange using column or batch stirred tank 
Ion exchange has been used most widely used in the laboratory and industrially to 
extract LF and LP from skim milk and whey. It would be the preferred method for 
extracting LF and LP from raw whole milk. Raw whole milk contains large 
suspended particles that make it more difficult to process in column chromatography 
than whole (full-fat) processed milk, which has been homogenised in the factory to 
produce a uniform consistency. Raw or whole milk normally will not be expected to 
pass through a chromatography column because of its low processing temperatures. 
Milk is normally stored at 4-10°C to minimise bacterial growth during long holding 
periods and chromatographic extractions to fractionate milk proteins are also usually 
performed at these temperatures. 
Limitations of batch stirred tank extractions include: 
• low recoveries because of equilibrium considerations 
• slow throughput because of long process times 
• large equipment as the tanks must hold all the feed and the resin, and 
• fractionation may be difficult because changing buffers usually requires 
emptying the tank 
The major drawback of column chromatography is fouling, especially for milk, 
which has a high solids and particulate content. The low viscosity and presence of 
soluble aggregates in milk further complicates column process. These factors may 
generate high back-pressures in a column procedure. Batch procedures are more 
desirable for the process being investigated as many problems associated with 
packed bed chromatography, such as consolidation of packing material, formation of 
channels, and column blocking by particles in the feed solution are reduced. 
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Designing cost-effective separation processes requires knowledge and understanding 
of the equilibrium and kinetics of the adsorption process. Langmiur isotherms, based 
on single component adsorption, were used to determine maximum adsorption 
capacities of the resin (Chapter 3). Dynamic capacity would be a more useful 
characteristic to indicate capacity during ion exchange of raw whole milk and will be 
determined from breakthrough curves. The model of Rowe et al. (1999) is used to 
identify the parameters on the preparative chromatography and used for scale up 
(Chapter 5).  
2.16 Summary 
In this Chapter, minor components, LF and LP in milk that have potentially high 
value are discussed. Other components that were not discussed in detail but could be 
potential targets for on-farm extraction include components such as conjugated 
linoleic acid (anticarcinogenic fatty acid in milk fat), phospholipids, IgG, IgA, IgM, 
prolactin etc. LF and LP were widely extracted on a preparative scale as well as on 
industrial scale from skim milk and whey. Published purification technologies for 
their extraction were reviewed as well as a discussion on other techniques used in 
biopharmaceutical and dairy industry that may be suitable. 
Product recoveries are not generally reported and there were no published data on 
industrial processes due to commercial sensitivity. Laboratory methods give variable 
yields and researchers highlight the importance of process optimization when 
considering large-scale processing (Treloar et al. 2000; Bensch et al. 2005) and that 
small-scale, established laboratory methods may not necessarily lead to similar 
performance at larger scale. 
Even though raw whole milk was not universally used for fractionation, methods 
used to fractionation milk proteins and extract therapeutics from fermentation broths 
may be applicable to raw milk and are worthy of investigation. Column 
chromatography, after making allowance for fat content, and ion exchange 
membrane filtrations were methods worth investigating. The suitability of other 
techniques such as batch stirred tank and EBA for processing raw milk could also be 
investigated. 
 3 Laboratory Fractionation 
Materials and Methods 
3.1 Introduction 
An important pre-requisite when setting up a purification scheme is having an 
adequate assay procedure to follow changes in biological activity and protein 
content. Protein content can be measured by the Bradford method (Bradford, 1976), 
the Biuret method (Camara et al. 1991) with bincinchoninic acid (Smith et al. 1985) 
or by UV absorbance at 280 nm. Specific methods are used to quantify individual 
proteins and their activities. This chapter describes the materials and methods used to 
determine proteins and their activities. Techniques for protein purification, 
measuring resin performance (capacity, regeneration capability, capture efficiencies) 
and obtaining process parameters in laboratory experiments are also summarised. 
3.2 Equipment 
The major instruments/equipment used in laboratory experiments include: 
 
• AKTA Explorer10™ with Autosampler 900 and Unicorn 4.0 control software 
- liquid chromatography system (GE Healthcare Technologies, Uppsala, 
Sweden). 
• AKTA fplc ™ - fast protein liquid chromatography with Unicorn 4.0 control 
software (GE Healthcare Technologies) 
• UltraSpec® UV-Vis Spectrometry (GE Healthcare Technologies) 
• Scanning Electron Microscope (Hitachi S-4000 SEM, Hitachi Corporation, 
Japan) 
• Surface plasmon resonance (Biacore® SPR 3000, Biacore International AB, 
Uppsala, Sweden) 
• Masteriser S (Malvern Instruments Ltd., Worcestershire, United Kingdom), a 
dynamic light scattering (DLS) instrument 
• Optical microscope (Olympus BH2-UMA, Olympus Corporation, Tokyo, 
Japan) 
• Freeze dryer, Freeze Zone 2.5 (Labconco Corporation, Kansas, MO, U.S.A.) 
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• pH and conductivity meters (Cyberscan 100, Alphatech Systems, Auckland, 
New Zealand) 
• Portable (digital) temperature probe (-50 to 150oC) (Biolab Scientific, 
Albany, Auckland, New Zealand) 
• ELX800 Universal Microplate Reader (Bio-Tek Instruments Inc., Winooski, 
VT, U.S.A.) 
• Mini-centrifuge (Mini-Spin, Eppendorf, Hamburg, Germany) 
• Sigma Laboratory centrifuge (Osterode am Harz, Germany) 
• BioRad electrophoresis unit (BioRad Laboratories, Hercules, CA., U.S.A.) 
• Phastgel system (GE Healthcare Technologies) 
• Overhead stirrer (RW 20 DZMn, Labortechnik, Staufen, Germany) 
• Multi-head stirrer system (Boltac Industries, Hamilton, New Zealand) 
3.2.1 Standard proteins and buffers 
Protein standards of >99% purity were used. LF standards were obtained from Sigma 
(Sigma-Aldrich, St Louis, Montana, U.S.A.), Bethyl (Bethyl Laboratories) and 
Fonterra (Fonterra Cooperative, Palmerston North, New Zealand). LP, lysozyme, α-
La, β-Lg, BSA, IgG, α- and β-caseins were obtained from Sigma. The LF and LP of 
known purity and activity respectively were gifted by Tatua Dairy Cooperative 
(Morrinsville, New Zealand) and Fonterra Cooperative (Hautapu, New Zealand). 
Prepared HBS-EP buffer [10 mM HEPES, 0.15 M NaCl at pH7.4 with 3 mM 
ethylene diamine tetra acetic acid (EDTA) and 0.005% (v/v) P20 surfactant] was 
purchased from Biacore. The HBS-N used for HBS-EP consists of N-(2-
hydroxyethyl) piperazine-N’-(2-ethanesulfonic acid); 4-(2-hydroxyethyl) piperazine-
1-ethanesulfonic acid (HEPES). 
Affinity purified goat polyclonal anti-bovine LF antibody (1 mg/mL) from Bethyl 
Laboratories (A10-126A) was used for ELISA and SPR analyses. 
3.2.2 Resins (or media) for chromatographic adsorptions 
SP Sepharose Big Beads™ (SP BB) and SP Sepharose Fast Flow™ (SP FF) were 
gifted by GE Healthcare Technologies (Uppsala, Sweden). Bio Rex 70 (BR 70) resin 
was obtained from BioRad (BioRad Laboratories, Hercules, CA., U.S.A.). 
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3.3 Chromatography columns 
The following chromatography columns were used during laboratory studies: 
• Superdex 75, a pre-packed size exclusion column (GE Healthcare 
Technologies) 
• XK 16 columns (GE Healthcare Technologies) (1.6 cm id packed to required 
height) 
• Resource S (a pre-packed 1-mL cation exchange column) (GE Healthcare 
Technologies) 
• H5/5 column (0.5 mm id packed to required height) 
3.4 Analytical chromatography 
3.4.1 Size exclusion chromatography 
The AKTA Explorer10 was used to analyze skim milk and standard proteins. A 
calibration curve for the Superdex 75 column was constructed using a gel filtration 
low molecular weight (LMW) standard kit (GE Healthcare Technologies). Aliquots 
(40 µL) of Sigma standards (1 mg to 2 mg/mL) were injected onto the Superdex 
column using the autosampler. Skim milk was diluted 1:40 and filtered with a 0.45-
µm filter to remove particulate matter before analyses. Phosphate buffered saline 
(PBS, 10 mM, pH7.4 Sigma-Aldrich) was used as running buffer. Isocratic runs were 
done at 0.5 mL/min. 
3.4.2 Cation exchange chromatography 
A 1-mL Resource S (cation exchange) column was evaluated for quantifying LF, LP 
and lysozyme (LZ) using fplc. LF, LP and LZ standards of >99% purity (Sigma-
Aldrich) were made to 0.05, 0.10, 0.20, 0.50 and 1.00 mg/mL for low level 
calibration and 1.0, 2.0, 5.0 10.0 and 20.0 mg/mL for higher level calibration. 
Calibration curves were constructed for LF and LP only; elution of LZ was to 
evaluate LZ’s elution relative to LF and LP. 
Raw whole milk was centrifuged at 4800xg, pre-filtered with a 0.45-µm filter to 
minimize column blockages, diluted 5 to 10 times (10 mM phosphate buffer) and 
then applied to the column. A flowrate of 4 mL/min was used. The column was 
equilibrated with 4 column volumes (CVs) of 10 mM phosphate buffer       
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(Na2HPO4 /NaH2PO4, pH7.4). The 0.5-mL samples were injected using a fixed loop 
(1 mL) and a Superloop was used for repeated injections. The column was washed 
with 2 CVs of phosphate buffer, followed by linear gradient elution using 0-100% of 
1.0 M NaCl phosphate buffer over 20 CVs. Any residual protein was eluted using a 
further five CVs of 1.0 M NaCl. 
3.5 LF assays 
3.5.1 ELISA method 
A bovine ELISA quantitation kit (Bethyl Laboratories Inc., Montogomery, TX, 
USA) was used to measure LF concentrations with the following modifications 
(Turner 2003 et al. 2003b). After incubation with goat anti-bovine LF antibody, 
plates were washed with Tris-buffered saline (TBS; 50 mM Tris, 0.14 M NaCl, pH 
8.0) containing 2% w/v BSA. Goat anti-bovine LF horseradish peroxidase conjugate 
was diluted 1/100,000 in TBS containing 1% w/v BSA and 0.05% v/v Tween 20. The 
plates were developed by adding 100 µL 0.2 mg/mL 3,3’,5,5’-tetramethyl-benzidine 
(Sigma-Aldrich) and 1 mg/mL urea hydrogen peroxidase (Sigma-Aldrich) and 11% 
v/v dimethyl-formamide (BDH Chemicals) in 0.1 M citrate buffer to each well. After 
10-minute incubation at room temperature, the reaction was stopped by adding 100 
µL/well of 1 M H2SO4. Absorbance at 450 nm was read in an ELX800 Universal 
Microplate Reader. 
Calibration standards from the Bethyl ELISA kit were used for the standard curve 
(Figure 3-1). A 4-fit curve was used to calculate the unknown concentrations. This 
method is widely accepted for LF analysis (Martin et al. 2004, Takeuchi et al. 2004) 
and was used in the first half of the project before implementing the SPR assay. 
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Figure 3-1: A calibration curve of LF using ELISA method and Bethyl standard. 
 
3.5.2 LF concentrations using the surface plasmon resonance method 
The surface plasmon resonance (SPR) method (Indyk and Filzoni 2005) was used to 
determine LF concentrations. The only significant modification was in sample 
preparation: raw whole milk samples were centrifuged at 4800xg for 2 minutes to 
remove fat and filtered through a 5-µm filter (Sartorious AG, Goettingen, Germany) 
before making serial dilutions (to 2000x) in 500 mM HBS-EP buffer. The 150-mM 
HBS running buffer was obtained from Biacore and NaCl concentrations were 
increased to 500 mM for sample and standard preparations to reduce non-specific 
interactions.  
Goat anti-bovine LF (affinity purified) antibody was immobilised (Figure 3-2) on the 
CM5 sensorchip surface with N-hydroxy succinimide (NHS) and ethylene diamine 
(EDA) coupling reagents. The goat antibody was diluted to 50 µg/mL in 10 mM 
sodium acetate (pH 5.0). The antibody forms strong covalent bonds, which allow 
repeatable, quantitative measurements of LF in milk, eluates and processed samples. 
Ethanolamine-HCl (10 mM, pH 8.0) was used to flush the activated surface to 
remove loosely bound material and to block any unbound sites. This, together with 
the enhanced salt concentration of HBS-EP buffer (0.5 M NaCl), minimizes non-
specific binding. 
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Figure 3-2: Typical immobilisation of goat anti-bovine LF antibody on a CM5 chip. 
 
After a fresh CM5 chip was docked and primed, the immobilisation method was run 
at 50 µL/min for 7 minutes. Bethyl calibrator standards (1 mg/mL) were serially 
diluted to 0-1000 ng/mL and run on the SPR along with samples. A 4-fit calibration 
curve was generated and the unknown concentrations determined by matching their 
responses against the calibration curve (Figure 3-3).  
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 Figure 3-3: 4-fit calibration curve fit for LF standards analysed using SPR. 
Up to 800 individual analyses were possible on one immobilized flow cell of a CM5 
chip without a decrease in performance. A quality assurance sample (500 ng/mL LF) 
from a known LF source was routinely included in the analytical runs to monitor 
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performance of the method and the instrument. Relative responses of 1200 RU 
(response units) were obtained for the 1000 ng/mL standard. 
3.5.3 Comparison of ELISA and SPR methods 
The ELISA method is widely used for determining LF and was used during the first 
half of this project. When the SPR method became available, methods were 
compared before the SPR method was adopted for LF analyses. A set of 10 LF 
samples were analysed by both methods. The same Bethyl standard was used to 
construct the calibration curves for both analyses. Differences were within 
experimental error (Figure 3-4). Both methods agreed within 8% for all samples. 
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Figure 3-4: Comparison of LF concentrations obtained from SPR and ELISA 
methods. 
 
3.5.4 Inter-laboratory comparison of LF determinations 
To evaluate assay variability, an inter-laboratory comparison of LF in raw whole 
milk from 10 individual cows using the same batch of LF standards was undertaken. 
Raw whole milk samples were defatted by centrifugation before being sub-sampled 
and dispatched to participating laboratories. Samples and standards were supplied at 
the same time and run in one consecutive run by all laboratories. The methods used 
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were SPR (2 laboratories), Bethyl ELISA (1 laboratory) and HPLC (2 laboratories, 
with 1 running ELISA alongside HPLC), giving six data sets from five laboratories. 
Data were within 10%, irrespective of the laboratory and method used (Figure 3-5). 
It is very important to obtain inter-laboratory data because the LF product has many 
claimed benefits and has significant commercial value. A validated analytical method 
assists in obtaining accurate values for yield and purity of the extracted protein.  
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Figure 3-5: Inter-laboratory comparison of LF content in milk of 10 cows. 
Data from the SPR at lab 1 were consistently higher than other methods. However, 
SPR data from lab 1 and lab 3 were within 5%. Although the trend is unrelated a 
factor can be applied to reflect true results since the trend is consistent. 
3.5.5 Filtration for analytical cation exchange and SPR analyses 
Initial SPR data for LF in raw whole milk samples varied widely. The sensor chip 
technology is very sensitive and any particles in the sample can cause variations and 
damage the chip surface. Particles in raw whole milk were measured using laser light 
scattering to determine the filtration required for the SPR analysis. 
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The mean diameter of particulates in the skim milk was 0.2± 0.1 µm, which 
corresponds to the mean diameter of casein micelles (0.03-0.3 µm). The fat globules 
in the raw whole milk were 1-12 µm in diameter (mean of 3 µm). Centrifugation 
removed most of the fat. Coarse filtration (about 5 µm) removed large particles and 
was used for samples for SPR analyses, or to remove resin from resin/milk slurries. 
Soluble LF and LP would not be affected by the filtration. Large variations in LF 
data for raw whole milk samples were eliminated by centrifuging (4000 rpm for 2 
minute in a Mini-Spin centrifuge) to defat the milk and filtering.  
3.6 LP Analysis 
The 2,2’-azinobis[3-ethyl-benzothiazoline-6-sulphonic] diammonium salt (ABTS) 
enzyme was used to determine LP activity and concentration. The assay involved 
oxidizing the synthetic substrate, ABTS and comparison with a Sigma standard. The 
method was adapted from a published method (Chiu et al. 1997) and only measures 
active LP. It is a recognized method for testing level of preservation in pasteurized 
milk (EC 1.11.1.7, Keesey 1987). 
After diluting the milk with 10 mM phosphate buffer, the conversion of ABTS per 
unit time was determined by photometric analysis. The following reaction occurs: 
OHABTSHOHABTS 222 2222 +⎯→++ +⋅+  (3.1) 
The amount of ABTS radical cations (ABTS+) liberated per unit time is proportional 
to LP activity and is determined photometrically from the green colour at 420-436 
nm. The following calculations were used to obtain the LP activity and 
concentration. 
 
enzymemLsolidmg
enzymemLunitssolidsmgUnits
/
// =  (3.2) 
enzymemgproteinmg
enzymemLunitsproteinmgUnits
/
// =  (3.3) 
One unit of LP oxidizes 1.0 µmole of ABTS per minute at pH 5.5 at 25°C. 
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Sigma standard was used to monitor LP activity during analysis of samples. 
Typically 1:150 dilutions were applied to a stock Sigma standard of 1 mg/mL with 
an activity of 127 IU/mL (140 IU/mL Lowry). Results were usually between 120 to 
140 IU/mL of standard. Data from the Sigma standard were used to calculate the 
protein content of the samples based on the activity obtained (i.e. sample activity was 
converted to mg LP). 
3.7 Milk assays 
3.7.1 SDS-PAGE 
Sodium dodecyl sulphate - poly acrylamide gel electrophoresis (SDS-PAGE) 
analysis using Phastgels and 20 x 16 cm gels were done for purity analyses on 
proteins in the initial fractionation experiments. Phastgel SDS-PAGE is a rapid 
measurement to indicate protein in the purified and unpurified fractionation samples 
and was used according to Separation Technique File No.111 (Amersham Pharmacia 
Biotech AB, now GE Healthcare Technologies, 1998). This was a useful technique 
for rapid qualitative checks on purity of standards and of the purified proteins but 
was not quantitative. 
The sandwiched gels were cast in the laboratory using a BioRad kit. 30% acrylamide 
bis and SDS were from BioRad Laboratories. A running gel was poured with a softer 
25-mm stacking gel on top using the Laemmli method (1970). The 8-µL samples and 
standards were applied to the gels. Gel electrophoresis was run in a Hoefer ® SE 600 
(GE Healthcare Technologies) electrophoresis unit. Buffer temperature was 
maintained between 8-10oC using recirclating chilled bath. Gels were stained using 
Phastgel blue R stain overnight and destained overnight using 20% acetic 
acid/isopropanol mixture. The destain solution was changed three times until most of 
the background was removed. 
The gels were visualized using an ultraviolet trans-illuminator (TFX 35M Gibco-
BRL UV Transilluminator) and photographed using a UV gel camera. Images of the 
gels were scanned using Scion Imaging Software (Frederick, MD, USA). A typical 
SDS-PAGE gel (Figure 3-6) shows purity of LF and LP proteins along with milk 
proteins. 
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Figure 3-7: Calibration curve for BSA standard protein using the BCA assay. 
 
3.7.3 FT-IR Spectroscopy (FT120 milk composition analyses) 
The MilkoScan™ FT120 (Foss, Denmark) uses a Fourier-Transform Infrared 
Spectroscopy measuring principle and complies with IDF (International Dairy 
Federation) and AOAC standards for analysing fat, protein, lactose, crude protein, 
casein protein and total solids content of milk. Samples were analysed externally 
(Dexcel Limited, Hamilton, New Zealand). The FT120 was used to monitor bulk 
milk composition before and after fractionation by analyzing feed and outflow milk 
samples. 
3.8 Laboratory-scale fractionation 
3.8.1 Packed bed chromatography 
Raw whole milk was obtained from the Greenfield’s research farm (Dexcel Limited). 
SP BB and BR-70 ion exchange resins were packed into water-jacketed XK 16 
columns to a bed height of 5.0 (following the manufacturer’s instructions). The feed 
was maintained at 37oC and a recirculating water bath was used to maintain column 
temperature of 37oC. Fractionation was carried out using the AKTA fplc (Figure 3-8) 
with flowrates of 10 and 15 mL/min (linear velocities of 300 and 450 cm/hr 
respectively). The resin was equilibrated with 5 CVs of 10 mM phosphate buffer 
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(pH6.7). Several experiments were undertaken with varying amounts of raw whole 
milk (100-1000 mL). The captured LF and LP were washed using 2.0 CVs of 
phosphate buffer and 2.0 CVs of 0.1 M NaCl in phosphate buffer and then eluted 
using a 10-100% gradient of 1.0 M NaCl over 20 CVs. The elution stream was 
monitored at 280 nm and 5.0-mL fractions were collected. The fractions were 
analysed for LP activity using the ABTS assay. Both LF and LP content were 
measured by (Resource S) cation exchange chromatography. A process schematic for 
extracting LF and LP using packed bed chromatography is shown in Figure 3-9. 
 
 
 
Figure 3-8: The AKTA fplc system for packed bed chromatography of raw whole 
milk at 37oC. 
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Held with stirring at ~40 rpm  
(processed within 2 hours of collection) 
Resin equilibration 
5 CVs of 10 mM phosphate buffer (pH 6.7) 
Raw whole milk 
100-2000 mL introduced to column 
10 or 15 mL/min 
Column wash 
2 CVs each of phosphate buffer 
2 CVs 0.1 M NaCl in phosphate buffer 
LF and LP elutions 
20 CVs of 0.1-1.0 M NaCl (in phosphate buffer)  
Column regeneration 
5 CVs 1.0 M NaCl, 2 CV 1.0 M NaOH 
10 CV Milli-Q water wash, 5 CVs phosphate buffer
Water-jacketed XK-16 column 
packed to 5 cm bed height (CV 10 
mL) at flowrate of 20 mL/min 
Raw whole milk (from AMS) at 37oC 
 
Figure 3-9: Procedure for extracting LF and LP from raw, whole milk. 
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3.9 Resin characteristics 
3.9.1 Particle size distribution 
Particle size distribution of chromatography media, raw whole milk and fat globules 
were determined by dynamic light scattering (DLS). The dv0.9 and dv0.5 (diameter 
below which 90 and 50% respectively of the volume of particles) and dv(m) 
(diameter of spheres of equivalent volume to measured particles) were determined.  
SP FF was screened using a 42-µm sieve. Particle size distribution of the oversize 
and undersize fractions were determined. 
3.9.2 Scanning electron microscopy (SEM) 
Resin samples were freeze dried, placed on aluminum mounting disks, and platinum-
coated before microscopy. Upon scanning, images were taken at resolutions of 750, 
200 and 100 µm. 
3.9.3 Optical microscopy 
Resin particles were routinely observed by optical microscope to monitor the effects 
of processing and handling. This allowed resin appearance to be quickly evaluated 
before proceeding to the more rigorous experiments. 
3.9.4 Effect of pumping on SP BB 
Centrifugal pumps are normally used to pump milk in the milking parlours. Pumping 
may irreversibly damage the milk and may also damage the resin and reduce its 
practical lifetime. The effect of pumping SP BB was investigated by continuously 
recirculating 200 mL of SP BB suspended in 100 L of water through a centrifugal 
pump for 10 minutes at 20% power, a further 10 minutes at 50% power, and a further 
10 minutes at 120% power representing volumetric flow rates of 0.6, 1.55 and 2.95 
L/s respectively. A sample was taken at each pumping rate and drained through filter 
paper (Whatman No.41) to recover the resin. The resin was mounted on slides and 
observed under the optical microscope and the SEM. 
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3.9.5 Effects of high linear velocity on SP BB 
SP BB resin was packed in a 1-mL HR 5/5 column (GE Healthcare Technologies) 
with a 42-µm end filter mesh. The column was rated at 1.5 MPa and resin at 0.5 
MPa. Skim milk and ethanol were passed through the column at 5, 10, 15 and 20 
mL/min. Subsamples of the resin were mounted and viewed under the SEM. 
3.10 Extracting LF and LP from raw whole, skim milk and 
whey 
The LF and LP were extracted from raw whole milk, skim milk and whey to mimic 
the effects of supply chain and dairy factory processing operations on LF and LP 
yields and activity. Processes applied to the skim milk and whey samples in the 
laboratory were: cooling, mixing, transportation, pasteurisation, defatting, acid 
coagulation (removal of casein); filtration (to produce whey); and ion exchange 
chromatography to capture LF and LP. Processing steps usually undertaken in the 
factory but not investigated in the laboratory were: homogenisation (to produce 
uniform fat and particles in milk); and ultrafiltration (clarifying the whey and 
removing lactose) before chromatographic capture (ion exchange step). A second 
chromatographic process used commercially to produce higher purity LF and LP was 
also not investigated in the laboratory. The shear forces applied in these trials were 
less extensive than in factory operations. The LF and LP were extracted using single-
stage, stirred tank batch chromatographic capture with SP BB (pre-equilibrated with 
10 mM phosphate buffer, pH 6.7). Factory capture of LF and LP is generally done 
using packed bed chromatography.  
3.10.1 Milk treatment 
Milk from cow 9201 was obtained from the AMS milking unit and transported to the 
laboratory. The LF and LP were then extracted from raw whole milk, skim milk and 
whey (Figure 3-10). 
For each feed (raw whole milk, skim and whey), 20 mL of swelled, drained resin was 
added to 1.0 L of feed in a beaker in 37oC (water bath). The milk/resin slurry was 
stirred at 150 rpm with an overhead stirrer. After 5 minutes, stirring was stopped and 
the slurry passed through Whatman No.41 (25 µm) filter to recover the resin. The 
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resin was washed with 500 mL of Milli-Q water at 37oC. Elutions were done with 
100 mL of 0.4 M NaCl, and two 100 mL aliquots of 1.0 M NaCl. At each elution 
step the salt and resin slurry was stirred for 5 minutes before the resin was recovered 
by filtration. Subsamples from feed and eluates were analysed for LF and LP content. 
 
Skim IEX 
Sample 
Raw whole 
milk IEX 
sample 
Raw milk  
(fresh from the AMS) 
4oC storage (overnight) 
Transport (T <12oC) 
Pasteurisation 
(72oC for 15 s) 
Cream Centrifugation  
(45-50oC) 
Filtration 
Casein precipitation 
pH to 4.5 
Skim 
Cool to <12oC 
Whey IEX 
Sample 
Casein 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3-10: Process to produce samples for cation exchange of LF and LP from raw 
whole milk, skim milk and whey. 
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3.10.2 LF and LP extraction  
• Raw whole milk 
20 mL of equilibrated SP BB were added to 1.0 L of raw whole milk. 
 
• Pasteurized, skim milk 
Raw whole milk was centrifuged at 4000 rpm (Sigma Laboratory centrifuge) for 15 
minutes in 250-mL centrifuge flasks. The centrifuged milk was left at 4oC overnight 
to allow the cream to harden. It was then decanted to obtain skim milk. 
A 4.0-L sample of skim milk was pasteurised at 72oC with a 15-second holding time 
in a lab-made spiral core (coil) heat exchanger. The milk, initially at 18.8oC, was 
heated to 72oC by pumping at 0.25 L/min through a 2.4-m long, 5-mm i.d. coiled 
copper tube immersed in a 76oC water bath. This flowrate gave a 15-second holding 
time at 72oC. The LF and LP were extracted from 1 L of the pasteurised, skim milk. 
• LF and LP from whey 
A 2.0-L sample of pasteurised skim milk in a beaker was placed in a 40oC water bath 
(40oC helps minimise formation of fines, which make removal of coagulated casein 
by centrifugation or filtration difficult). The milk was gently stirred with an overhead 
stirrer while slowly adding 0.1 M HCl until skim milk was pH 4.6. The coagulated 
whey was then filtered through a Whatman No.1 filter to remove casein. The LP and 
LF were extracted from 1.0 L of filtered whey. 
3.11 Adsorption studies 
3.11.1 Equilibrium (static) capacity 
To model preparative chromatography, the adsorption isotherm is required. The 
reversible adsorption in ion exchange chromatography is often described by the 
Langmuir isotherm (Equation 3.4). Values for the components in the equation can be 
calculated from batch adsorption to obtain equilibrium (static) capacity. 
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[ ]AK
AKQQ += 1*  (3.4) 
where Q is the desorption capacity in equilibrium with solute at concentration [A], 
Q* is the maximum adsorption capacity, and K is a rate constant. Solute 
concentration is expressed as mg/mL; adsorption capacities are expressed as mg 
protein per ml of resin.  
Finite bath experiments were done to measure equilibrium adsorption capacities of 
BR 70, SP BB and SP FF resins. Aliquots (0.2 g) of equilibrated, swelled, drained 
resin were quantitatively weighed into 10-mL centrifuge tubes. The LF and LP 
standards from samples of known purity (Tatua Dairy Cooperative Limited) were re-
constituted to 0.05 to 20.0 mg/mL. A 5-mL aliquot of each standard solution was 
added to the resin and left for 24 hours on a rotating plate in 37 ± 0.2oC incubator. 
Tubes were then centrifuged to remove the resin and the supernatant was filtered in a 
5-µm filter. Equilibrium LF (CLF*) and LP (CLP*) concentrations of the solutions 
were determined using the BCA protein assay. If required, samples were diluted to 
be within BSA calibration range. Equilibrium protein content in the resin was 
calculated as the difference between initial and final liquid-phase concentrations. A 
known weight of resin was settled in a measuring cylinder to obtain the equivalent 
volume for mass-volume conversion calculations. 
The amount of protein bound to the resin was calculated from differences between 
initial and final solution protein concentrations. The equilibrium binding capacities 
for LF and LP (QLF* and QLP* respectively) were presented as the amount of protein 
bound per unit volume of resin (mg protein per mL resin). Langmuir isotherms were 
fitted to the experimental data. 
3.11.2 Dynamic capacity 
The effects of temperature on LF and LP extractions and breakthrough curves in 
packed bed chromatography were investigated. Dynamic capacities (breakthrough 
curves) for SP BB and BR 70 were determined using XK 16 columns packed to give 
a 10-mL CV. Raw whole milk (100 to 2000 mL) was processed (section 3.8.1 and 
Figure 3-9) at given flow rates and linear velocities (Table 3-1). Samples of the 
outflow were taken at 50-mL and then 100-mL intervals and analysed for LF and LP 
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content. The LF and LP in the feed were also determined. Breakthrough curves were 
generated. Yield and purity from the fractions collected after elutions were 
determined from selected experiments.  
Table 3-1: Column dimensions, flowrate and linear velocities for breakthrough 
experiments.  
 Column Flowrate Linear velocity 
diameter (cm)      height (cm)         volume (mL)        (mL/min)   (cm/hr) 
1.6 5.0 10.0 10 298.4 
1.6 5.0 10.0 15 447.6 
 
The effect of temperature in packed bed 10 mL/min with SP BB were determined at 
20, 25, 30, 35, 40 and 45oC by maintaining feed and the column temperatures. 1000 
mL feeds were used and samples taken at 100-mL intervals and analysed for LP 
activity and content and used to generate breakthrough curves. Pressure data was 
obtained from the Unicorn software and plotted for each of the processing 
temperatures.  
3.12 LF and LP adsorption rates in a single-stage stirred tank 
Dynamic capacities of SP BB and SP FF were determined using known 
concentrations of LF and LP in batch trials before undertaking more detailed kinetic 
adsorption experiments. Separate samples with 2.0 mg/mL LF or LP (Tatua Dairy 
Co-operative) at 36 ± 1oC were continuously stirred at 150 rpm with an overhead 
stirrer (RW 20 DZ Mn). Samples were taken at regular intervals, filtered and 
analysed for protein content. Different resin:milk (v/v) ratios (0.10 - 0.055) were 
used, and two separate raw whole milk samples were also used. 
Detailed data for extracting LF from raw milk with SP BB and SP FF were 
determined using 2.0, 2.5, 3.3 and 5.0-mL aliquots of swelled, drained resin in 200 
mL of raw whole milk in beakers in a water bath at 36 ± 1oC. The resin to milk ratio 
(Φ) represented 250 mL media in 25, 20, 15 and 10.4 L of milk. Gentle, uniform 
stirring (150 rpm) was achieved using a multi-head stirrer system (Boltac, Figure 3-
11). Approximately 1-mL aliquots were withdrawn from the milk/media slurry with 
a syringe at known times, passed through a 5-µm filter (Sartorious AG, Goettingen, 
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Germany) and analysed for LF content (SPR method). Data were used for kinetic 
modelling (Rowe et al. 1999). 
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3.13.1 Controlled monitoring of performance using LF 
Because raw whole milk must be processed immediately after collection to reduce 
degradation and LF concentrations vary between cows, reconstituted LF of known 
purity (Tatua Cooperative Limited) was used to measure resin performance after 1, 5, 
10, 20, 30, 40 and 50 cycles. Using reconstituted LF ensured consistent feed. Fresh, 
raw whole milk was used for all other process cycles. Other components in milk such 
as fat, other proteins and lactose may also affect resin performance. Concentrations 
of these components also vary in individual cow’s milk and it would have been 
unlikely that fresh milk samples would have consistent composition, especially using 
the voluntary milking system (AMS). 
Samples (1 L) of fresh raw whole milk (from individual cows) was processed at 
~37oC in a single-stage stirred tank with an overhead stirrer (RW 20 DZMn) using a 
resin to milk ratio of 0.017. The resin milk slurry was stirred at 200 rpm. After 
processing, the resin was weighed, a SEM sample taken and fresh resin added to 
make up for any losses during processing. 
The following processing sequence was used: 
• Capture LF from feed (raw whole milk or reconstituted LF) on resin at 37oC 
for 10 minutes. During this time take 1-mL samples at 1-minute intervals, 
pass though 5-µm filter and store at 4oC for further analyses 
• Drain resin on 25-µm paper filter (Whatman No.41) using suction to assist 
the draining process 
• Wash with 3-5 CVs of distilled water or buffer 
• Elute protein in two steps: 
4-5 CVs of 0.4 M NaCl 
4-5 CVs of 1.0 M NaCl 
• Clean resin: 
Wash with 100 mL of 1.0 M NaOH 
Rinse with 200 mL of distilled water 
Wash with 100 mL of 1.0 M acetic acid 
Rinse with 200 mL of distilled water 
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• Regenerate resin 
Wash with 100 mL of 2.0 M NaCl (5.0 CVs) 
Rinse with 200 mL of distilled water 
• Equilibrate resin 
Rinse with 10 mM phosphate buffer 
Check pH and adjust to to pH6.7-6.8 by repeated rinses with 10 mM 
phosphate buffer until desired pH is reached 
Resin samples from the 1st, 5th, 10th, 20th, 30th, 40th and 50th cycles were examined by 
optical microscopy and SEM. The LF concentrations in feed, and eluates were 
determined using the SPR method. 
3.13.2 Solvent evaluation – physical effects of fat uptake 
Resin used for raw whole milk extractions gradually accumulated fat and required a 
more rigorous cleaning protocol with a solvent that solubilised and removed the fat. 
The effectiveness of food grade solvents (ethanol, isopropanol and ethyl acetate 
widely used in the food industry and recommended by the resin manufacturer) was 
evaluated. 
Fresh whole milk was centrifuged and kept at 4oC for an hour to allow the cream to 
harden. The cream was then decanted off and rinsed with water. Samples (1.0 and 
5.0 g) of cream were weighed into separating funnels and then 100 mL aliquots of 
30%, 40% isopropanol or 70% ethanol was added to the separating funnel. The 
mixture was gently shaken to promote solvation. The amount of fat taken into the 
organic phase was inconclusive. Further analyses need to be done to determine the 
amount of fat dissolved in the organic phase. Gravimetric analyses were not possible 
because the cream and fat-containing organic phase could not be effectively 
separated. Ethyl acetate (approved for food usage) was also used to clean a small 
sample of resin. 
Ethanol which has the highest polarity [(ethanol (C2H5OH) > isopropanol 
(C(CH3)3OH) > ethyl acetate (C2H5COOC2H5)] would be most effective in removing 
fat. A solvent cleaning step (200 mL of 40% isopropanol at ambient temperature, due 
to it’s lower volatility relative to ethanol) was added to resin cleaning procedure. 
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3.13.3 Dairy cleaning solution 
Optimum or Horolith Farm (Ecolab Limited, Hamilton, New Zealand) is a non-
quaternary ammonium compound (QAC) acid detergent-sanitiser used in the food 
processing and dairy industries. New Zealand Food Safety Authority has approved 
its use for food contact surfaces. Optimum contains 0.1 M sulphuric acid and 0.1 M 
orthophosphoric acid. A 1:1000 dilution is used for cleaning milking equipment, 
followed by water rinses. This procedure can be an alternative to 1.0 M acetic acid. 
3.13.4 Simplified cleaning protocol 
The LF standards used to monitor resin performance were initially not fully 
recovered. The cleaning procedure was modified. Initially, each cleaning step had a 
two-minute desorption period. This was increased to at least ten minutes to allow 
reversible reactions to go to completion (e.g. recovering proteins using NaCl). The 
cleaning cycle, especially using NaCl and NaOH were undertaken at 37oC. The 
modified procedure included rinsing with water at 37oC for fat malleability. 
In on-farm trials, protein was eluted from the resin, which was then pooled for 
cleaning and regeneration. 
The following modified protocol as used: 
Cleaning 
• Wash to remove lipids (40% isopropanol, 37oC for 10 min) 
• Wash with 5 CV of 1.0 M NaOH (15 min in bath) 
• Rinse with 10 CV of distilled water (water at 37oC) 
• Wash with 5 CV of 0.1% Tween in 1.0 M Acetic acid (15 min in water 
bath) 
• Rinse with 10 CV L of distilled water (37oC) 
Regeneration 
• 5 CV of 2.0 M NaCl (5.0 CV) 
• Rinse with 10 CV of distilled water 
Equilibration 
• Equilibration with 10 mM phosphate buffer 
• pH checked to be within 6.7-6.8 (else repeat rinses with 10-20 mM 
phosphate buffer) 
 
 4 Laboratory Fractionation 
     Results and Discussion 
4.1 Analytical chromatography 
4.1.1 Size exclusion chromatography 
Good separation for most proteins typically present in milk such as α-casein, β-
casein, α-La, β-Lg, BSA, IgG and LP could be obtained with the Superdex 75 
column (Figure 4-1). 
The peak for the LF standard was diffused and the detection level was low (1 
mg/mL). Sensitivities of 0.05 to 0.50 mg/mL are desired because these are the usual 
LF levels in milk.  Using higher concentrations (up to 4 mg/mL) of LF standard did 
not improve the response. The LF may have been interacting with the size exclusion 
media because it was eluted during the 1.0 M NaOH wash cycles. Repeat injections 
of LF standards after rigorous cleaning did not improve the results.  
 
Figure 4-1: Size exclusion chromatogram of milk proteins using the Superdex 75 
column. 
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4.1.2 Cation exchange chromatography 
Detection level for LF and LP on cation exchange chromatography was 0.025 
mg/mL. The area of the peaks in the UV traces were integrated and used to indicate 
the total mass, and hence concentration, in the samples. Replicate analyses (n=5) 
were used to construct the 0-20 mg/mL calibration curves, which had a linear 
regression of >0.999 (Figure 4-2). 
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 Figure 4-2: Standard calibration curves for LF and LP using a 1-mL Resource S 
column. 
A typical chromatogram showed good resolution of LF and LP peaks but the LZ and 
LP peaks overlapped (Figure 4-3) and could not be separated even when the gradient 
was changed. Because the LZ content in milk is low, it will not be routinely detected. 
Capture effects of competing proteins such as LZ when fractionating LF and LP from 
raw whole milk was not evaluated but is expected to be insignificant at the normal 
target LF and LP purities of around 90%. 
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Lysozyme 
Figure 4-3: Typical resolution of LF, LP and LZ using a Res
with UV monitoring at 280 nm. 
4.2 pH and conductivity 
Raw whole milk used in the study normally had a pH betw
conductivity between 4.8 and 6.2 mS/cm. These values are s
for bovine milk (Coulon et al. 1998; Mabrook and Petty
Huppertz and Fox, 2006). 
4.3 Laboratory-scale fractionation 
4.3.1 Packed bed chromatography 
A typical UV trace of cation exchange of raw whole milk
(Figure 4-4 a and b). The first peak was confirmed as LP u
assay and the second peak was identified as LF after anal
column. This elution order agrees with published studies (Yo
1998). The LP activity in the collected fractions correlated
profile. Fractions 12-20 had the maximum LP activity (Fig
elution profiles for BR 70 and SP BB resins were similar. 
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10-40 mg/L and 120-300 mg/L respectively. These values compare well to reported 
LP and LF values (Kawakami et al. 1990; Elgar et al. 2000; Indyk and Filonzi 2005). 
Early work in the study (Chand and Fee 2004) demonstrated that fat globules or 
casein micelles did not need to be removed before extracting LF and LP from raw 
whole milk using SP BB in a packed bed provided processing temperature was 
sufficiently high (section 4.6.2). More than 100 column volumes of raw whole milk 
at 35oC could be passed through a 5-cm packed bed at 300 cm/hr (10 mL/min) 
without exceeding the maximum backpressure of the media (0.5 MPa) and column 
(Figure 4-5). The dynamic media capacity for LF was approximately 48.6 mg/mL. 
Flow rates of 10 mL/min or 15 mL/min (linear velocities of 300 or 450 cm/hr) were 
achieved within the recommended pressure maximum of 0.5 MPa for the XK 16 
column (Figure 4-5). 
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Figure 4-5: Pressure profiles when fractionating LF and LP from raw whole milk 
(37oC) in a 10-mL XK 16 column packed with SP BB resin. 
The capacities obtained for packed bed chromatography were similar to the capacity 
of 34 g LF per L skim milk for the SP BB resin reported by Etzel et al. (1998). Etzel 
et al. recovered 80% of the feed LF and suggested that other components may 
compete with LF for binding sites on the resin, reducing the net recovery. Trials 
showed that LF and LP could be successfully extracted from fresh whole milk by ion 
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exchange chromatography without affecting overall milk composition and the 
resultant milk could still be used in the traditional processes (Table 4-1). 
Table 4-1: Composition (%) of bulk raw whole milk before (feed) and after (outflow) 
LF and LP extraction. 
 Fat Protein Casein Lactose  Total solids 
 (% w/v) (% w/v) (% w/v) (% w/v) (% w/v) 
Sample 1 
Feed 4.11 3.27 2.61 4.84 13.2 
Outflow 4.04 3.29 2.63 4.84 13.1 
Sample 2 
Feed 3.64 3.15 2.44 4.21 11.8 
Outflow 3.55 3.07 2.35 4.35 11.6 
4.4 Resin characteristics 
4.4.1 Particle size characterization 
Suspended particles in 10 individual raw milk samples had a dv(m) of 2.91±0.9 µm, a 
dv(0.9) of 5.52 µm and a dv(0.5) of 2.91 µm. These values compare well with 
published values for milk fat globules (Etzel 1998; Michalski et al. 2005). The size 
of casein micelles was not measured but published values report that casein micelles 
in raw milk have a diameter of 0.15 µm. The SP BB resin had a dv(m) of 154±67 µm, 
a dv(0.9) of 219 µm and a dv(0.5) of 155 µm (Figure 4-6).  
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Figure 4-6: Laser size distribution of SP BB particles. 
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4.4.2 Screening to remove fines from SP FF 
Smaller resin particles (fines) could be effectively removed by screening the SP FF 
resin with a 42 µm sieve (Table 4-2). Fines will increase the potential to clog the 
column and increase draining time when recovering resin in a stirred-tank system. 
Removing fines could make on-farm extractions with SP FF feasible. 
Table 4-2: Effect of sieving SP FF with a 42-µm filter on particle size distribution 
(µm). 
Source of sample dv (0.1) dv(0.5) dv(0.9) dv(m) 
SP FF (fresh) 36.57 79.22 129.73 80.89 
Oversize 46.49 89.19 136.30 89.14 
Undersize (fines) 17.49 43.86 63.17 42.44 
4.4.3 Effect of pumping on SP BB  
SEM images showed that resin subjected to centrifugal pumping at 1.55 or 2.95 L/s 
contained broken and cracked particles (Error! Reference source not found.ii-iii). 
Resin pumped at 0.60 L/s showed little or no sign of damage. Thus, the fastest rate 
that an individual volume of milk should be processed without undue resin damage is 
0.6 L/s.  
4.4.4 Effect of high linear velocity on SP BB  
The maximum back pressure on a 1-mL HR5/5 column for fplc when using feeds of 
skim or ethanol at flow rates between 5and 20 mL/min was 0.31 MPa (column rated 
at 1.5 MPa). The SEM images of the SP BB resin (Error! Reference source not 
found.iv and v) showed no evidence of any damage at linear velocities of up to 6000 
cm/hr. 
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i. Fresh unused resin 
 
ii. Exposed to 1.5 MPa in a packed 
column (HR 5/5) 
 
iii. After being pumped (2.65 L/s). 
 
iv. After 6000 cm/hr with standard 
filter (CV 0.55 mL; HR 5/5)
 
 
iii) After 6000 cm/hr with 200 µm filter (CV 0.3 mL; HR 5/5) 
 
Figure 4-7 (i-v): SEM images of SP BB resin subjected to various physical stresses. 
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Data from this series of experiments indicated that it would be best if the resin was 
not pumped as most damage was sustained through centrifugal force. The resin was 
not very susceptible to high linear velocities in packed columns and earlier work 
using packed bed chromatography showed no evidence of the SP BB resin 
compacting. However, at these high flow rates, damage may occur at the filter 
interface even though samples taken from the bulk part of bed were not damaged. Ion 
exchange column chromatography is normally operated at 300-600 cm/hr, and SP 
BB can be operated to at least 1000 cm/hr provided adsorption rates are suitable. 
4.5 Equilibrium (static) capacity 
Langmuir isotherms fitted to experimental data (Figure 4-8) showed the that 
maximum equilibrium capacities for swelled resin after 24 h adsorption were 200 mg 
LF and 225 mg LP per g of SP BB resin and 100 mg LF and 125 mg LP per g of BR 
70 resin. 
 
Figure 4-8: Langmuir isotherm fit for the experimental equilibrium adsorption data 
of SP BB and BR 70 resins for LF and LP after 24 h. 
The SP FF resin, which has a similar average particle size to BR 70 resin (90 µm) 
also has similar maximum equilibrium capacity of 100 mg LF (Figure 4-9) or LP per 
g of SP FF resin. 
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Figure 4-9: Langmuir isotherm fit for the experimental equilibrium adsorption data 
of SP BB and SP FF resins for LF after 24 h. 
 
The measured maximum static binding equilibrium capacity that SP BB resin had for 
LF (Mr 77 kDa) is very similar to the manufacturer’s claims for its dynamic capacity 
of approximately 200 mg BSA (Mr 67 kDa) per mL resin at 12 cm/h rate (GE 
Healthcare Technologies, 2005). Similarly, the maximum capacity measured for SP 
FF resin is comparable to the manufacturer’s claim for human serum albumin (Mr 67 
kDa) of 110 mg/mL. 
The maximum capacity of media is very high for standard solutions but QLF* is 
strongly dependant on CLF* below 1 mg/mL. Although the maximum equilibrium 
capacity of the resin is 100 to 200 mg/L for high solution concentrations (>5 mg/mL) 
of LF and LP, the equilibrium resin capacity at the normal concentrations of these 
proteins in milk will be much lower than the maxima. Also, during processing, the 
maximum capacity of the resin cannot be achieved as the high contact times required 
would compromise milk quality by allowing microbial growth. Processing ideally 
should be completed in the average time for milking (a few minutes). Other milk 
components may adversely affect the LF binding but this was not investigated. 
The experimental data showed that the cation exchangers investigated (BR 70, SP 
BB or SP FF) could capture LF and LP from raw whole milk. If the adsorption 
process is rate dependant, the smaller bead size of BR 70 and SP FF is advantageous 
because there is more surface area per unit volume of resin. However the higher 
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static adsorption capacity of SP BB resin, together the lower back-pressure due to its 
larger size, make it more suitable for milk processing. 
4.6 Dynamic capacity of resins 
4.6.1 Breakthrough curves 
Trials showed that for LP and LF feed concentrations of 12.5 and 207 mg/L, 100 
CVs of raw milk could be processed at a linear velocity of 300 cm/h (10 mL/min) in 
10-mL XK 16 columns before LP and LF breakthrough occurred (Figure 4-10 and 4-
11 respectively). Column pressures remained below 0.5 MPa during processing. 
Protein adsorption by the resin depended on linear velocity and protein concentration 
in the feed. Virtually all the LP and up to 95 % of LF could be extracted using 
packed bed chromatography of raw whole milk at 37oC before breakthrough 
occurred. 
 
Figure 4-10: Effect of linear velocity on LP breakthrough when processing raw 
whole milk in a 10-mL XK 16 column packed with SP BB resin. 
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Figure 4-11: Effect of linear velocity on LF breakthrough when processing raw 
whole milk in a 10-mL XK 16 column packed with SP BB resin. 
Etzel et al. (1990) investigated the effects of processing parameters in packed bed 
chromatography with SP BB and EBA with Streamline™ SP (density 1.2 g/L) using 
skim milk with enhanced levels of LF (0.5 g/L) to reflect levels present in transgenic 
milk and reported that SP BB had a dynamic capacity of 34 mg LF per mL resin, 
which compares well with the dynamic capacities (35 and 48.8 mg LF per mL SP 
BB) observed during this study using raw whole milk. 
4.6.2 Effects of temperature on breakthrough 
Increasing the temperature improved processing and adsorption kinetics. More milk 
passed through the column before allowable pressure limits were reached (Figure 4-
12) and more protein was adsorbed onto the resin before breakthrough occurred 
(Figure 4-13). Also, while freshly obtained milk could be processed at 20oC, the raw 
whole milk that had been refrigerated or left standing for a few hours could not, 
mainly because some of the fat had separated out. 
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Figure 4-12: Effect of temperature of feed (raw whole milk) on the backpressure on 
column during processing using packed bed chromatography with SP BB at 20, 25, 
30, 35, 40 and 45oC. 
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Figure 4-13: The effects of temperature on breakthrough of LP at 20, 25 30, 
35, 40 and 45oC using SP BB resin. 
The size of the milk fat globules (up to 10 µm), effect of temperature on fat viscosity, 
and the strong influence of processing temperature on column backpressure may 
make milk fat globules become more malleable as temperature increases, allowing 
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them to pass through the bed. At lower temperatures, the fat hardens or solidifies, 
preventing passage. The larger size of SP BB resin compared to FF and BR 70 resins 
assists in processing raw whole milk by allowing larger particles to pass through 
before the resin becomes clogged. Etzel et al. (1998), while processing skim milk at 
a miniature whey refinery, reported that robustness improved slightly by increasing 
temperature (which decreased viscosity) from 10°C to 20°C but felt that the risk to 
process hygiene possibly outweighed the improvement achieved. 
4.6.3 Effects of temperature, milk and fat retention on column 
processing  
An analysis of data (Figure 4-12) shows that the number of CVs that could be 
processed before pressure exceeds on arbitrary value of 0.3 MPa increases with 
temperature ( 
Figure 4-14). 
 
 
 
 
 
 
 
 
 
 
0
20
40
60
80
100
120
0 20 40
Temperature (oC)
C
V'
s 
be
fo
re
 p
re
ss
ur
e
ex
ce
ed
s 
0.
3
M
Pa
10 30 5014
C
V'
s 
be
fo
re
 p
re
ss
ur
e
ex
ce
ed
s 
0.
3
M
Pa
Figure 4-14: Effect of temperature on CVs that can be processed in a packed bed of 
SP BB resin before pressure exceeds 0.3 MPa. 
Particles in milk typically have diameters from 0.1 µm (caseins) to 10 µm (fat 
globules) (Bylund and TetraPak 2003). Fat globules usually cause problems in 
chromatographic separations because they block packed columns as soon as the feed 
is introduced. Therefore, fat is normally removed before cation exchange capture of 
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LF and LP from milk. Raw whole milk contains larger suspended particles than 
whole (full fat) processed milk, which has been homogenized in the factory to a 
uniform consistency. Thus, raw whole milk might be more difficult to process using 
column chromatography. The generally accepted view that raw whole milk can not 
pass through a packed bed chromatography column is likely caused by low 
processing temperatures.  
Milk is processed nominally at 4oC to minimise microbial growth. At approximately 
14oC, very little milk can pass through the packed bed column. An investigation of 
the composition of the fatty acids in milk fat triglycerides, along with their individual 
melting points (Table 4-3) shows that oleic acid (C18:1), which is up to 40% of the 
fatty acid in milk fat, and has a melting point of 14oC. This temperature corresponds 
well with the temperature at which processing through packed bed becomes 
impossible. 
Table 4-3: Composition and melting points of the major fatty acids in milk fat 
(Bylund and TetraPak 2003). 
 Fatty acid   % of total fatty acid content Melting point (◦C) 
 Butyric  3.0–4.5  −7.9 
 Caproic 1.3–2.2  −1.5 
 Caprylic  0.8–2.5 16.5 
 Capric  1.8–3.8  31.4 
 Lauric  2.0–5.0  43.6 
 Myristic  7.0–11.0 53.8 
 Palmitic  25.0–29.0  62.6 
 Stearic  3.0–7.0  69.3 
 Oleic  30.0–40.0  14.0 
 Linoleic 2.0–3.0  −5.0 
 Linolenic <1.0  −5.0 
 Arachidonic  <1.0  −49.5 
Fresh raw milk, immediately after milking is about 35-37oC. Although this 
temperature is below the melting points of several fatty acids, notably myristic and 
palmitic acids, it is above the melting point of oleic acid. Fat globules hardness will 
be affected by the relative fatty acid compositions of the milk fat triglycerides. At 35-
37oC, milk fat globules may be soft enough to easily deform and pass through a 
packed bed if the chromatography resin has a sufficiently large particle diameter. 
Also, milk viscosity decreases with increasing temperature so column backpressure 
for low fat milk decreases at higher temperatures. The lower viscosity, combined 
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with higher protein diffusivities at higher temperatures can enhance chromatographic 
separations. 
4.7 LF and LP extractions from raw whole milk, skim milk 
and whey feeds 
Milk (12.8 L) from cow 9201 was used in trials to investigate extraction of LP from 
raw whole milk, skim milk or whey. The highest LP recovery in the eluates (72%) 
was from skim milk (Table 4-4). This recovery, after accounting for LP 
concentration due to cream removal, represented 64% of the original LP in the whole 
milk compared with 59% yield from raw whole milk. The lower yield may indicate 
that fat in raw whole milk affects LP recovery. The lower capture of LP present in 
the whey (26.8%) indicates that extensive processing may adversely affect the 
extraction process; only 22% of LP present in whole milk was recovered from the 
whey fraction. Another reason could be that the protein (LP) is longer present in the 
form to be captured under the processing and elution conditions used in the column 
(where almost all LP was captured). 
Table 4-4: Activity, recovery and yields of LP extracted from 1 L of raw whole milk 
or the equivalent skim milk and whey with SP BB after 10-minute adsorption in 
single-stage stirred tank. 
Stream and  Volume LP Total LP    LP mass LP Yield in LP relative 
process          recovery      yield     eluates   to original 
   (mL) (IU/mL) (mg)     (%)    % (%) (%) 
Fresh whole milk 1000 2.2 15.7  100.0 
Eluate 1 100 9.24 6.6  42.0 
Eluate 2 100 3.66 2.6  16.6 
Outflow 1000 0.9 6.4  40.9 
    99.5  58.6 58.6 
Skim milk 889 2.89 16.3  100.0 
Eluate 1 100 18.17 10.3  62.9 
Eluate 2 100 2.64 1.5  9.1 
Outflow 889 0.73 4.1  25.3 
    97.3  72.0 64.0 
Whey 738 0.98 3.8  100.0 
Eluate 1 100 0.91 0.4  9.3 
Eluate 2 100 1.72 0.7  17.6 
Outflow 738 0.7 2.7  71.4 
    98.3  26.8 22.3 
 
The trend for the amount of LF extracted from raw whole milk, skim milk and whey 
was similar to that observed for LP, (Table 4-5) but less was extracted (25.3, 32.4 
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and 19.9% respectively). The higher capture of LF from skim milk than from raw 
whole milk could be due to fat content impacting on adsorption. Removing the cream 
increases concentrations of milk components in the skim. For example, the LF 
concentration increased from 1590 mg/mL in raw whole milk to 1716 mg/mL in the 
skim milk. Having higher feed concentrations will increase the adsorption kinetics 
(i.e. rate) which increases binding rate and hence the yield obtained in a given time. 
The low pH of whey (4.6 compared with 6.8 of skim and whole milk) can also affect 
LF yields. Hahn et al. (1998) attributed acidity of the (mineral) whey to the low LF 
yields they obtained. 
Table 4-5: Recovery and yields of LF extracted from raw whole milk, skim milk and 
whey with SP BB after 10-minute adsorption in single-stage stirred tank. 
Stream and Volume  Total LF LF mass  LF Yield in  LF  
process   recovery yield  eluate  relative to 
 (mL) (mg)               (%)                   (%)         (%)     original 
Fresh whole milk 1000 1590  100.0 
Mill-Q wash 500 21  1.3 
Eluate 1 100 13  0.8 
Eluate 2 100 369  23.2 
Outflow 1000 1241  78.1 
   103.4  25.3 25.3 
Skim milk 889 1526  100.0 
Milli-Q wash 500 11  0.7 
Eluate 1 100 7  0.5 
Eluate 2 100 477  31.3 
Outflow 889 999  65.5 
   98.0  32.5 28.9 
Whey 738 889  100.0 
Milli-Q wash 500 29  3.3 
Eluate 1 100 13  1.5 
Eluate 2 100 134  15.1 
Outflow 738 669  75.3 
   95.2  19.9 14.7 
 
Further investigations are needed to optimize adsorption of both LF and LP in a 
single-stage stirred tank system before the process can be adopted for on-farm 
capture. The SP FF resin which has smaller particles (average 90 µm) may give 
better adsorption and yields.  
Extraction time and temperature effects were also investigated and mathematical 
modelling assistance used to enhance understanding the kinetics of adsorption 
(section 4.9 and Chapter 5). 
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4.8 Lifecycle studies 
Because resins are very expensive, economic performance of chromatographic 
separations are very dependent on resin stability over repeated extractions. Ideally, 
SP Sepharose resin may be recycled for at least 500 cycles provided adequate 
cleaning and regeneration protocols are used (GE Healthcare, 2004). The lifecycle 
studies carried out showed that SP FF could be used for at least 50 cycles without 
any decrease in performance (Figure 4-15). Further work is required to confirm the 
maximum lifetime of the resin. 
Cycle Number 
 
Figure 4-15: Effect of resin reuse (up to 50 cycles) on LF adsorption from a LF 
standard solution (0.5 mg/mL). 
Data from cycles 5 and 10 have not been included in Figure 4-15. The feed/resin 
slurry during these runs was in a Perspex container in a water bath (37oC). However, 
due to the slow heat transfer, the temperature of the slurry was only at 24oC after 10 
minute. Thus, the lower performance for cycles 5 and 10 was attributed to procedural 
error rather than lower resin performance. For the remaining trials, a glass container 
was used and the milk and reconstituted LF were pre-warmed to 37oC before being 
placed in the bath. The SEM images (Figure 4-16 a-h) of fresh resin and resin after 
various absorption cycles show no evidence of damage or physical distortion of resin 
particles. 
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a. Fresh resin b. After cycle 1 c. After cycle 5 
   
d. After cycle 10 e. After cycle 20 f. After cycle 30 
  
 g. After cycle 40 h. After cycle 50 
Figure 4-16: SEM images of SP FF resin before (a) and after cyclic processing (b-h). 
4.9 Kinetics of adsorption 
4.9.1 Batch extraction of LF in a single-stage stirred tank 
Data on the amount of LF extracted from standard solutions showed that SP FF resin 
has faster rate uptake than SP BB resin (Figure 4-17). The uptake rate increased with 
increased resin:milk ratios. 
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Figure 4-17: Effects of time and resin amount on LF adsorption with SP BB and SP 
FF resins with standard LF (0.5 mg/mL) in a single-stage stirred tank at 36oC. 
The approach to equilibrium is fast enough to absorb significant amounts of LF 
within 10 minutes.  After 45 minutes adsorption, uptake appears to be at or near 
equilibrium. Laboratory experiments were done at a nominal temperature of 36 ±1oC 
and the effect of temperature on kinetics of adsorption during batch extraction was 
not studied because on-farm extractions were expected to be at nominal milk 
secretion temperatures (approximately 37oC). However, temperature had a 
favourable effect on adsorption in packed bed chromatography (section 4.6.2). 
Further detailed investigations of the effects of initial LF concentrations and 
resin:milk ratio values that would be encountered in the proposed on-farm system 
were done using milk from individual cows (Chapter 5). The LF adsorption was 
influenced by resin:milk ratio (Φ), time and initial concentration (Figure 4-18). 
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Figure 4-18: Effect of time and resin:milk ratio on LF adsorpt
sample from cow 3423). 
 
4.10 Summary 
This chapter investigated the most practical and easily scale-u
and LP from raw whole milk. Conventional column chromato
BR 70 were used for processing raw whole milk at 35-
dynamic capacities for the resins indicated that both res
effectively capture LF and LP. It was found that ideally the pr
close to milk secretion temperature was most suitable for 
Results from single-stage stirred tank system showed that
captured in stirred tank but optimisations were necessary. 
The resin lifetime studies showed that SP Sepharose could b
50 cycles. This infers that it could be possible to use the resi
50 cycles without compromising performance. 
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5 Protein Adsorption  
Kinetic Modelling and Analysis  
5.1 Introduction 
Modelling simulates a process for prototyping and is useful if scale-up data are not 
available. Once a model for a protein purification process is experimentally verified, 
it can be used to predict performance and yields. An objective in this study was to 
model adsorption data so protein purification could be understood, and to use the 
model to predict process performance if feed concentration; amount of resin, and 
adsorption time required for processing was known. 
Rowe et al. (1999) developed a novel composite non-linear (CNL) kinetic model 
with four independent parameters to describe batch adsorption that could simulate 
protein concentration-time profiles over a wide range of initial (feed) protein 
concentrations and phase ratios (resin:feed volume ratio, Φ). This approach, unlike 
Langmuir and solid film linear kinetic models, does not require an adsorption 
isotherm (Skidmore et al. 1990). The advantage of the CNL model is that kinetic 
capacity (qk) is linearly related to the physically measurable quantity of feed 
concentration (initial and changes in feed concentration over time). After a certain 
finite time, the relationship ln(1-q/qk)ln(C/Co) for protein adsorption on suspended 
anion exchange resin particles is linear with time i.e.  
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where q is protein absorbed on the solid phase (mg/mL resin); qk is a kinetic 
parameter; C is protein concentration in solution (mg/mL); Co is initial concentration 
(mg/mL); k is a rate constant (min-1), and y(0) is the zero-time intercept. 
More generally: 
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where a is a parameter for deviation from the straight line at times less than 5 
minutes (Figure 5-1). 
 
 
 
 
 
 
 
 
Figure 5-1: The CNL model for batch ion exchange adsorption of proteins. Data 
points deviate from a straight line below 5 minutes. 
Adsorption data for SP BB and SP FF resins were obtained in laboratory extractions. 
However, because on-farm trials were only done with SP BB, only these data were 
used to obtain values for qk, k, a and y(0) in the CNL model.  The model would allow 
adsorption uptake to be predicted from feed and operating conditions, ideally Co and 
Φ. Data obtained for extracting LF from raw whole milk over 45 minutes was 
transformed using steps in section 5.2. The limiting factors of the parameters 
(parameterisation) and their application are discussed.  
5.2 Methodology for determining CNL model parameters 
5.2.1 Determining qk, k and y(0) 
Feed concentrations were converted to mg/mL and
 
q was calculated as: 
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An initial value was given to qk (a useful value is one slightly higher than the 
experimentally observed last, or final, value of q). Then the left hand side of 
Equation 5.1 was plotted with time and the linear portion of the plot used to 
determine k (gradient) and y(0) using Excel Solver. The initial guess for qk was then 
refined to maximize the regression coefficient for the fit to Equation 5.1. 
5.2.2 Determining a 
For lower resin:feed ratios (0.05<Φ<0.15), a was assigned an initial value between 
0.25-0.5. Higher values were assigned for higher Φ values. Once qk was determined, 
the estimate of a was adjusted to minimize the sum of difference of squares of errors 
between a complete set of adsorption data and results using Equation 5.2. 
5.2.3 Fitting the CNL model and experimental data 
The original methodology of Rowe et al. (1999) included differentiating Equation 
5.2 with time to give:  
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At t=0, q=0 (no absorption), so Equation 5.4 is undefined. The initial adsorption rate 
was therefore determined by twice differentiating Equation 5.2 and assuming that 
adsorption begins after immediately initial contact, taken as 0.01 min. 
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Equations 5.4 and 5.5 were solved simultaneously using the Ordinary Differential 
Equation solver (ODE) function (“rkadapt”) in MathCad™ (Mathsoft, Cambridge, 
MA, USA). The values for a and k, obtained using Excel Solver, were adjusted 
slightly (within 10%) to obtain the best fit in MathCad. Values for parameters y(0), a 
and k were optimised by trial and error so the model fitted the experimental data. 
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5.3 Assessing parameters of the CNL model 
5.3.1 Kinetic capacity, qk  
For each initial feed concentration used, qk was asymptotically related to Φ (Figure 
5-2). When Φ was >0.017, qk approached a constant value for each initial protein 
concentration. Although the actual meaning of qk in the Rowe et al. (1990) model is 
unclear, it may represent the approach to equilibrium adsorption capacity, which is 
demonstrated by the data obtained. 
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Figure 5-2: qk vs Φ for milk from individual cows. 
The data can also be presented as the effect of initial protein concentration (Co) on qk 
for various resin:milk ratios, (Φ). 
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Figure 5-3 Effect of Φ and Co on qk value. 
A sensitivity analysis showed that qk values significantly affected the best fit for the 
CNL model. Once values of qk had been determined, changing a and k had relatively 
little effect on the fit of the model.   
After the model has been obtained, information on milk volume (measured as a cow 
is milked), and its LF content (from information on the particular cow), together with 
the amount of resin being used to capture the protein, means that qk can be predicted 
and then the expected yield can be predicted. This information could be used in a 
dynamic on-farm scenario to selectively accept or reject protein capture from specific 
milk based on predicted yield. 
Values for the intercept and gradient of the relationship between qk and Co for 
different Φ values (0.010 - 0.024) show that qk can be related with Co by: 
cxCoqk += ; (5.6) 
where  Φ−= 8821.66x  and Φ−= 5169.33c  
or  )5169.33()8821.66( Φ−+Φ−= Coqk  (5.7) 
 
Φ = 0.010 
Φ = 0.012 Φ = 0.024 
Φ = 0.017 
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Figure 5-4: Effect of Φ on the intercept and gradient for the linear relationship 
between qk vs Co (slope and intercepts obtained from Figure 5.3). 
 
5.3.2 Rate constant, k  
For all Φ values investigated there was a positive linear relationship between the rate 
constant, k, and Co (Figure 5-5). 
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Figure 5-5: Effect of Φ and Co on k value. 
Φ = 0.024 
Φ = 0.017 
Φ = 0.012 
Φ = 0.010 
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A summary of the gradient for relationship between k and Co at various Φ values 
(Table 5-1) show: 
05.105.0 Cok =  
If 05.1Co  can be approximated to Co, then: 
Cok 05.0=  (5.6) 
 Table 5-1 Power log fit of k and Co for given resin:milk ratios (Φ). 
  Φ  Gradient (k vs Co) 
0.010 0.03 
0.012 0.04 
0.017 0.05 
0.024 0.06 
 
 
A sensitivity analysis showed that 0.03<k<0.06 did not significantly affect the CNL 
model. A plot of k vs Φ (Figure 5-6) shows that k is constant for low Co and then 
increases with Φ for higher Co values.  
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Figure 5-6: Effect of Co on the relationship between Φ and k.  
The characteristics for the curves are summarised in Table 5-2. 
 
Co (mg/mL) 
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Table 5-2: Summary of relationships between k and Φ for given Co values. 
Co Relationship to k Regression (R2) 
0.220 0.6871Φ + 0.011 0.9514 
0.240 0.3629Φ + 0.005 0.9213 
0.640 5.5837Φ - 0.027 0.9679 
0.750 2.5248Φ - 0.0001 0.8465 
There is a linear relationship between Φ  and the gradient of the relationship between 
k and Φ (at given Co) (R2=0.95), which can be expressed as: 
Cok )013.001.2( +Φ=  (5.7) 
5.3.3 a for adsorption 
Values for the time constant, a, were generally small (0.12 to 0.30; average of 0.20) 
at the Φ values used. For given Φ, Co did not affect a (Figure 5-7), therefore Co 
could be expressed in terms of Φ. There was no significant relationship between a 
and Φ (Figure 5-8) and most of the variation is likely to be due to experimental 
(measurement) error (or random scatter). 
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Figure 5-7: Effect of Φ on a. 
The sensitivity analysis showed that the CNL model is not affected if 0.18<a<0.22 so 
a could be approximated as 0.2. This was lower than the 0.3 - 0.8 obtained by Rowe 
et al. (1999) for anion exchange of BSA at concentrations up to 3 mg/mL. They used 
Co 
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a second order equation to relate the effect of Φ on a whereas data obtained in the 
current experiments on cation exchange of LF can be approximated as a single value. 
Raw whole milk is a natural product with a LF concentration between 0.07 and 1.0 
mg/mL. Therefore it was not possible to investigate LF concentrations above 1.0 
mg/mL because 1.0 mg/mL is the maximum concentration expected in milk from 
individual cows during majority of the lactating period.  
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Figure 5-8: Effect of Co and Φ on a. 
5.4 Effect of a, Co and Φ on y(0) 
Values for y(0), obtained by extrapolation of plots from left side of Equation 5.2 
were then used to generate a CNL model fit experimental data using MathCad. The 
parameter y(0) is an artefact due to deviation from straight line adsorption and could 
be related to a and k. The y(0) values were generally small (-0.07≤y(0)≤-0.01). If y(0) 
was set at smaller negative or positive values, a solution could not be obtained using 
the ODE (MathCad). 
As a is relatively constant (~0.2) and k depends on Co and Φ, y(0) may also be 
affected by values of Co and Φ. However, no obvious relationships between y(0) and 
Φ or Co (Figure 5-9) were observed, probably because y(0) is very small compared 
with a and k.  
Φ 
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Figure 5-9: Investigation on whether Φ affects y(0) for LF adsorption from 
individual cow’s milk. 
 
The linear relationships between y(0) and a for milk from individual cows over the 
range of Co tested (Figure 5-10) can be expressed as regression equations (Table 5-
3). If the value a = 0.2 is substituted into the overall composite regression equation 
(Equation 5.9), then y(0) = -0.023.  
Table 5-3: y(0) vs a relationship for milk from individual cows with regression data. 
 Cow Id y(0) vs a relationship R2 
 3423 0.2333a - 0.077 0.9708 
 1607 0.085a - 0.0405 0.7581 
 324 0.2421a - 0.0642 0.8975 
0606.01868.0)0( −= ay  (5.8) 
Sensitivity analysis showed that as for the constant a, value of y(0) did not affect the 
CNL fit significantly. 
Rowe et al. (1999) found that there was a relationship between y(0) and k/a. 
However, the scatter plots showed no obvious relationship between y(0) and a 
(Figure 5-10) or y(0) and k/a (Figure 5-11). This may be because a much smaller 
range (0.1 to 1.0 mg/mL) of Co values were used in the LF adsorption studies 
compared with 0.0 to 3.0 mg/mL BSA used by Rowe and co-workers. 
Co (mg/mL) 
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Figure 5-10: Effect of Co and a values on y(0). 
 
-0.10
-0.08
-0.06
-0.04
-0.02
0.00
0.00 0.10 0.20 0.30 0.40
k/a
Y(
0) 0.75
0.24
0.64
0.22
0.58
 
Figure 5-11: Effect of Co and k/a values on y(0). 
5.5 Practical use of the CNL model 
The CNL model could be fitted to batch adsorption of LF from raw whole milk. The 
amount of LF extracted, over the range of Φ values tested for extraction times of 30 
minutes or longer, was almost independent of Φ. The data indicate that overall 
adsorption rates were more dependant on qk than the rate constants k and a. The 
value of qk was affected by Co but this effect decreased as Co increased. 
Co 
Co 
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Correlations obtained in sections 5.2-5.4 show that the CNL model for cation 
exchange adsorption of LF from whole milk can be represented by: 
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−  (5.9) 
where )5169.33()8821.66( Φ−+Φ−= Coqk  
and  Cok )013.001.2( +Φ=  for 0.18≤a≤0.22 and y(0) = -0.023 
This CNL model can be used to predict the amount of LF that would be extracted for 
a known volume of resin and volume of milk with known initial LF concentration. 
Milk from six individual cows was used for laboratory-scale LF adsorptions in a 
single-stage stirred tank over 45 minutes for different Φ. The Co and Φ values were 
used to obtain the CNL model parameters. 
There was good agreement between predicted values for LF adsorption with time for 
Φ=0.017 (being Φ for average volume of milk produced by an individual cow and 
250 mL of resin) by the CNL model (Equation 5.10) and experimental data (Figure 
5-12). 
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Figure 5-12: Comparison of experimental and simulated data (Equation 5.10) 
for Φ=0.017. 
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Equation 5.11 
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5.6 Data from on-farm experiments 
The Co values in milk from individual cows used in on-farm fractionations were 
between 0.08 and 0.48 mg/mL and the Φ values were between 0.010 and 0.030 
(section 7.3.3). These Co and Φ values were used to predict LF extraction with time 
using Equation 5.10 (Figure 5-13). Some trends observed in the on-farm studies were 
noted on the simulated graphs. For example, higher Φ values (e.g. when Cow 3532, 
3022 and 9570 produced less milk, resulting in Φ = 0.030, 0.028 and 0.024 
respectively) gave faster absorption rates and therefore higher yields for 10-minute 
extraction (Figure 5-14). Because of the limited range (0.08 to 0.048 mg/mL) of 
initial LF in the milk used, effects of concentration were not observed. 
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Figure 5-13: LF adsorption simulations using Co and Φ from on-farm experiments 
and Equation 5.10. 
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Figure 5-14: Predicted LF yields using Co and Φ from on-farm experiments and 
Equation 5.10. 
The CNL model does not include elution efficiency (i.e. recovering protein from the 
resin). Simulations for on-farm extraction represent complete recovery of protein that 
has been absorbed onto the resin concentrated into small volumes. 
Data from on-farm experiments differed from the simulations by an average of 14% 
(Table 5-4), indicating that the model developed can be used to predict protein yields 
at a specific time in the process. Experimental yields are full recovery of protein but 
simulated yields are based on adsorption only. Therefore, the latter overestimates 
yield, which can be treated as the losses that occur during elution. This infers that the 
fit between experimental and predicted yields is better than 14%. A factor that may 
affect values predicted by the model that was not studied in the current trials is the 
effect of fat on protein absorption. 
 
 
 
 
Cow ID 
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Table 5-4: Experimental (on-farm) and predicted (using Equation 5.10) yields of LF 
after 10-minute adsorption. 
 Cow  LF  % Yield  Variation† 
 Identification (mg/mL) Predicted Experimental  
3532 0.254 58.7 55.2 0.94 
3022 0.373 60.1 46.0 0.77 
9570 0.157 48.9 48.9 1.00 
3109 0.374 46.8 25.6 0.55* 
1922 0.239 41.2 27.6 0.67 
1922 0.408 46.1 47.8 1.04 
3402 0.392 44.6 23.4 0.52* 
1607 0.330 40.6 36.1 0.89 
2409 0.078 33.9 36.7 1.08 
9564 0.240 36.8 43.5 1.18 
694 0.145 32.5 35.3 1.09 
5710 0.333 39.6 29.5 0.74 
480 0.478 40.4 34.9 0.86 
1401 0.260 34.0 28.5 0.84 
7656 0.101 26.7 19.7 0.74 
Overall difference*     0.91±0.16 
†
 Expressed as experimental over predicted. * Excluding Cow 3109 and 3402 data 
5.7 Summary 
The most valuable aspect of modelling is being able to predict the amount or yield of 
target protein (in this case LF) that can be extracted from a given a volume of milk, 
with a known initial feed concentration using a known amount of resin and extraction 
time. The kinetic model described by Rowe et al. (1999) assisted in understanding 
the effect of contact time between feed and resin when developing relationships 
between feed concentrations, amount of resin, contact time and expected yields. The 
model can be used to show typical extractions profiles for initial feed LF 
concentrations of 0.1-1.0 mg/mL in the average milk volume (15 L/cow), with a 
resin: milk ratio of 0.017 over 45 minute (Figure 5-15). 
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Figure 5-15: Simulated LF extraction for Co of 0.10 to 1.00 mg/mL over 45 minutes 
with Φ = 0.017. 
 
An investigation of the effects of initial feed concentration and volume (10-20 L) on 
LF yield using 250 mL of SP BB resin showed that yield increases as initial LF 
concentration increases and that the highest yield was obtained when processing 10 L 
because this was at the highest Φ (Figure 5-16). Therefore, in an optimised system, 
higher process yields (and hence productivity) will be obtained when processing milk 
with a higher content of the target protein (high Co). A targeted system for LF would 
be ideal when milk has highest LF levels just after calving (i.e. in the colostrum) and 
total milk volume is low. This also occurs at the end of the season, where milk 
volume per cow is decreasing and LF concentration is increasing. 
 
Co 
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Figure 5-16: Effect of Co (initial LF content) and milk volume on yields when using 
250 mL of SP BB resin and 10-minute contact time in a single-stage stirred tank. 
Milk volume 
6 On-Farm Fractionation 
Materials, Methods and Prototype Design 
6.1 Introduction 
Two on-farm trials for capturing target milk proteins were done at the Greenfield 
dairy unit (Dexcel Limited). The first experiment (section 6.2), done during the early 
stages of the project, evaluated the concept of on-farm fractionation. The data 
showed that manual on-farm fractionation was possible and a patent was 
subsequently granted (Claycomb, 2004). The second trial (section 6-13) used the 
fully automated prototype Protein Fractionation Robot (PFR), which was connected 
to the AMS. The AMS has full automated control, a data management system, and 
traffic control (Fusion Electronics, Diksmuide B-8600, Belgium). Design 
considerations and developing the PFR are described in sections 6.4-6.10. 
6.2 Proof of concept for on-farm fractionation 
The aims of this experiment were to: 
• demonstrate that proteins could be captured on-farm using freshly 
harvested raw whole milk 
• test feasibility of capture using pleated filter cartridges filled with resin 
and 
• obtain preliminary data for intellectual property protection 
6.2.1 Pleated cartridge filter capture 
Two Aqua-PureTM (AP11T, CUNO, Blacktown, N.S.W., Australia) water filter 
housings with AP1020 20-µm polyester pleated cartridges (Figure 6-1) were filled 
separately with approximately 600 mL of swelled cation exchanger resin (SP BB or 
BR 70). A peristaltic pump (Watson-Marlow Bredel Inc, Wilmington, MA, U.S.A.) 
was used to pack the slurries into the cartridges. Phosphate buffer flow rates of up to 
3 L/min through the packed cartridges were achieved with the peristaltic pump 
without significant back pressure. 
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Figure 6-1: AP11T Aqua-PureTM water filter housing with AP1020-20 µm polyester 
pleated cartridge. 
Milk from an individual cow was diverted from the AMS using a centrifugal pump at 
2 L/s into a secondary receiving can (Figure 6-2). The milk was then pumped at 1 
L/min (peristaltic pump) through the cartridge filter containing BR 70 resin.  
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 6-2: Process flow sheet for milking using the AMS showing the standard milk 
route and diversion for on-farm fractionations. 
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6.2.2 Batch stirred-tank capture 
The LF and LP in fresh raw whole milk were captured with SP BB resin immediately 
after milking (harvesting). The resin (600 mL of SP BB, pre-equilibrated to pH 6.7 
with 10 mM phosphate buffer) was placed in the secondary processing can.  
Milk (8.1 L, pH 6.88) from an individual cow was diverted from the AMS into the 
can and the milk/resin slurry was manually stirred for 10 minutes. The milk/resin 
slurry was then passed at 1 L/min through a fresh cartridge filter using a peristaltic 
pump. The filter cartridge was then rinsed with approximately 3 L of phosphate 
buffer and transferred to the laboratory to elute the proteins. 
Protein was eluted by batch washes. The resin was first washed with 2 L of 10 mM 
phosphate buffer before eluting the LF and LP in two steps. The LP was the eluted 
with 1.0 L of 0.25 M NaCl in phosphate buffer and then the LF was eluted with 1 L 
of 0.8 M NaCl in phosphate buffer. Resin was then cleaned by consecutive washes of 
0.5 L of 1.0 M NaCl, 0.5 L of 1.0 M NaOH and 2 x 1-L washes of Milli-Q water. 
Cleaned resin was stored in 20% ethanol. 
Total protein in feed and eluates were determined by the BCA protein assay. The pH, 
fat, protein, lactose, total solids, LP activity, and LF and LP content of samples from 
raw whole milk (feed) and processed milk (outflow) were determined. Five-mL 
samples of eluates were desalted on a 5-mL HiTrap desalting column on the AKTA 
fplc and then the LF and LP content were analysed using a Resource S column. 
6.3 Contactor design considerations 
The experiments (section 6.2) for processing volumes of milk expected in a robotic 
milking system, indicated that it was possible to process fresh, raw whole on the farm 
and that an engineering solution was needed for the efficient capture of LF and LP.  
Observations from on-farm fractionation (section 6.2) and other laboratory 
experiments (Chapter 4) indicated that: 
• the concept of using a cartridge filter, pre-coated with resin, is not viable. 
Non-uniform coating and redistribution of resin during milk loading 
resulted in milk by-passing the resin almost entirely 
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• the size of fat globules in the raw whole milk, combined with the milk’s 
viscosity, contributed to resin fouling and decreased processing efficiency  
• raw whole milk at 37oC could pass through a packed bed containing SP 
BB or BR 70 resin 
• SP BB resin had better flow characteristics, less back pressure, less bed 
compaction and better absorption capacity (perhaps due to the larger 
particle size) than BR 70 resin 
• SP BB resin has the added advantage that it is approved as Generally 
Regarded As Safe (GRAS) by the FDA (GE Healthcare Technologies 
2004, 2005). 
6.4 PFR design considerations for a prototype 
6.4.1 Prototype specifications 
A design brief was created and a team assembled to design, fabricate and assemble a 
PFR. The overall approach was to design a system that could transfer a laboratory-
based fractionation operation to an on-site processing, that is to couple a 
chromatographic extraction unit onto an existing AMS so that proteins could be 
extracted, directly from raw, untreated milk, immediately after each milking. The 
prototype had to be able to process milk from individual cows as they were being 
milked, without disrupting the normal milking process. A protein purity target was 
not set for the prototype. However, yields greater than 80% were desirable. The 
prototype had to be robust enough to withstand the dairy parlour environment, be 
reliable and work without needing a technician on-site. In other words, the principle 
of minimal human intervention, as for the AMS, was to be maintained and applied to 
this system. 
6.4.2 Design constraints 
The PFR system ideally, had to be able to consecutively process from each cow that 
came to be milked by the AMS. The AMS takes an average of 8 minutes (range of a 
few to 20 minutes) to milk one cow. This time is similar to the reported average 
milking time (6-7 minutes) for a cow producing 20 L of milk (Mein 1998). This 
meant the prototype had to be able to complete one process cycle within 6-7 minutes, 
 6-5 
including preparing the system to accept milk from the next cow. Thus, the time for 
actual adsorption had to be no more than 5 minutes. 
All materials, buffers, chemicals, fittings, etc had to be approved for dairy or food 
usage. Losses in milk volume processed due to void volumes and transfers had to be 
minimal. Temperature affects adsorption rate and pressure drop through the resin 
during recovery when straining through a fine mesh, so milk temperature had to be 
maintained as close to the secretion temperature as possible. The PFR has to have a 
facility for CIP and sanitisation so it could be cleaned and hygiene maintained. 
Fresh, raw whole milk harvested using the AMS had to meet the following 
specifications: 
• its quality had to be maintained throughout the process. For example, 
increases in somatic cell counts or spoilage of milk should not occur 
during processing 
• able to be further processed (i.e. transported to a factory) 
• not kept at ambient temperature for prolonged periods (e.g. > 30 minutes) 
• contain no residues (i.e. no foreign matter could be introduced during 
processing). 
The PFR was to be: 
• manufactured from food-compliant dairy-approved materials and 
components 
• simple yet versatile so variations in processing time, volumes, etc could be 
accommodated 
• automated with minimal operator assistance 
• user-friendly, with an interface for the farmer or operator 
Because the AMS is operating in a commercial dairy unit, coupling the PFR to the 
AMS had to be done without disrupting daily milking operations or causing down-
time. 
6.4.3 Feed stream and temperature effects 
Milk secretion temperature is nominally 37oC. However, the final temperature of 
batches of harvested milk depends on ambient temperature, the time it takes to milk 
 6-6 
(some cows milk faster than others) and the volume of milk produced. Small 
volumes of milk cool quickly because the surface area to milk volume is higher. 
Milk is a regulated food material in New Zealand. General manufacturing practice 
means that milk is usually cooled as quickly as possible to minimize microbial and 
chemical deterioration. Milk must be pasteurized before any further processing is 
done. However, milk is legally defined as such only after it enters the factory; current 
pasteurisation regulations do not apply on the farm. 
Earlier studies indicated (section 4.6.2-4.6.3) that protein uptake by the resin 
increases with temperature. However, cation-exchanger containing the captured LF 
and LP must be stored at low temperature (e.g 4oC), to minimize microbial growth 
and to maintain product bioactivity. It would also be desirable to store fresh resin at 
4oC until processing. 
6.4.4 Selecting the chromatographic media 
In food processing, chromatography resin (media) is generally treated as a raw 
material. Resins used in the food processing industry must be approved by the 
appropriate regulatory authority such as FDA (for food being exported to U.S.A.) 
and/or Food Standards Australia and New Zealand (FSANZ) for product being used 
in New Zealand and Australia. Two resins (BR 70 and SP BB) were used in the 
initial packed bed trials in the laboratory. The BR 70 resin had been used in previous 
experiments and was included for comparison. SP BB and SP FF resins have GRAS 
status. This dextran-based matrix is already used in the New Zealand dairy industry 
for similar applications such as processing LF and LP from skim milk and whey.  
Fractionating LF and LP from raw whole milk is not considered downstream 
processing. They are only minor components in milk and it is envisaged that the milk 
would essentially be unchanged and suitable for normal consumption or further 
processing after the extractions had been done. Thus, any extraction process will 
leave the milk as near to normal state as possible. Hence, only food grade approved 
resin can be used.  
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Physical stability of SP BB 
Trials showed that high centrifugal forces and contact with fast moving impellers 
damaged the resin. Peristaltic pumps are gentler but may not provide uniform flow 
rates due to tube fatigue. High linear velocities (up to 6000 cm/hr) in a packed 
column did not damage the resin (refer to section 4.4.3). 
6.4.5 Traceability 
The AMS has Crystal management software and can identify each animal from radio 
frequency identification tags, control milking events, collect milking data for each 
animal, interface with online sensors, and control ancillary equipment. If the 
adsorption device was linked to the AMS, it would be possible to control the process 
and optimise extraction from each animal. Data on product yield and activity for 
individual animals and information from the AMS would allow the farmer to identify 
high-producing animals and to relate various farm management practices (milking 
frequency and time, feeding regimes, etc) to yield of specific proteins.  
The food value chain may also benefit from advanced, rapid product traceability. For 
example, if there was a disease alert (such as Bovine Spongiform Encepthalphy), this 
traceability would allow affected batches to be easily and quickly isolated. Also, the 
regulatory process for producing recombinant proteins for human therapeutic use 
from milk of transgenic animals may be more readily satisfied if the protein could be 
traced back to individual animals. If an animal develops ill-health or infection, 
product from that animal could be traced and withdrawn from further processing or 
disposed of. Likewise, any problems with individual product identified during quality 
checks could be tracked to the individual animal rather than the whole herd. 
6.5 Assessing the available adsorption processes 
The design brief included fast, effective and rapid protein captures. The contact mode 
for on-line fractionation is one of the critical steps. After evaluating the resin and the 
delivery mode, it was necessary to scale-up, modify, and incorporate the system on 
the AMS. The amount of resin required was based on laboratory experiments with 1-
L samples of milk. Because resin is one of the major raw material costs in this 
process, it is important that the adsorption process is optimised and the minimum 
amount of resin used.  
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6.5.1 Packed bed chromatography 
Column chromatography was first evaluated, as it is the most widely-used technique 
for protein extraction. Cation-exchange resins are currently used for commercial 
production of LF and LP from whey and skim milk. Laboratory experiments 
demonstrated that proteins could be separated chromatographically, directly from 
untreated raw, whole milk. The SP BB resin was selected because it has a relatively 
large particle diameter, which gave lower column back pressures than smaller 
diameter resin. No attempt was made in the current study to compare the 
performance of SP BB with resins other than BR 70. 
Approximate dimensions of a scaled-up, packed bed chromatographic extraction unit 
were investigated. Two options for packed bed chromatography were considered: 
• One or two large columns to process a defined number of cows or the milk 
collected over a long period (e.g. 24 hr) 
If the linear velocity between laboratory and farm was maintained, a 5-cm high, 36-
cm diameter column was needed to extract almost all of the LP and 95% of LF from 
the average milk volume (15 L) of 33 cows. However, the milking process is 
voluntary in the AMS; and cows arrive throughout the 24-hr day and sometimes 
there are periods when there is no milking. Microbial growth becomes an issue if a 
column is repeatedly loaded with raw milk and maintained at 35oC for extended 
times. To manage contamination, the column would need sanitation between 
milkings. The adsorbed protein will probably deteriorate with prolonged storage at 
35oC and/or repeated cleaning cycles. These aspects could be dealt with by eluting 
the protein between milkings but would require a column sized for single milking 
and equipment to elute, store and retrieve the captured protein. 
• Single, packed bed columns to process milk from individual cows 
A 15-L batch of milk contains approximately 8 g of LF and LP. About 150 mL of 
resin with a dynamic capacity of 50 mg/mL would be required per milking. If total 
processing time is arbitrarily set to 3 minutes per milking to minimise the time milk 
is at 35oC, a 36-cm diameter fixed bed is required to maintain the linear velocity at 
300 cm/hr. The bed height for 150 mL of resin is only 1.5 mm, which is not practical. 
Reducing column diameter to obtain a practical bed height will increase flow rates 
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(which increases back pressures, reduces dynamic capacity and blocks column faster) 
or increase processing time (which increases microbial growth and means longer 
times than the time to milk an individual cow). 
Column diameter affects three design parameters: bed height, time required to 
process at a linear velocity of 300 cm/hr and the flow rate required to process a given 
volume e.g. 15 L in three minutes (Figure 6-3). Bed height only reaches a practical 
(though still very small) value (2 cm) if column diameter is reduced to 10 cm but it 
will take 40 minutes to process 15 L of milk at 300 cm/hr. To complete processing in 
three minutes with this column diameter requires a flow rate of 5 L/min. Also, 
insufficient adsorption will occur at the high flow rates. 
 
Figure 6-3: Effect of column diameter on design parameters while maintaining the 
linear velocity of 300 cm/hr. 
A packed bed column was not a suitable process to meet the design brief for 
capturing proteins from milk of individual cows. A second column chromatography 
option is a multi-column system such as a simulated moving bed on a carousel, with 
a column for each cow. Ion exchange systems generally operate at 300-600 cm/hr to 
obtain appreciable protein adsorption. To process milk within the average milking 
time would require linear velocities of 2000-4000 cm/hr, making column design 
impractical. Also, most preparative-scale protein chromatographic resins cannot 
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withstand the back pressure generated if linear velocities are above 1000 cm/hr. 
(Prolonged exposure to high linear velocities were not tested for SP BB resin).  
6.5.2 Ion exchange membranes 
Because column-based chromatography had many disadvantages, other processes 
were investigated. The membrane ion exchange systems currently available have 
small pores (0.2-0.5 µm) and no prototype membranes with bigger pore sizes were 
available for trial. The manufacturers’ dairy specialists advised that raw whole milk 
could not be processed with these membranes because the fat globules and other 
suspended matter would cause excessive fouling. In hindsight, the membranes 
available probably could process raw milk at 35-37oC but the membrane suppliers 
have not considered this operating temperature when advising on process feasibility. 
The cost for 10-mL and 100-mL ion exchange membranes was NZ$980 and $4300 
respectively (2005 prices, Sartorius Sartobind). Some ion exchange membranes are 
available as disposable cartridges for pharmaceutical use where validation, hygiene 
and contamination are important process considerations. If the 100-mL membrane 
could be reused for 1000 cycles, the membrane cost would reduce to $4 per cycle, 
but this is considered too expensive for on-farm processing. The effect of membrane 
pore size and the cost for processing milk from individual cows needs to be 
investigated. 
6.5.3 Batch chromatography in a single-stage stirred tank 
Batch processes are less efficient than column processes but have advantages if feed 
viscosity is high and particles in the feed make column chromatography unsuitable. 
A batch process has many advantages in this study, especially because of the high fat 
content in the feed. 
These considerations led into investigating protein adsorption from individual 
animals using a single-stage stirred tank. Laboratory trials on the effect of LF feed 
content on protein capture using SP BB resin in a batch process showed that adequate 
LF and LP yields could be obtained provided the resin to milk ratio was appropriate 
and sufficient time was allowed for adsorption. 
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Most of LP and up to 95% of LF was captured at acceptable linear velocities in 
column chromatography but similar levels of capture were only possible in a batch 
process if a 30-minute adsorption time was used. An alternative resin, SP FF 
(average bead size of 90 µm) gave better yields (section 4.9.1). 
The simplest method to recover ion exchange resin in a compact volume after 
adsorption is by straining (sieving). Milk should be at or near the temperature it 
comes from the cow to maintain flow through the resin being collected on the 
strainer. Adsorption uptake, which should ideally be fast enough to be done within 
the time to milk each animal, is also higher at the secretion temperature. The 
efficiency of straining was explored (section 6.9). 
6.6 Protein uptake rate 
Detailed adsorption studies showed that the rate of protein uptake and final product 
yields depended on initial feed LF concentrations, adsorption temperature, type of 
resin (e.g. 200 µm vs 90 µm diameter), the resin:milk ratios (Φ), and adsorption time. 
The effects of other milk components were not evaluated. Yields could be predicted 
from the CNL model (section 5.5 – 5.7). Results from modelling showed that milk 
volume had little effect on adsorption above a Φ of 0.02. Resin is the major raw 
material cost (Chapter 8) so it is important to operate at the minimum Φ. 
Laboratory trials showed that SP FF resin, with smaller beads and higher dynamic 
capacity, gave higher protein yields at 10 minutes than an equivalent volume SP BB 
resin, which has a higher equilibrium capacity (Chapter 4.5). Because yield within 10 
minutes processing was is the most important process factor, the dynamic capacity 
rather than equilibrium capacity was the most relevant resin characteristic.  
6.7 Cleaning, sanitisation and sterilisation procedures 
Equipment and resin must be sanitised between adsorption cycles to reduce cross 
contamination. Any fat on the resin will reduce adsorption. Dairy equipment must be 
sterilised after cleaning to destroy micro-organisms in the system. Caustic soda 
(NaOH), a very efficient sanitiser and cleaner that solubilises precipitated proteins 
and lipids, can be effectively combined with solvent or detergent-based cleaning 
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methods. Dairy equipment is usually sterilised with steam after NaOH sanitisation. 
Resin manufacturers supply recommended cleaning procedures (Table 6-1).  
Table 6-1: Suggested cleaning protocol for SP Sepharose resin. 
Procedure Reagent amount and concentrations 
Removing precipitated proteins 1.0 M NaOH (2-3 bed volumes) 
Removing lipids, hydrophobic proteins, 70% ethanol or 30% isopropanol (3 to 
 lipoproteins   4 bed volumes) 
0.5% non ionic detergent in 1.0 M acetic 
acid (3 to 4 bed volumes) 
Sanitisation 1.0 M NaOH 
Sterilsation Autoclave media at 121oC for 15 min. 
Cleaning-in-place (CIP) allows equipment to be sanitized without disassembling the 
equipment. The AMS CIP procedure includes an acid wash using Optima (Ecolab 
Limited, Hamilton, New Zealand) and NaOH hot rinses followed by water rinses, 
which are standard washing protocols used in the dairy industry. Protocols for 
cleaning and regeneration of resin were evaluated in section 3.13.3. 
6.8 Capacity of the PFR  
One cow at the AMS dairy unit had produced 37 L of milk, which was unusually 
high compared with the average of 15 L. To allow for the maximum likely milk 
production, a 37-L processing can was selected for processing. Volume of milk 
produced by a cow at each milking in the AMS dairy unit can be altered by changing 
the milking frequency in a 24-hour period.  
Simultaneous processing of several cows using multiple receiver cans in the 
extraction unit would increase flexibility. However, this requires a more 
sophisticated system and will increase costs. The system had to be designed, 
constructed and evaluated within one year; incorporating the possibility of multiple 
processing would have taken too long to implement. 
6.9 Mixing and resin recovery (straining) 
Mixing suspends resin in the raw whole milk. Fines are generated if the resin is 
stirred too vigorously, which can increase filtration time, so upper stirring speeds 
were limited. Speeds of up to 200 rpm have been used during adsorption without 
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damaging the resin (Huppertz et al. 2003), although this will depend on the impeller 
blade and tank geometry. Having an adjustable stirrer would be useful for controlling 
stirring rates. 
After the adsorption cycle, the resin must be recovered. This can be done by straining 
the resin on a polymeric membrane or a stainless mesh. Stainless steel mesh is safe, 
robust, chemically inert, corrosion resistant, and comes in wide range of sizes. 
Stainless steel mesh such as T316 is designed for use in the food industry.  
The SP BB and SP FF resin had to be sieved. While being drained by gravity through 
a mesh in a dead-end filtration mode, a cake of retained resin quickly builds up. Flow 
resistance increases and draining rate drops rapidly. The decrease in drainage rate is 
very high if the milk/resin slurry drains too quickly initially (e.g. by suddenly 
opening a valve), presumably because resin particles are driven into, and then plug, 
the mesh. However, if drainage rate is controlled and the resin remains suspended 
during draining by stirring near the mesh surface, mesh blockage is minimised, and 
drainage rates can be maintained. 
Slurry draining experiments were done in a 0.5-m, 70-mm i.d. Perspex tube with a 
44-µm stainless steel filter (mesh 325, Mounts Wire Industries, Auckland, New 
Zealand) across the bottom. The tube was inserted into a tightly-fitting funnel and 
sealed with silicon sealant. A 12-mm PVC ball valve was attached to outlet of the 
funnel and a three-blade turbine impeller was placed 5 cm above the mesh (Figure 6-
4). Raw milk at 35oC was poured to a height of 35 cm and then 48.5 mL of swelled, 
drained resin was added (Φ = 0.016). After 30 seconds mixing, the outlet valve was 
opened carefully and the height of the milk/resin slurry recorded with time. 
 6-14 
  
Figure 6-4: Modified Perspex-tube used to study draining characteristics of 
resin/milk slurry. 
 
Stirrer speed affected slurry draining time (Figure 6-5) but the slurry drained quickly 
enough at the higher stirring rates for the planned process conditions. A stirrer with 
two impellers was best. The upper impeller was placed to give gentle stirring at 150 
rpm during adsorption and the lower impeller assisted both suspension during 
adsorption and minimised resin build-up on the mesh during draining. The variable 
speed motor allowed stirrer speed to be increased during the draining process. 
 
Figure 6-5: Effect of stirring speed on draining of a SP FF/milk slurry. 
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Liquid level sensors (Honeywell Control Systems Limited, Scotland, U.K.) were 
placed in the process vessel to sense milk level during processing and draining so 
stirrer speed could be controlled and the rinse step started. 
6.10 The PFR mechanical design and assembly team 
Over the summer period (2004/2005), the mechanical design of the PFR was 
undertaken by a group of students from The University of Waikato Florian Kern (a 
Mechanical Engineering PhD student and overall project team leader), with Andrew 
Hall (a 4th year BE student), and Nathan Scott (a recent BE graduate). The team was 
given various concepts to evaluate in terms of costs and time to manufacture a single-
stage stirred tank reactor operation. Once design drawings were completed, parts 
were contracted for manufacture and components were ordered. The PFR was 
assembled, semi-automated, tested and transferred to the Greenfield’s site (Figure 6-
6). A process schematic for the PFR is given in Figure 6-7. Detailed design drawings 
are given in Appendix A. 
 
Figure 6-6: The Protein Fractionation Robot prototype for on-farm capture of LF and 
LP. 
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Figure 6-7: Process schematics for the Protein Fractionation Robot prototype. 
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6.11 On-farm fractionation using the PFR  
Samples of milk, taken via the in-line autosampler on the AMS, were used to 
determine LF in milk from cows milked over a 24-hr period. 
Not all aspects of the extraction purification process could be accomplished on-farm 
(Figure 6-8). A complete fractionation system should ideally include all aspects of 
protein purification, with most of the processing done on-farm. The PFR was 
designed to extract and store the proteins at 4oC before further processing was done. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 6-8: Protein fractionation process to capture and recover high-value proteins. 
Individual cows usually produce similar milk volumes from day to day. As cows go 
through the drying-off period, milk volumes gradually decrease to between 2 and 5 
L. As the lactation season progresses, milking frequency (number of visits to the 
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milking parlour) can be reduced or increased based on milk volumes. The Greenfield 
No 4 dairy operates on a 4-season calving basis. At any time there are cows at early, 
mid and late stages of lactation. 
Extra Programmable Logic Controllers (PLCs) were put on the AMS to allow the 
PFR to be coupled in. Milk was pumped from the AMS receiver can into the 
prototype using a reversible, liquid ring pump (Fristam Pumps Inc. Middleton, 
Wisconsin, U.S.A.) on the prototype. The system was set so that once the “selected 
cow” (specific cow selected based on unique identification), “correct cow” (cow 
selected on milk volume or other variable such as colostrum), or “any cow” (any cow 
reporting for milking) conditions were met the harvested milk would be immediately 
diverted to the PFR for processing. The system was able to process (a) any cow 
consecutively or (b) any selected cows provided the PFR was ready to accept milk 
(i.e. not in a process or cleaning cycle). 
6.11.1 Preliminary runs 
The control algorithm is summarized in Figure 6-9. The first runs were done with 
empty cassettes. The processing (adsorption period) for single-stage batch adsorption 
was set to five minutes. Milk from the AMS was set for acceptance by the PFR, 
regardless of volume of milk produced. Once a cow reported for milking and the 
AMS successfully attached all teat-cups, it sent a signal to the PFR requesting the 
PFR to load an empty cassette and send a ready signal back to the AMS. The PFR 
picked up a cassette and loaded it into place, then sent a signal to the AMS for milk 
acceptance. A 30 second interval was provided for receipt of the ready signal before 
milk diversion was abandoned. Once the PFR was ready and the AMS was notified, 
the AMS would notify the PFR when that particular milking was complete. This 
allowed the PFR to divert the milk for processing using the reversible pump. The 
stirrer was set at 150 rpm. After the adsorption period was completed, the processed 
milk was pumped from the tank using the same pump, with the cassette still in place 
(load position). The tank was rinsed twice with water (~ 40oC). The cassette was then 
stacked in the second rack (processed cassettes). 
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Figure 6-9: Procedure for on-farm capture using the PFR and the AMS. 
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6.11.2 Comparing SP BB and SP FF resins 
One of the design challenges for on-farm extraction was the decrease in drainage rate 
as resin cake formed on the sieve. The drainage characteristics of SP BB and SP FF 
resins were compared by diverting milk from individual cows (cow 9705, 18.1 L for 
SP BB; cow 8730, 18.6 L for SP FF) to the PFR and adding 200 mL of resin. After 5 
minute adsorption, the resin/milk slurry was drained to recover the resin. The SP BB 
particles were recovered from the resin/milk slurry in 45 seconds. Most of the milk 
drained from the SP FF/milk slurry in 5 minutes but it took a further 6 minutes to 
drain the next 1 L of milk, and some milk was still present when draining was 
stopped. The outflow temperature during the draining was 32.7oC for SP BB resin 
and 27oC for SP FF resin. 
Bead size was an important factor on draining times. Prolonged stirring and exposure 
to the elements (such as ambient temperature) makes processing inefficient and can 
cause irreversible damage to the resin. It could also affect milk quality. The 
temperature observed during SP FF trials (27oC) may have adversely affected results. 
However, time constraints meant the effect of temperature was not investigated. 
The milk cools further if drainage times are extended. Fat solidifies and milk 
viscosity increases. The stirrer had a maximum speed of 450 rpm. Trials had shown 
that it took at least 100 seconds to drain 1 L of SP FF/milk slurry at 515 rpm and at 
37oC (Figure 6-5). High stirrer speeds were needed to drain SP FF quickly and it was 
not practical to achieve complete milk recovery within a minute. Although milk is 
secreted at 37oC, it cooled to 25-32oC (depending on ambient temperature and milk 
volume) during milking and storage in the un-insulated primary receiving can. 
6.11.3 On-farm adsorption using the PFR  
The SP BB resin was equilibrated in 10 mM phosphate buffer and 250 mL of swelled 
drained resin (also weighed) was packed into cassettes and loaded into the PFR 
(which was 4oC). A contact time of 10 minutes was allowed for adsorption, followed 
by up to 1 minute draining to recover resin. The resin was rinsed twice with water at 
approximately 40oC. Cassettes with the captured proteins were stored at 4oC for 0.5 
to 4 hours before being transferred to the laboratory for further processing. 
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The acceptance criteria for processing was set on the AMS as a minimum volume of 
8.0 L of milk, partly because the AMS could not automatically sub-sample volumes 
less then 5.0 L. Cow identifications were noted and samples (milk feed and outflow) 
were analysed for bulk milk composition, total protein, and LF and LP content. Milk 
feed sample (i.e. before processing) was obtained from the automatic sampler on the 
AMS (except when the autosampler was not working, so manual sampling were 
taken). Samples of outflow milk (i.e. after processing) were obtained by inserting a 
5-mm i.d. sampling tube into the outflow milk-line and taking continuous sub-
samples during the draining process. Sampling variations may have occurred because 
sometimes sampling was not stopped during rinse cycles or before all the milk had 
drained. 
The LF and LP were recovered using two 10-minute step elutions at 37oC (water 
bath). The LP was eluted with 750 mL of 0.4 M NaCl, with a further 250 mL used 
for rinsing (total eluted volume 1 L). The LF was eluted with 2 x 750 mL of 1.0 M 
NaCl. The resin was cleaned, regenerated and stored in 20% ethanol. 
 7 On-farm Fractionation 
      Results and Discussion 
The results from the on-farm experiments with manual capture and trials using the 
PFR prototype are presented and discussed.  
7.1 Pleated filter cartridge capture 
When milk was passed through a cartridge filter pre-loaded with resin, milk filled the 
region with resin, flowed into the central region and then through the exit chamber. 
After the initial flow regime was established, the bed compacted and the rest of the 
milk bypassed the resin entirely. This meant no adsorption occurred because milk 
was not contacting the resin so this method was discarded. 
7.2 Batch stirred-tank capture 
Milk temperature before and after the 10-minute processing was 36.7 and 32oC 
respectively. Milk composition (% w/v) before (feed) and after (outflow) processing 
was similar (Table 7-1). 
Table 7-1: Gross milk composition (% w/v) before and after batch adsorption. 
 Milk Fat  Protein  Casein  Lactose  Total solids 
Feed 4.53 3.67 2.73 4.45 13.5  
Outflow 4.43 3.68 2.77 4.35 13.4 
Of the original LP in the feed, 13.8 and 61.5% were in eluates 1 and 2 respectively 
(Table 7-2). 
Table 7-2: LP concentration in feed and eluates. 
Sample  Volume  LP Total LP  LP yield 
 (L) (mg/mL) (mg) (%) 
Milk (feed) 8.1 0.010 77.5 -- 
Eluate 1 0.97 0.011 10.7 13.8 
Eluate 2 0.98 0.048 47.7 61.5 
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Purity (Equation 7.1) and purification factor (Equation 7.2) indicate effectiveness of 
the capture and separation. The greater the purification factor, the more effective the 
operation (a value of 1 indicates no change in purity). 
proteintotalofmg
LP)(egproteintargetofmgPurity =  (7.1) 
feedinpurity
eluateinpurityfactoronPurificati =   (7.2) 
The high purification factors (Table 7-3) show that LP and LF had been successfully 
captured from raw whole milk and that protein in the eluates was of high purity. 
Table 7-3: LF and LP purity and total yields in feed and eluates. 
 LF & LP Total LF & LP Total protein Purity Purification 
 (mg/mL) (mg) (mg/mL) (%) factor 
Milk (feed) 0.08 1119.4 36.4 0.2 -- 
Eluate 1 0.34 338.1 0.343 99.1 451 
Eluate 2 0.38 380.0 0.424 89.5 407 
7.3 On-farm fractionation with the PFR 
7.3.1 LF concentrations in raw whole milk 
Average milk production from 48 cows, milked by the AMS over a 24-hr period, was 
14.7±5.7 L, with 38 cows producing >10 L. The LF concentrations ranged from 115 
to 1317 mg/L. High concentrations of LF (e.g. 1317 mg/L) could be due to milk 
being from cows in early stages of lactation. The LF concentration varies during 
lactation (Turner 2002; Turner et al. 2003); it is highest in colostrums (milk 
immediately postpartum), is low during normal lactation, and increases in the drying-
off (late lactation) period when milk production is low (<5 L /day) (Figure 7-1).  
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Figure 7-1: The LF concentration in cow’s milk over a lactation period. 
7.3.2 Processing milk from consecutive individual cows 
In dummy runs with an adsorption cycle time of 5 minutes, it was possible to process 
all milkings from the AMS. If a resin with fast protein uptake were available, then 
contact time for adsorption will not be the limiting factor when processing and the 
PFR would be able to process milk from all cows, regardless of milk volume 
produced or time taken to milk an individual cow. 
7.3.3 On-farm capture of LF and LP 
The average milk volume from individual cows in the on-farm trials was 16.0 ± 4.6 L 
(Table 7-4). The milk feed contained 7-18 mg/L and 78-480 mg/L of LP and LF 
respectively. 
The average volume of fresh, clean resin before processing and after regeneration 
was 250.2 ± 1.8 and 248.2 ± 13.6 mL respectively, indicating minimal loss of resin.  
Milk from a Jersey cow (cow 480) had a high fat content (8.09%), which may have 
adversely affected LP recovery (only 51% compared with average of 87%), although 
LP yields generally were not particularly low (Table 7-4). Therefore, this data was 
excluded from statistical analyses. 
Drying-off period 
Colostrum period 
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Table 7-4: Milk characteristics and LF and LP recoveries (yields) from individual 
cows using on-farm capture with the PFR. 
Cow ID pH Conductivity    Temperature (oC)   Milk Resin:milk Protein recovery 
  (mS/cm) Feed Outflow  (L) ratio (v/v) (% LF) (% LP) 
480 7.08 5.69 29.9 30.0 19.2 0.013 34.9 51.2 
694 6.82 4.09 33.6 31.6 17.8 0.014 35.3 92.4 
1401 6.74 4.65 31.5 30.8 21.1 0.012 28.5 81.6 
1607 6.88 4.77 31.9 31.6 16.6 0.015 36.1 94.6 
1922 6.70 5.45 32.0 30.2 14.4 0.017 27.6 77.1 
1922 6.72 5.51 31.8 30.8 14.8 0.017 47.8 92.0 
2409 6.74 4.07 31.7 30.2 16.8 0.015 36.7 90.4 
3022 6.99 4.42 28.3 25.8 9.0 0.028 46.0 91.0 
3109 6.81 5.06 32.0 30.0 13.6 0.018 25.6 84.7 
3402 6.66 4.71 30.9 30.9 15.6 0.016 23.4 92.9 
3532 6.70 4.68 30.1 29.3 8.2 0.030 55.2 99.5 
5710 6.70 5.01 31.7 31.5 18.4 0.014 29.5 98.8 
7656 6.70 5.25 32.0 31.8 26.0 0.010 19.7 81.9 
9564 6.67 4.61 31.0 30.7 17.4 0.014 43.5 95.9 
9570 6.79 4.50 32.0 30.2 10.6 0.024 48.9 82.9 
Mean 6.78 4.83 31.4 30.4 16.0 0.017 35.6 87.1 
Std Dev* 0.12 0.49 1.2 1.4 4.6 0.006 10.2 12.0 
*standard deviation 
Although there were insufficient data (n=14) to obtain conclusions, trends were 
noticed that are further discussed. The variability of individual milk components 
between individual cows meant the effects of individual feed characteristic or 
processing conditions on the amount of LF and LP extracted were not conclusive but 
indicated aspects that could be examined in a controlled environment (e.g. laboratory 
experiments). Preliminary correlation coefficients were obtained (Table 7-5).  
Table 7-5: Correlation coefficients for feed characteristics and LF and LP yields. 
 Factor % LF extracted % LP extracted 
Milk volume (L) -0.619* -0.048 
LF feed (mg/L) -0.168 0.186 
LP feed (mg/L) 0.063 -0.544 
Fat (% w/v) 0.619* 0.517 
Protein (% w/v) 0.465 0.439 
Casein (% w/v) 0.423 0.447 
Lactose (% w/v) -0.104 -0.050 
Total Solids (% w/v) 0.610* 0.528 
Resin:milk ratio (v/v) 0.677* 0.115 
pH 0.181 -0.082 
Conductivity (mS/cm) -0.171 -0.219 
Temperature feed (oC) -0.370 -0.240 
* p = 0.05, r ≥ 0.553 
Usually at least 80% of the LP (mean of 87.1%) was extracted but LF yields were 
much lower (35.2±10.2% of input LF) and very variable (Table 7-4). The higher LP 
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extraction may be because (a) the original LP concentration in the milk is lower and 
(b) preferentially binding of LF to the resin. In laboratory packed-bed 
chromatography experiments, almost all the LP but only 95% LF was extracted 
(sections 4.3.1 and 4.7.1). Etzel (1998) also reported incomplete LF extraction from 
skim milk during packed bed chromatography with SP BB resin. 
There is a high correlation (p=0.05) between LF extracted and milk volume, 
resin:milk ratio (Φ), fat, and total solids. Because a fixed amount (250 mL) of resin 
was used in each extraction cycle in the PFR, Φ is influenced by the volume of milk 
produced per cow. Higher LF yields were achieved at higher Φ values (Figure 7-2), 
but Φ did not affect LP yields. Again this could be due to the lower LP 
concentrations and a different interaction between LP and the cation (SO3-) on the 
resin. The LP elutes at lower NaCl concentration, but LF binds more strongly and 
requires up to 1.0 M NaCl for desorption. 
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Figure 7-2: Effect of resin:milk ratio on LF extraction using SP BB resin (250 mL),  
in the PFR for milk volumes of 8.2 - 26.0 L. 
Milk volume and LF yield were negatively correlated (-0.619) but there was no 
relationship (r= -0.048) between milk volume and LP yield (Figure 7-3). A fixed 
resin volume was used for on-farm experiments. Therefore, processing an increased 
milk volume from an individual cow will reduce the Φ value.  
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Figure 7-3: Effect of milk volume on LF and LP yields. 
The LF and LP yields were not influenced by initial LF and LP content or milk 
volume (Figure 7-4 and 7-5) and LP yields were high irrespective of initial 
concentration (Figure 7-5). The Rowe et al. (1999) extracted BSA (initial 
concentrations of 0.1 to 3.0 mg/mL) with anion exchange resin and reported that 
initial protein concentration influences yield. However, milk in the on-farm studies 
contained only 0.07 to 0.48 mg LF/mL. The laboratory studies for kinetic modelling 
used a limited range (up to 1.0 mg/mL) of initial LF concentrations (section 5.5), 
which covered the levels normally found in cow milk. Perhaps the initial feed LF 
concentration range studied was not wide enough to see the trends observed by Rowe 
et al. 
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Figure 7-4: Effect milk volume and milk LF content on LF yields. 
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Figure 7-5: Effect of milk volume and milk LP content on LP yields. 
Extraction with resin significantly (p<0.05) affected composition of the milk (Table 
7-6) (Student's t-test, Excel 2003, Microsoft Corporation, U.S.A.). 
 
  
7-8 
Table 7-6: Effect of on-farm LF and LP extraction on milk composition (% w/v).  
 Feed Outflow 
Cow Fat  Protein  Casein Lactose  Total Fat     Protein Casein  Lactose  Total 
Id           solids solids 
480 7.83 3.82 3.01 3.74 15.9 8.09 3.74 2.95 3.71 16.1 
694 4.59 3.75 2.93 4.90 13.8 4.67 3.68 2.85 4.74 13.8 
1401 5.13 3.09 2.45 4.91 13.7 4.94 3.08 2.39 4.79 13.4 
1607 3.91 3.40 2.68 4.72 12.7 3.78 3.27 2.50 4.51 12.2 
1922 2.94 2.87 2.22 4.47 11.0 2.97 2.84 2.15 4.32 10.9 
1922 5.51 2.92 2.31 4.37 13.3 5.17 2.91 2.21 4.37 13.0 
2409 4.07 3.40 2.74 5.18 13.2 4.13 3.34 2.62 5.17 13.1 
3022 4.09 3.46 2.59 4.74 13.0 4.35 3.34 2.42 4.48 12.8 
3109 1.91 2.78 2.09 4.46 10.0 1.85 2.64 1.88 4.15 9.5 
3402 4.34 3.34 2.62 4.94 13.2 4.12 3.25 2.46 4.71 12.7 
3532 6.38 3.48 2.68 4.50 15.0 6.08 3.37 2.51 4.35 14.4 
5710 5.00 3.41 2.67 4.59 13.7 4.77 3.27 2.50 4.41 13.1 
9564 4.63 3.84 3.03 4.79 13.9 4.98 3.74 2.92 4.72 14.0 
9570 4.90 3.87 3.00 4.96 14.4 3.93 3.20 2.36 4.31 12.3 
Mean 4.66 3.39 2.64 4.66 13.3 4.56 3.26 2.48 4.48 13.0 
Std dev* 1.36 0.35 0.29 0.34 1.42 1.38 0.31 0.29 0.33 1.49 
* standard deviation 
The effects of milk pH and conductivity on adsorption were not investigated. Milk 
pH ranged from 6.66 to 6.99 (average pH 6.78, Table 7-4) and conductivity from 
4.09 to 5.69 mS/cm (average 4.83 mS/cm, Table 7-4). Milk processing temperature 
was expected to be near 37oC. However, significant cooling occurred in the receiver 
can and milk temperature after the milking was completed was 31.4 (±1.2oC) (Table 
7-4). The trials were done in winter and ambient temperature could also affect milk 
temperature at the end of milking. For example, milk temperature was 36.7oC 
immediately after milking in earlier experiment during the summer (section 7.2). 
7.3.4 Overall LF yield 
During the test period, 239 L of milk was processed in the PFR and 44.2% of LF in 
the raw milk was captured (11.6 g/100 L raw whole milk). After elution from the 
resin, 21.6 g of LF (or 35.6% of LF the raw milk) was obtained. 
Industrial LF extractions report yields of 10 g/100 L of skim milk (Nimmo-Bell, 
2003). Without any optimisation, yields with the PFR were 15% higher than those 
from centralised, commercial extraction of feed such as skim or whey. 
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The PFR extraction can be optimised to give better yields. For example, SP FF resin 
(section 4.9.1) has better protein uptake and can absorb 65-75% of LF after 10 
minute contact. This represents 42-48 g of LF from 239 L of raw whole milk (or 
17.6-20.1 g LF per 100 L of raw milk), or twice that reported for an optimised 
commercial process. Because laboratory performance of SP BB resin was transferred 
to the on-farm situation, it is expected that SP FF resin performance in the laboratory 
can also reliably be extrapolated to the on-farm situation. 
7.4 Summary and future prospects for the PFR 
The PFR met most of the design objectives and performed well against project 
objectives. Several aspects could be improved to enhance PFR’s functionality. 
Currently, the CIP on the PFR is operated semi-automatically and independent of the 
AMS. This could be automated for ease of operation. The CIP program could be 
controlled by using the AMS software to CIP the PFR and AMS at the same time 
using same cleaning solutions. However, because the CIP on the AMS is a scheduled 
operation, its access is difficult, which limits flexibility and availability. An 
independent, automated CIP facility is the preferred option. 
There was unnecessary dead volumes in pipes (0.5 to 0.6 L) connecting the PFR to 
the AMS. Positioning the PFR closer to the AMS would reduce pipe length and 
hence volumes needed to transfer milk. 
The reversible pump was self-priming. However, it did not prime sufficiently at the 
start of the run. Rinsing the system with hot water would pre-clean and assist 
priming. It would also warm the processing can and thus help maintain processing 
temperature of the first lot of milk received by the can. 
The stainless steel processing can could be lagged or have a heating jacket or heating 
tape to maintain milk at the secretion temperature (35-37oC) for a short time (10-15 
minutes depending on the process time). A higher temperature assists adsorption and 
may increase overall yields. 
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The effects of temperature (section 4.6.2) and adsorption time (section 4.9) were 
studied in the laboratory. On-farm trials indicated that milk components (e.g. fat, 
other proteins, etc) may also affect yields. These factors could be considered when 
selecting cows for processing or for yield calculations. 
Aeration during milking and/or pumping results in frothy milk, which increases 
draining times and could decreases process efficiency. This was not a problem for 
most milkings but could be an issue if it occurred frequently. The reasons for 
frothing could be introduction of air into milk-line during milking process and/or 
milk components (the causes were not investigated). The control system can identify 
cows individually; any cow that produces milk that is difficult to process could be 
excluded. 
The PFR prototype is mounted on a skid for portability. The cassette LOAD position 
under the processing can must be aligned to obtain a good seal. Any leakages could 
result in some resin loss. 
The smaller diameter resin (SP FF, 90 µm) had long draining times. However, it 
captures more LF and LP than the larger SP BB (200 µm) in a given process time, 
resulting in better yields. Aspects that would make extractions with SP FF possible 
include: maintaining milk and processing can temperature at 35oC; increasing stirrer 
speed (without damaging the resin) during draining; redesigning the impeller blade 
and adjusting its position in the processing can; and removing the finer resin beads 
(<40 µm) before using the resin. 
The following are some aspects worthy of investigation: 
• whether processing from selected cows milk with enhanced LF and LP (or 
other target concentrations) would enhance process economics 
• optimising impeller design and flow through the cartridge holding the resin so 
smaller and more efficient beads (resin) can be used 
• identify a better resin with higher binding capacity to achieve better yields 
• replacing expensive pharmaceutical-grade resins with cost-effective capture 
media (beads, resin or other means), which can be used for food processing 
• other forms of capture on-farm that may enhance yield and purity (such as 
membranes, activated filter system)  
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• exploring whether the process can be used to capture and purify transgenic 
proteins  
• investigating whether other valuable proteins such as immunoglobulins, 
prolactin, CD14, etc can be processed. For example, Protein A media could 
be used to recover immunoglobulins directly from standard or hyperimmune 
milk or from colostrum 
• determining quality attributes of LF and LP and other proteins extracted from 
raw whole milk 
 
 8 On-farm Fractionation 
     Economic Analysis 
8.1 Introduction 
Data from the on-farm trial using the PFR were used to calculate profitability of on-
farm capture. Costs of raw materials, capital for the PFR, and labour for elutions, 
together with LF and LP yields and market prices were used for the economic 
feasibility study. Process simulations and economic analysis was done using 
SuperPro Designer® (version 5.1, Intelligen Inc., MIT, U.S.A.). An example of the 
inputs and outputs from SuperPro Designer (case 19) is included in Appendix C. 
Sensitivity analyses were done on key variables such as raw material costs 
(especially milk), resin binding capacities and yields, and product price to assess 
robustness of the economic analysis on profitability, net present value (NPV) and 
payback period. 
The effect of the following factors on profitability and rate of return were 
investigated: 
Scenario 1: Variable LF and LP prices reflecting market and end-user prices where: 
• on-farm fractionation does not markedly affect milk properties and milk 
retains its value to the farmer (cases 1-6) 
• milk is purchased at cost and is discarded after LF and LP extraction 
because it has no value (cases 7-10) 
• milk retains 80% of its value and can be further processed (cases 11-15) 
Scenario 2: Average LF and LP yields achieved on-farm using the PFR (section 7.3) 
and realistic and conservative LF and LP prices where:  
• on-farm fractionation does not markedly affect milk properties and milk 
retains its value to the farmer (cases 16) 
• milk is purchased at cost and is discarded after LF and LP extraction 
because it has no value (case 17) 
• milk retains its value and a better resin (for example SP FF) is used for 
the extraction, (case 18) 
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Scenario 3: Milk retains its value and on-farm LF and LP extraction is optimized by 
using high (1000 mg/L) LF milk and resin with fast adsorption, for example, 
SP FF (case 19) 
Scenario 4: Extracting proteins worth $5000 to $20000 per kilogram from transgenic 
milk, where price of raw whole milk is higher and includes a disposal cost 
(cases 20-23) 
The costs, parameters and assumptions of each case are described and sensitivity 
analyses based on different scenarios are tabulated.  
8.2 Lactoferrin market and prices 
The current world market for LF is around 100 tonnes per year. Japan is both the 
largest producer and consumer. Increased demand could easily be met by processing 
more whey and it is feasible to produce 1000 to 2000 tonnes worldwide (Anon 2005; 
Thiersch 2004). However, the elasticity of LF price is unknown. Producing such high 
quantities could decrease the prices from the usual US$500/kg. The growth of the 
market is slower than the increase in production. It is relatively easy to produce LF 
with greater than 95% purity with reported wholesale prices of US$300/kg (Fonterra, 
NBR 2004), US$350-400/kg (Tatua Nutaceuticals, Nimmo-Bell 2003) or US$350-
500/kg (Gloy 2004). Retail and end-user prices average US$1500/kg (range 
US$1.13- $3.50 per gram). Gloy (2004) reported that the proprietary nature of new 
products makes it challenging to identify market prices on most milk protein 
fractions. 
Most milk in New Zealand is processed for export. New Zealand dairy farmers 
receive NZ$3.50 and $5.00 per kilogram milk solids (MAF, 2005). At conservative 
selling prices (US$300/kg), the LF in milk (1000 mg/L) represents the value farmers 
currently get for their raw milk (NZ$0.24 to $0.40/L). 
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8.3 Costs and variables used in economic analyses 
All prices are in New Zealand dollars, unless otherwise specified. Processing costs 
include raw material, buffer and chemicals, costs for eluting captured proteins into 
concentrated solutions, and resin regeneration. Processing costs do not include 
diafiltration and freeze drying to obtain protein powder. 
8.3.1 Raw material costs 
The costs of materials such as buffers, mineral acids, base, and salt were obtained 
from Harrison et al. (2003). Current resin costs (from New Zealand agents for litre 
amounts) were used because SP BB resin is contract manufactured and not readily 
available. 
Phosphate buffer (10 mM) $0.0784 /L 
Sodium hydroxide (1 M) $0.0560 /L 
Hydrochloric acid (1 M) $0.0650 /L 
Isopropanol (40%) $0.8680 /L 
Sodium chloride (1.0 M) $0.0420 /L 
Resin $1.00 /mL 
Milk solids (2005/06 season) $4.00 /kg milk solids 
Raw whole milk (L) $0.24-0.40 /L 
8.3.2 Production capacity 
The PFR operating capacity was estimated from actual PFR operation. Between 11 
am to 5.00 pm, milk from 16 individual animals was successfully diverted to the PFR 
for LF and LP capture. At approximately 1 pm, a scheduled 35-minute CIP for the 
AMS occurred. The PFR operation was uninterrupted and there was no malfunction 
or downtime during processing. Limitations to the number of units processed through 
the PFR, if any, were due to asynchronisation of the AMS milking and PFR cycles, 
because the 10-minute time for processing (adsorption) made the PFR cycle longer 
than an average milking time. 
Processing vessel volume 37.22 L 
Dead volume (pipes) 0.65 L 
Production capacity of prototype 40 units or individual cows per 24 hr  
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8.3.3 Costs of major capital items 
Costs for major capital items, based on actual cost of components and materials 
purchased, and assembling the PFR are summarized in Table 8-1. Manufacturing 
cost should decrease if multiple units were produced. 
Table 8-1: Cost of major capital items and assembling the PFR. 
Item Amount ($) 
Tank assembly 12 000 
PLC 2 000 
Pump (lobe) 5 500 
Motor 500 
Variable speed drive 1 000 
Trolley 1 000 
Total equipment purchase cost (PC) 22 000 
Assembly, wiring, fabrication, polishing, valves, dummy cassette 26 000 
Programming, auxillary etc (not included in above) (DC) $58 000 
Total direct fixed capital cost (DFC) $119 250 (incl GST) 
PC - Equipment purchase cost, DC - Direct cost in equipment costs, DFC – direct fixed capital costs (consistent with terms used 
in SuperPro Designer) 
Factors (between 10-30% of PC) were added to the equipment cost for piping, 
plumbing, electrical components, etc, installation (Lang, 1948), and the initial cost of 
chromatography resin to obtain total investment. Working capital in the economic 
analysis covers the cost for 30 days of labour, raw materials, utilities and waste 
treatment and depends on the assumed cost of milk. 
8.3.4 Process and economics consideration 
Project time 20 years 
Inflation 2% 
Net present value interest  7% 
Income tax 33.0% 
Days in operation 250 days per annum (or milking season) 
Cycles per annum 10000 cycles (250 days @ 40  
 cassettes per day i.e. milk from 40 cows) 
Processing (adsorption) time 10 minutes 
Resin per cycle 250 mL 
Resin retention/cycle 99.5 % 
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8.3.5 Market prices 
LF (wholesale price) $450-500/kg 
LP (wholesale price) $300-350/kg 
Retail price (end-user products) $2000-3000/kg (Appendix B) 
The LF market price used in the economic analyses reflects current prices ($NZ450-
500/kg), a deflated price (NZ$300/kg), end-user based prices (NZ$1000-3000/kg) 
and a projected price ($NZ600/kg) with a premium for LF extracted on-farm from 
milk that has not been pre-treated. 
8.3.6 Resin characteristics 
Resin capacity (static capacity) 30 mg protein/mL resin 
Binding 80% LF, 80% LP 
Yield (relative to initial feed) 95% LF, 95% LP 
Resin life 500 cycles 
8.3.7 Feed 
Volume of raw whole milk 16.0 L/cycle 
LP content in raw milk 30 mg/L 
LF content in raw milk 500 mg/L 
Transgenic protein content 500 mg/L 
In scenarios 1-4 evaluations were based on resin dynamic capacity (30 mg/mL) and 
80% binding. These characteristics may be expected for SP FF resin. Even though 
transgenic protein content is expected to be much higher than 500 mg/L, similar 
concentrations were maintained so the same production capacity is used throughout 
the analysis to give comparative values. 
8.4 Profitability and rate of return for on-farm processing 
Parameters used to calculate the effect of LF prices on profitability are the same 
(section 8.3) in all analyses unless otherwise specified. 
8.4.1 Effect of product price on profitability and rate of return 
Economic analyses show that if the processed milk can be sold at its normal price, 
the breakeven point for on-farm extration occurs when LF can be sold for 
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approximately about $850/kg. At high LF selling price (e.g. $2000/kg) a very short 
payback time (1.3 years) is achieved for the for the investment (Table 8-2) 
Table 8-2: Effect of product price on profitability if milk was bought and sold for 
$0.33/L; total investment = $125 280. 
 Case 1 Case 2 Case 3 Case 4 Case 5 Case 6 
LF price ($/kg) 3000 2000 1000 875 500 300 
LP price ($/kg) 1000 700 350 305 150 100 
 
Revenue ($/yr) 174 420 116 394 58 197 50 992 29 013 17 442 
Operating costs ($/yr) 36 135 36 135  36 135 36 135 36 135 
Production (kg/yr) 57  57 57 57 57 57 
Production cost ($/kg) 633 633 633 633 633 633 
 
Gross margin (%) 79.3 69.5 38.0 29.0 -24.3 -107.2 
ROI (%) 78.7 47.48 16.4 12.5 1.1 -10.3 
Payback time (years) 1.27 2.11 6.12 8.02 -- -- 
IRR (%) (after tax) 141.9 62.7 12.4 7.1 -- -- 
NPV (7%) ($) 862 978 456 321 48 466 270 -199 810 -320 367 
8.4.2 Effect of product price on profitability if milk has no resale value 
If the milk has no residual value, the breakeven price occurs if LF can be sold for 
$1760/kg (Table 8-3), which is near the current retail price of end-user products 
($2000-3000/kg). Therefore, the processed milk must have a value to ensure the 
process is profitable. 
 
Table 8-3: Effect of product price on profitability if milk purchased at $0.33/L with 
no resale value; total investment = $143 585. 
 Case 7 Case 8  Case 9 Case 10 
LF price ($/kg) 3000 2000 1760 1000 
LP price ($/kg) 1000 700 600 350 
 
Revenue ($/yr) 174 420 116 394 102 389 58 197 
Operating costs ($/yr) 85 233 85 233 85 233 85 233 
Production (kg/yr) 57 57 57 57 
Unit production cost ($/kg) 1495 1495 1495 1495 
 
Gross margin (%) 51.2 26.7 16.7 -46.2 
ROI (%) 45.8 18.5 12.0 -14.8 
Payback time (years) 2.19 5.40 8.4 -- 
IRR (%) (after tax) 57.11 15.86 7.11 -- 
NPV (7%) ($) 505 654 98 998 840 -420 528 
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8.4.3 Effect of product price on profitability if milk retains 80% of its 
value 
If the processed milk retains 80% of its original value (an arbitrary value), the 
breakeven selling price occurs if LF can be sold for about $1100/kg (which is above 
the current wholesale price) (Table 8-4). 
Table 8-4: Effect of product price on profitability if milk retains 80% of its value 
(milk purchased at $0.33 and sold at $0.25 L; total investment = $143 575) 
 Case 11 Case 12 Case 13 Case 14 Case 15 
LF price ($/kg) 3000 2000 1070 1000 500 
LP price ($/kg) 1000 700 380 350 150 
 
Revenue ($/yr) 213 699 155 673 102 138 97 476 68 292 
Operating costs ($/yr) 85 233 85 233 85 233 85 233 85 233 
Production (kg/yr) 57 57 57 57 57 
Unit production cost ($/kg) 1495 1495 1495 1495 1495 
 
Gross margin (%) 60.0 45.5 16.6 12.6 -24.8 
ROI (%) 64.2 37.0 11.8 10.3 7.8 
Payback time (years) 1.56 2.71 8.4 10.3 -- 
IRR (%) (after tax) 93.1 42.2 6.6 4.3 -- 
NPV (7%) ($) 780 927 374 270 -600 -31 568 -315 351 
 
8.4.4 Profitability if PFR operation is optimised 
Several factors can increase economic viability of the PFR operation. For example, if 
a better resin with high capacity (80%) (and ideally with a high adsorption rate is 
used) the production capacity is increased 3 times (case 18, Table 8-5). The 
production capacity increases 10 times (109 kg compared to 10.5, for example, if 
binding capacity is increased from 50% to 80% in addition to processing from 
selected cows milk that has LF concentration of 1000 mg/L. In this case the payback 
time for investing into a PFR system decreases to 2.6 years (i.e. 1000 mg/L 
compared with the average of 278 mg/L is processed). This can be achieved by 
identifying higher producing cows and/or cows in the correct stage of lactation cycle 
(case 19, Table 8-5). One of the disadvantages of this system include not having 
enough milk to process because only a fraction of the normal herd produces milk 
with the required LF content (e.g. only 3 of the 48 cows tested, produced LF over 
1000 mg/L, section 7.3.1). Therefore, a specialised herd will be needed. However, 
this introduces the possibility of breeding or selecting a herd that expresses high 
levels of a target component in their milk. 
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Table 8-5: Effect of resin binding capacity and concentration of LF and LP in milk 
on process profitability (Investment = $125 281). 
 Case 16 Case 17 Case 18 Case 19 
LF price ($/kg)) 400 400 400 400 
LP price ($/kg) 150 150 150 150 
 
Resin capacity (mg protein/mL resin) 50 50 80 80 
Binding (%) 50 50 95 95 
Yield (%) 80 80 95 95 
 
LF feed (mg/L) 278 278 278 1000 
LP feed (mg/L) 10.5 10.5 10.5 10.5 
Milk volume procesed (L) 16 16 16 16 
Milk purchase price ($/L) 0 33.0 0 0 
Milk sell price ($/L) 33 0 0.33 0.33 
 
Revenue ($/yr) 53 400 4290 61 368 92 868 
Operating costs ($/yr) 28 501 77 611 28 501 28 501 
Production (kg/yr) 10.5 10.5 30.2 109.2 
Unit production cost ($/kg) 2714 7391 942 261 
 
Gross margin (%) 46.6 -1709 53.6 69.3 
ROI (%) 18.0 -47.1 22.1 39.0 
Payback time (years) 5.6 -- 4.5 2.6 
IRR (%) (after tax) 14.5 -- 20.0 46.6 
NPV (7%) ($) 68 350 -902 774 124 191 344 947 
 
8.4.5 Profitability of processing transgenic protein 
Recombinant human proteins can be expressed in the milk of transgenic cows (van 
Berkel et al. 2002) in g to kg quantities. Although it is difficult to predict the price of 
transgenic proteins, some therapeutics are worth billions of dollars (van Berkel et al. 
2002). Conservative prices of $5 000 to $20 000 per kg were used in the analyses. 
The raw milk would cost much more than normal milk because strict quality 
assurance regulations will apply. The economic analysis assumes that the raw milk 
will cost three times that of normal milk and an extra cost of $NZ0.25/L has been 
included for milk disposal because milk from transgenic animal will not be accepted 
in the food chain nor can it be dumped because of environmental problems. The 
economic analysis shows that the PFR operation is economically viable, even if the 
transgenic protein is only worth $5000/kg (case 23, Table 8-6). If the protein can be 
sold for $10,000/kg, the payback time is less than 1 year (case 22, Table 8-6). 
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Table 8-6: Effect of transgenic protein price on profitability with milk price 
($0.98/L) and disposal cost (-0.25/L) and investment = $198 158. 
 Case 20 Case 21 Case 22 Case 23 
Transgenic protein price ($/kg) 20 000 15 000 10 000 5 000 
Milk purchase price ($/L) 0.98 0.98 0.98 0.98 
Milk sell price ($/L) 0 0 0 0 
Disposal costs ($/L) -0.25 -0.25 -0.25 -0.25 
 
Investment ($) 198 158 198 158 198 158 198 158 
Revenue ($/yr) 1 140 000 855 000 570 000 285 000 
Operating costs ($/yr) 232 103 232 103 232 103 232 103 
Production (kg/yr) 57 57 57 57 
Unit production cost ($/kg) 4071 4071 4071 4071 
 
Gross margin (%) 80.8 74.1 60.8 21.8 
ROI (%) 320.4 222.3 122.6 25.0 
Payback time (years) 0.31 0.45 0.81 4.00 
IRR (%) (after tax) 818.36 441.64 187.42 19.77 
NPV (7%) ($) 6 264 933 4 275 438 2 285 944 292 658 
 
8.5 Summary 
Economic analyses show that the PFR process for extracting LF and LP from milk 
can be viable but depends on the farmer receiving a premium for a specialty protein 
such as LF as well as being paid for total milk solids. This is based on the 
assumption that a farmer invests in an optimised PFR system. At current wholesale 
LF and LP prices, the system will have a payback of approximately five years. 
Targeting high-producing cows (1000 mg/L LF) and using a resin that can capture 
80% of the LF in the milk, increases profitability substantially. If LF and LP 
obtained immediately after milking has better quality (in terms of functionality) than 
similar product obtained from bulk processing, a premium may be possible.  
The profitability analysis can be incorporated into a business plan, which could 
encompass the likely commercial and supply chain model for establishing on-farm 
fractionation. The trade-off between manufacturing cost, target extraction 
percentage, processing time, media volume per batch, final activity and yield of 
target protein(s) vary widely, depending on objectives of each extraction. For 
instance, on-farm extraction of LF and LP from milk that can be further processed 
into other products is different from extracting a recombinant protein from transgenic 
milk that cannot be used in the normal food chain. 
 9 Conclusions and Recommendations 
for Future Work 
9.1 Laboratory studies 
This study demonstrated that significant quantities of raw whole milk can pass 
through a shallow chromatography column packed with commercially available resin 
provided the processing temperature is kept at or near the temperature of freshly 
collected milk (35-37oC). Adsorption rate at these temperatures were higher than 
those at normal milk chromatography temperatures (4-8oC). 
Design considerations led to using a single-stage stirred tank for extracting the model 
proteins, LF and LP, in an on-farm environment. The cation exchange resins SP FF 
and SP BB were chosen as candidates for on-farm capture because they are approved 
for food use by the FDA. Equilibrium capacities were 200 and 110 mg LF per mL of 
resin for SP BB and SP FF respectively. For designing the system, resin dynamic 
capacity was more relevant than its equilibrium capacity because faster protein 
uptake rates were most important in achieving high extraction yields due to the 
limited time available for adsorption between milking individual cows. 
9.2 Kinetic modelling and analysis 
Data from batch adsorption experiments with raw whole milk showed that the new 
composite non-linear (CNL) model of Rowe et al. (1999) could be used to predict 
extraction yields as a function of time, feed concentration and milk volume for a 
fixed volume of resin. The four independent parameters qk, k, a and y(0) in the CNL 
model to describe batch adsorption dynamics, could be obtained from Co and  Φ 
(resin:milk volume) and related to LF extracted with time or for a pre-determined 
adsorption period. 
An investigation of the modeling showed that kinetic capacity parameter, qk was the 
most important factor in adsorption kinetics. Higher feed LF and higher Φ ratios 
gave greater yields for a given amount of resin. The LF obtained from on-farm 
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extraction using SP BB resin agreed to within 14% of the values predicted from the 
CNL model. The CNL model can be used to evaluate performance of other resins. 
9.3 Protein Fractionation Robot prototype 
Design data obtained from laboratory trials together with a design brief was 
successfully used to produce a PFR unit. The unit mounted on a skid for transport 
and consisted of: 
• a single-stage 37-L stirred tank system which had an overhead stirrer with 
two impellers to maintain resin suspension and to aid draining when 
recovering resin after an adsorption cycle, 
• a 4oC chiller to store cassettes with fresh resin and resin with captured 
protein 
• cassettes with a 44-µm sieve base to hold resin, allow resin suspension 
with positive milk flow, and to capture suspended resin after processing 
• a reversible pump to transfer milk from the AMS to the PFR and to 
remove milk after the adsorption process 
• variable speed drives to control stirring speeds and pumping rate 
• a timer to control the adsorption time, PLCs for automation 
• pneumatic rams for loading and unloading of cassettes 
• an automated warm water (40oC) rinse cycle  
• a semi-automated CIP cycle 
9.4 On-farm fractionation studies 
Valuable milk components were successfully extracted in the PFR, on-farm, from 
fresh, raw whole milk collected immediately after milking. The LF and LP could be 
extracted using SP BB cation exchanger without disrupting the milk harvesting 
process. Milk yield and composition were slightly lower after fractionation but the 
processed milk would be acceptable for consumption or further processing. 
Extractions cycles could be achieved within the time to milk an individual cow. Milk 
required no pre-treatment and its temperature, as obtained from the cow, was very 
suitable for the extraction process. 
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Average LF and LP yields from 16 individual cows were 35.6 and 87.1% feed LF 
and LP respectively. Although the experiment did not selectively target high-LF 
milk, the LF yield of 9.1 g/100 L is 15% higher than current practices used in 
centralised processing from skim milk. Selective milk processing and further 
optimisation will enhance LF yields. 
9.5 Benefits from this research 
Processing raw whole milk is not limited to ion exchange; other chromatographic 
techniques such as affinity or reverse-phase chromatography could be used, which 
would allow extraction of other minor milk components such as immunoglobulins, 
and lysozyme. 
A significant aspect of on-farm processing is that bioactive proteins in their native 
state and at their maximum activity can be obtained from fresh, raw whole milk. The 
repeated cycles of heating, cooling and shear that occur during transportation and 
bulk processing are bypassed. On-farm processing provides an opportunity to extract 
minor but high-value proteins before their value is lost by combining milk in big 
silos and bulk processing. The value of using farm management practices that 
produce milk with elevated levels of specific components can be maximised by on-
farm processing. 
Economic studies showed that the stand-alone process is profitable provided the unit 
operations are optimized. Profitability is markedly improved if milk from selected 
animals was processed for target protein(s) and the farmer is to be paid for high-
value protein as well as the bulk milk. 
On-farm extraction was successful for producing minor, high-value proteins from 
conventional milk. The system would be very suitable for processing recombinant 
proteins from milk of transgenic animals. Coupling the AMS and the PFR allows 
milk from individual cows to be identified, provides explicit traceability, and 
contains all raw materials and products. An extra benefit is that immediate 
processing maximises yields and retains bioactivity. This approach allows a new 
business model in dairy processing, where the farmer can produce crude, high-value 
protein fractions as well as a liquid (or milk solids) for commodity dairy 
manufacturers. 
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9.6 Recommendations for future work 
Although many separation processes are technically feasible, extraction efficiency is 
a key determinant of commercial success. It is recommended that closely monitored 
extractions and processing are done using the PFR to give more data for assessments. 
This was not possible because of constraints on available testing time during this 
project. The effects of bulk milk composition (protein, lactose, total solids and 
especially fat) on extractions also need to be further studied as well as whether on-
farm processing affects bulk milk composition. Data from laboratory experiments 
indicated that extractions did not affect bulk milk composition but data from on-farm 
experiments were inconclusive. 
The following work, which would assist in developing and validating the concept 
and identifying technology associated with on-farm processing, is highly 
recommended: 
• examining whether bioactivity is retained during processing and distribution. 
In vitro trials could be routinely used to measure bioactivity. In vivo trials 
may then be needed to satisfy authorities that claimed effects are real 
• assessing whether heat-sensitive bioactive proteins can be produced 
economically 
• identifying other minor, high-value milk proteins or components that could be 
extracted on-farm (i.e. possible commercial targets) and their extraction 
characteristics 
• optimising PFR mechanical operations. For example, adding insulation to 
maintain the processing can at 37oC (and hence increase adsorption), 
designing and optimizing the impeller blade to improve resin mixing and 
suspension during draining, developing a method to recover smaller resins 
(such as 90-µm SP FF) and other rigid resins (e.g. Capto™) with high 
adsorption characteristics 
• optimise the adsorption process and overall yields by using resins that bind 
protein more quickly. This could be combined with processing milk only 
from individual cows that have high initial target protein concentration 
• modelling the effects of other milk components (fat, protein, lactose) on the 
extraction process. These may be more pronounced when processing milk 
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from individual cows. Understanding and quantifying these effects will help 
optimise the adsorption process and hence increase overall yield 
• evaluating other resins for on-farm protein extraction of from raw milk (e.g. 
Protein A media, special affinity media for IgA, IgM etc) and identifying 
cheaper resins. Resin cost used in the economic analyses was based on the 
expensive (~$1/mL), commercially-available resins manufactured for 
pharmaceutical use. Opportunity exists for developing robust, cheap, food 
safe resins, and activated ceramic membranes for specialist food applications 
• investigating other suitable process options such as ion exchange membranes, 
activated filters, etc. and testing them on-farm. For example, the effect of 
membrane pore size and the cost for processing milk from individual cows 
needs to be investigated 
• assessing the impact of this on-farm technology on transportation costs, 
which are high for dairy industry  
• developing a value-chain and a business model for implementing on-farm 
processing 
• extending this technology to situations such as recovering pharmaceuticals 
from fermentation broths 
 References 
Al-Mashikhi SA, Li-Chan E, Nakai S. (1988). Separation of immunoglobulins and 
lactoferrin from cheese whey by chelating chromatography. Journal of Dairy 
Science. 71:1747-1755. 
Al-Mashikhi SA, Nakai S. (1987). Isolation of bovine immunoglobulins and 
lactoferrin from whey proteins by gel filtration techniques. Journal of Dairy 
Science. 70:2486-2492. 
Andrews AT, Harris DP, G. Wright, Pyle DL, Asenjo JA. (2000). Affinity gel 
electrophoresis as a predictive technique in the fractionation of transgenic 
sheep milk proteins by affinity aqueous two-phase partitioning. 
Biotechnology Letters. 17:1349-1353. 
Andrews AT, Taylor MD, Owen AJ. (1985). Rapid analysis of bovine milk proteins 
by fast protein liquid chromatography. Journal of Chromatography. 348:177-
185. 
Anon. (2005) Lactoferrin - Panacea for patients or biotechnologists? Genes and-
Dairying. July 2005. 
Anon. (2003) Lab Notes, Dairy Fields: Career and Technical Education. Feb 2003. 
62. 
Arguello MA, Alvarez S, Riera FA, Alvarez R. (2005). Utilization of enzymatic 
detergents to clean inorganic membranes fouled by whey proteins. Separation 
and Purification Technology. 41(2):147-154. 
AROQ Limited. (2004). Global market review of functional foods-forecasts to 2010. 
AROQ Limited, Worcester, United Kingdom. 
Auldist MJ, Johnston KA, N.J. W, Fitzsimons WP, Boland MJ. (2004). A 
comparison of the composition, coagulation characteristics and cheesemaking 
capacity of milk from Friesian and Jersey dairy cows. Journal of Dairy 
Research. 71(1):51-57. 
Auldist MJ, Thomson NA, Mackle TR, Hill JP, Prosser CG. (2000). Effects of 
pasture allowance on the yield and composition of milk from cows of 
different beta-lactoglobulin phenotypes. Journal of Dairy Science. 83:2069-
2074. 
Auldist MJ, Walsh BJ, Thomson NA. (1998). Seasonal and lactational influences on 
bovine milk composition in New Zealand. Journal of Dairy Research. 
65(3):401-411. 
Avramescu ME, Borneman Z, Wessling M. (2003). Mixed-matrix membrane 
adsorbers for protein separation. Journal of Chromatography A. 1006(1-
2):171-183. 
Avramescu ME, Sager WFC, Wessling M. (2003). Functionalised ethylene vinyl 
alcohol coploymer (EVAL) membranes for affinity protein separation. 
Journal of Membrane Science. 216:177-193. 
  
R-2 
Bargeman G, Koops G-H, Houwing J, Breebaart I, van der Horst HC, Wessling M. 
(2002). The development of electro-membrane filtration for the isolation of 
bioactive peptides: the effect of membrane selection and operating parameters 
on the transport rate. Desalination. 149(1-3):369-374. 
Barth CA, Schlimme E. (1988). Milk proteins: nutritional, clinical, functional and 
technological aspects. Darmstadt, Germany. 72-111 p. 
Baruah GL, Couto D, Belfort G. (2003). A predictive aggregate transport model for 
microfiltration of combined macromolecular solutions and poly-disperse 
suspensions: testing model with transgenic goat milk. Biotechnology 
Progress. 19:1533-1540. 
Bendicho S, Barbosa-Canovas GV, Martin O. (2002). Milk processing by high 
intensity pulsed electric fields. Trends in Food Science and Technology. 
13(6-7):195-204. 
Bensch M, Wierling PS, von Lieres E, Hubbuch J. (2005). High throughput 
screening of chromatographic phases for rapid process development. 
Chemical Engineering Technology. 28(11):1274-1284. 
Bezwooda WR, Mansoor N. (1986). Isolation and characterisation of lactoferrin 
separated from human whey by adsorption chromatography using Cibacron 
Blue F3G-A linked affinity adsorbent. Clinica Chimica Acta. 157(1):89-93. 
Blackberg L, Hernell O. (1979). Isolation of lactoferrin from human whey by single 
chromatographic step. FEBS Letters. 109(2):180-184. 
Blomkalns AL, Gomez MR. 1997. Purification of bovine alpha-lactalbumin by 
immobilized metal ion affinity chromatography. Preparative Biochemistry & 
Biotechnology. 27(4):219-226. 
Borneman Z, Zhang W, van den Boomgaard T, Smolders CA. (2002). Semi-
continuous protein fractionating using affinity cross-flow filtration. 
Desalination. 144(1-3):295-299. 
Bounous G, Turgeon S, Aurouze B; (1994). Process for producing an undenatured 
whey protein concentrate. WO 9413148 A1 940623. 
Bounous G; (1990). Biologically active whey protein composition, a method for 
producing it and use of its composition. EP 0375852 A1 900704. 
Bradford MM. (1976). A rapid and sensitive method for the quantitation of 
microgram quantities of protein utilizing the principle of protein-dye binding. 
Analytical Biochemistry. 72:248-254. 
Brans G, Schroen CGPH, van der Sman RGM, Boom RM. (2004). Membrane 
fractionation of milk: state of the art and challenges. Journal of Membrane 
Science. 243(1-2):263-272. 
Brink LES, Elbers SJG, Robbertsen T, Both P. (1993). The anti-fouling action of 
polymers preadsorbed on ultrafiltration and microfiltration membranes. 
Journal of Membrane Science. 76(2-3):281-291. 
Brock JH. (2002). The physiology of lactoferrin. Biochemistry and Cell Biology. 
80:1-6. 
  
R-3 
Buchanan CM. (1994). Evaluation of cation exchangers for the extraction of 
lactoferrin from bovine milk: MSc. Thesis, The University of Waikato, 
Hamilton, New Zealand. 
Burling H; (1989). Process for extracting pure fractions of lactoperoxidase and 
lactoferrin from milk serum. WO 8904808A1. 
Bylund G, TetraPak. (2003). Dairy processing handbook. 2nd edn.: Tetra Pak 
Processing Systems AB, Lund, Sweden. 
Capezio L, Romanini D, Pico GA, Nerli B. (2005). Partition of whey milk proteins in 
aqueous two-phase systems of polyethylene glycol-phosphate as a starting 
point to isolate proteins expressed in transgenic milk. Journal of 
Chromatography B. 819(1):25-31. 
Chand A, Fee CJ. (2004). Chromatographic fractionation of milk proteins directly 
from raw, whole milk. SCENZ Conference (Society of Chemical Engineers, 
Society of Materials and Food Engineering Association), Hamilton, New 
Zealand. 
Chaplin LC. (1986). Hydrophobic interaction fast protein liquid chromatography of 
milk proteins. Journal of Chromatography. 363(2):329-325. 
Cheang B, Zydney AL. (2003). Separation of α-lactalbumin and β-lactoglobulin 
using membrane ultrafiltration. Biotechnology and Bioengineering. 
83(2):202-209. 
Cheang B, Zydney AL. (2004). A two-stage ultrafiltration process for fractionation 
of whey protein isolate. Journal of Membrane Science. 231(1-2):159-167. 
Chen J, Wang C. (1991). Microfiltration affinity purification of lactoferrin and 
immunoglobulin G from cheese whey. Journal of Dairy Science. 56:701-706. 
Chilukuri SVV, Marshall AD, Munro PA, Singh H. (2001). Effect of sodium dodecyl 
sulphate and cross-flow velocity on membrane fouling during cross-flow 
microfiltration of lactoferrin solutions. Chemical Engineering and 
Processing. 40(4):321-328. 
Chisti Y, Moo-Young M. (1990). Large scale protein separations: Engineering 
aspects of chromatography. Biotechnology Advances. 8(4):699-708. 
Chiu CK, Etzel MR. 1997. Fractionation of lactoperoxidase and lactoferrin from 
bovine whey using a cation exchange membrane. Journal of Food Science. 
62(5):996-1000. 
Claeys WL, Van Loey AM, Hendrickx ME. (2002). Kinetics of alkaline phosphatase 
and lactoperoxidase inactivation, and of α-lactoglobulin denaturation in milk 
with different fat content. Journal of Dairy Research. 69:541-553. 
Claycomb RW; 2004. On-farm separation of milk components. 
Colby CB, O'Neill BK, Vaughan F, Middelberg APJ. (1996). Simulation of 
compression effects during scale up of a commercial ion-exchange process. 
Biotechnology Progress. 12(5):662-681. 
  
R-4 
Coulon JB, Agabriel C, Brunscwig G, Muller C, Bonaitp B. (1994). Effects of 
feeding practices on milk fat concentration for dairy cows. Journal of Dairy 
Science. 77:2614-2620. 
Coulon J-B, Verdier I, Pradel P, Almena M. (1998). Effect of lactation stage on the 
cheesemaking properties of milk and the quality of Saint-Nectaire-type 
cheese. Journal of Dairy Research. 65:295-305. 
Craddock R. (2001). Isolation of prosaposin from bovine milk: MSc Thesis, The 
University of Waikato, Hamilton, New Zealand. 
Datta N, Deeth HC. (1999). High pressure processing of milk and dairy products. 
Australian Journal of Dairy Technology. 54(1):41. 
de Frutos M, Cifuentes A, Amigo L, Ramos M, Diez-Masa JC. (1992). Rapid 
analysis of whey proteins from different animal species by revered-phase 
high-performance liquid chromatography. Z Lebensm Unters Forsch. 
195(4):326-331. 
de Koning K, van de Vorst Y. Automatic milking - Changes and Chances. (2002).  
Proceedings of the British Mastitis Conference, Brockworth, U.K. p 68-80. 
Degener A, Belew M, Velander WH. (1998). Zn2+-selective purification of 
recombinant proteins from the milk of transgenic animals. Journal of 
Chromatography A. 799:125-137. 
Demmer W, Nussbaumer D. (1999). Large-scale membrane adsorbers. Journal of 
Chromatography A. 852(1):73-81. 
Denman J, M, Hayes C, O'Day T, Edmunds C, Bartlett S, Hirani KM, Ebert KG, 
McPherson JM. (1991). Transgenic expression of a variant of human tissue-
type plasminogen activator in goat milk: purification and characterization of 
the recombinant enzyme. Biotechnology. 9(9):839-843. 
DeSilva K, Stockmann R, Smithers GW. 2003. Isolation procedures for functional 
dairy components - novel approaches to meeting the challenges. Australian 
Journal of Dairy Technology. 58(2):148-152. 
Dexcel. (2006). Greenfield Automatic Farm: New Zealand's first fully automated 
dairy farm. Hamilton, New Zealand. 
Dionysius D, Herse J, Grieve P. (1991). Extraction of lactoperoxidase and lactoferrin 
from whey using batch ion-exchange techniques. Australian Journal of Dairy 
Technology. 46:72-76. 
Donnelly WJ. (1991). Applications of biotechnology and separation technology in 
dairy processing. Journal of the Society of Dairy Technology. 44(3):67-72. 
Douglas FW, Greenberg R, Farrell HM, Edmondson LF. (1981). Effects of ultra-
high-temperature pasteurization on milk proteins. Journal of Agricultural 
Food Chemistry. 29:11-15. 
Doultani S, Turhan KN, Etzel MR. (2004). Fractionation of proteins from whey 
using cation exchange chromatography. Process Biochemistry. 39(11):1737-
1743. 
  
R-5 
Dubois E; (1990). Process for separating certain proteins from whey or milk. EP 
0368862 A1. 
Durham RJ, Sleigh RW, Hourigan JA. (2003). Blue sky to stainless steel: 
Commercialisation of a new dairy process. Australian Journal of Dairy 
Technology. 58(2):185. 
Durham RJ, Sleigh RW, Hourigan JA. (2004). Pharmaceutical lactose: a new whey 
with no waste. Australian Journal of Dairy Technology. 59:138-141. 
Ebert KM, Selgrath JP, DiTullio P, Denman J, Smith TE, Memon MA, Schindler JE, 
Monastersky GM, Vitale JA, Gordon K. (1991). Transgenic production of a 
variant of human tissue-type plasminogenactivator in goat milk. 
BioTechnology. 9:835-838. 
Ekstrand B, Bjorck L. (1986). Fast protein liquid chromatography of antibacterial 
components in milk: lactoperoxidase, lactoferrin and lysozyme. Journal of 
Chromatography A. 358:429-433. 
Ekstrand B. 1989. Antimicrobial factors in milk - A review. Food Technology. 
3(2):105-126. 
Elgar DF, Norris CS, Ayers JS, Pritchard M, Otter DE, Palmano KP. (2000). 
Simultaneous separation and quantitation of the major bovine whey proteins 
including proteose peptone and caseinmacropeptide by reversed-phase high-
performance liquid chromatography on polystyrene-divinylbenzene. Journal 
of Chromatography A. 878(2):183-196. 
Ena JM, Castillo H, Sanchez L, Calvo M. (1990). Isolation of human lactoferrin by 
affinity chromatography using insolubilized bovine beta-lactoglobulin. 
Journal of Chromatography B: Biomedical Sciences and Applications. 
525:442-446. 
Etzel MR, Helm TR, Vyas HK; (2006). Methods and compositions involving whey 
protein isolates. Provisional patent, U.S.A. 
Etzel MR, Liten AD, Moore PM. Chromatographic capture of proteins from milk; 
(1998); 2nd International Conference On Expanded Bed Adsorption, Napa 
Valley, California, USA. 
Etzel MR. (2004). The emerging role of dairy proteins and bioactive peptides in 
nutrition and health: Manufacture and use of dairy protein fractions1,2. 
Journal of Nutrition. 134(4):996-1002. 
Farr VC, Prosser CG, Clark DA, Tong M, Cooper CV, Willix-Payne D, Davis SR. 
(2002). Lactoferrin concentration is increased in milk from cows milked 
once-daily; Proceedings of the New Zealand Society of Animal Production. 
62:225-236. 
Fee CJ, Chand A. (2005). Direct capture of lactoferrin and lactoperoxidase from raw 
whole milk by cation exchange chromatography. Separation and Purification 
Science. 48:143-149. 
Felipe X, Law AJ. (1997). Preparative-scale fractionation of bovine, caprine and 
ovine whey proteins by gel permeation chromatography. Journal of Dairy 
Research. 64(3):459-464. 
  
R-6 
Fisher JW, McKnight DR, Rodenburg J. (2004). Economics of robotic milking 
systems for dairy cows. Dairy Farmers of Ontario and the Ontario Ministry of 
Agriculture and Food, Ontario, Canada. 
Foley AA, Bates GW. (1987). The purification of lactoferrin from human whey by 
batch extraction. Analytical Biochemistry. 162(1):296-300. 
Fox PF. (2001). Milk proteins as food ingredients. International Journal of Dairy 
Technology. 54(2):41-55. 
Francis GL, Regester GO, Webb HA, Ballard FJ. (1995). Extraction from cheese 
whey by cation exchange chromatography of factors that stimulate the growth 
of mammalian cells. Journal of Dairy Science. 78:1209-1218. 
FSANZ. (2002). Final Assessment Report, Application A404, Lactoperoxidase 
System, 06/03. Food Safety Association of New Zealand. 
Fuda E, Juraegi P, Pyle DL. (2004). Recovery of lactoferrin and lactoperoxidase 
from sweet whey using colloidal gas aphrons (CGAs) generated from anionic 
surfactant, AOT. Biotechnology Progress. 20(2):514-525. 
Fulton S. (2001). Transgenic Milk Processing. In Recovery of Biological Products: 
American Chemical Society, Cancun, Mexico. 
Gambero A, Kubota LT, Gushikem Y, Airoldi C, Granjeiro JM, Taga EM, Alcantara 
EFC. (1997). Use of chemically modified silica with beta-diketoamine groups 
for separation of alpha-lactoalbumin from bovine milk whey by affinity 
chromatography. Journal of Colloid and Interface Science. 185(2):313-316. 
GE Healthcare Technologies. (1998). Separation Technique File No.111. GE 
Healthcare Technologies, Uppsala, Sweden. 
GE Healthcare Technologies. (2004). SP Sepharose™ Big Beads, Food Grade, 11-
0026-62 AA. 
GE Healthcare Technologies. (2005). Q and SP Sepharose Big Beads: Bioprocess 
media, Data file 18-1104-91. 
Geberding SJ, Byers CH. (1998). Preparative ion-exchange chromatography of 
proteins from dairy whey. Journal of Chromatography A. 808:141-151. 
Gesan-Guiziou G, Daufin G, Timmer M, Allersma D, van der Horst C. (1999). 
Process steps for the preparation of purified fractions of alpha-lactalbumin 
and beta-lactoglobulin from whey protein concentrates. Journal of Dairy 
Research. 66(2):225-236. 
Ghosh R, Cui ZF. (2000). Purification of lysozyme using ultrafiltration. 
Biotechnology and Bioengineering. 68(2):191-203. 
Ghosh R. (2002). Protein separation using membrane chromatography: opportunities 
and challenges. Journal of Chromatography A. 952:13-37. 
Gloy A. (2004). The potential value of fractions: Milk protein market utilisation. 
Cornell Conference on Dairy Market and Product Research, Cornell 
University, N.Y., U.S.A. 
  
R-7 
Gosh R. (2002). Protein separation using membrane chromatography: opportunities 
and challenges. Journal of Chromatography A. 92:13-37. 
Grasselli M, Cascone O. (1996). Separation of lactoferrin from bovine whey by dye 
affinity chromatography. Netherlands Milk and Dairy Journal. 50(4):551-
561. 
Groves ML. (1965). Preparation of some iron iron-binding proteins and α-
lactalbumin from bovine milk. Biochimica BioPhysics Acta. 763:377-381. 
Groves ML. (1970). Minor milk proteins. In Milk Proteins: Academic Press, NY., 
USA. 
Hahn R, Schulz PM, Schaupp C, Jungbauer A. (1998). Bovine whey fractionation 
based on cation-exchange chromatography. Journal of Chromatography A. 
795(2):277-287. 
Harju ME, Heikkil HO; (1989). A process of recovering lactose from whey. EP 
0311977 A2. 
Harrison HG, Todd P, Rudge SR, Demetri PP. (2003). Bioseparations and 
Engineering. Oxford University Press, Oxford, U.K. p 340-361. 
Hayashi T, Kawamura T. (2002). Effect of an automatic milking system on milking 
traits. Animal Science Journal. 73:403-408. 
Hedhammer TG, Hober S. (2005). Protein engineering for selective purification. 
Chemical Engineering Technology. 28(11):1315-1325. 
Heebøll-Nielsen A, Justesen SFL, Thomas ORT. (2004). Fractionation of whey 
proteins with high-capacity superparamagnetic ion-exchangers. Journal of 
Biotechnology. 113:247-262. 
Henricus AWEM; (1983). Process for the preparation of a precipitate of casein and 
whey. US P 4,519,945. 
Hillerton JE. (1997). Milking equipment for robotic milking. Computers and 
Electronics in Agriculture. 17(1):41-51. 
Hobman PG. (1992). Ultrafiltration and manufacture of whey protein concentrates. 
In Whey and Lactose Processing. Zadow JG, (ed). London, United Kingdom: 
Elsevier Applied Science. U.K. 195-230 p. 
Hogeveen H, Ouweltjes W. (2003). Sensors and management support in high-
technology milking. Journal of Animal Science. 81(3):1-10. 
Houwing J, Billiet HAH, van der Wielen LAM. (2003). Mass-transfer effects during 
separation of proteins in SMB by size exclusion. AIChE Journal. 49(5):1158-
1167. 
Huffman LM, Harper WJ. (1999). Maximizing the value of milk through separation 
technologies. Journal of Dairy Science. 82:2238-2244. 
Humphrey RS, Newsome LJ. (1984). High performance ion-exchange 
chromatography of the major bovine milk proteins. New Zealand Journal of 
Diary Science and Technology. 19:197-204. 
  
R-8 
Huppertz T, Fox PF, Kelly AL. (2003). High pressure-induced changes in the 
creaming properties of bovine milk. Innovative Food Science and Emerging 
Technologies. 4:349-359. 
Huppertz T, Fox PF. (2006). Effect of NaCl on some physico-chemical properties of 
concentrated bovine milk. International Dairy Journal. In Press. 
Iannucci NB, Wolman FJ, Camperi SA, Cañizo AAN, Grasselli M, Cascone O. 
(2003). Affinity chromatography with pseudobiospecific ligands on high-
performance supports for purification of proteins of biotechnological interest. 
Brazilian Journal of Chemical Engineering. 20(1):27-32. 
IDF Bulletins. (1991). IDF Bulletins No 191 (1985) and No 264 (1991). 
Igarashi Y. (1995). An improved procedure for the preliminary fractionation of milk 
proteins. International Dairy Journal. 5(3):305-310. 
Indyk HE, Filonzi EL. (2005). Determination of lactoferrin in bovine milk, colostrum 
and infant formulas by optical biosensor analysis. International Dairy 
Journal. 15(5):429-438. 
James BJ, Jing Y, Chen DX. (2003). Membrane fouling during filtration of milk-a 
microstructural study. Journal of Food Engineering. 60(4):431-437. 
Jelen P. (1991). Pressure-driven membrane processes: Principles and Definitions. 
International Dairy Federation. 9201:7-14. 
Jelen P. (1983). Whey processing research: where are we going?: Energy 
Management and Membrane Technology in Food and Dairy Processing. 
Proceedings from the special Food Engineering Symposium held in 
conjunction with Food and Dairy Expo. Chicago, IL, USA. p 95-104. 
Jensen J, Larsen PH; (1995). Method for obtaining high-quality protein products 
from whey. EP 0639054 A1. 
Johanson B. (1960). Isolation of iron binding-containing red protein from human 
milk. Acta Chimica Scandinavia. 14(2):510-513. 
Jungbauer A, Pettauer D, Buchacher A, Wenisch E, Unterluggauer F, Uhl K, Steindl 
F. (1988). Scale-up of monoclonal -antibody purification using radial 
streaming ion-exchange chromatography. Biotechnology and Bioengineering. 
32(3):326-333. 
Kawai T, Saito K, Lee W. (2003). Protein binding to polymer brush, based on ion-
exchange, hydrophobic, and affinity interactions. Journal of Chromatography 
B. 790(1-2):131-142. 
Kawakami H, Dosako S, Lönnerdal B. (1990). Iron up-take from transferrin and 
lactoferrin by rat intestinal brush-border membrane vesicles. American 
Journal of Physiology. 258:G535-541. 
Kawakami H, Shinmoto H, Dosako S, Sago Y. (1987). One step isolation of 
lactoferrin using immobilised monoclononal antibodies. Journal of Dairy 
Science. 70:752-759. 
Kawakami H, Tanimoto M, Dosako S; (1988). Process for separating and purifying 
lactoferrin from milk using sulphate compound. WO 8808006 A1. 
  
R-9 
Keesey J. (1987). Methods of enzymatic analysis biochemica information. In: 
Boehringer Mannheim Biochemicals. Pütter J., Becker, R. 1983, (ed). 
Florida, U.S.A. p 286-293. 
Kilara A, Panyam D. (2003). Peptides from milk proteins and their properties, 
critical reviews. Food Science and Nutrition. 43(6):607-633. 
Konecny P, Brown RJ, Scouten WH. (1994). Chromatographic purification of 
immunoglobulin G from bovine milk whey. Journal of Chromatography A. 
673(1):45-53. 
Konrad G, Lieske B, Faber W. (2000). A large-scale isolation of native beta-
lactoglobulin: characterization of physicochemical properties and comparison 
with other methods. International Dairy Journal. 10(10):713-721. 
Korhonen H, Marnila P, Pihlanto-Leppälä A, Ryhänen E-L. (2001). Bioactive 
components of milk: natural ingredients for health promotion. Innovations in 
Food Technology. 10:23-27. 
Korhonen H, Pihlanto-Leppälä A. (2001). Milk protein derived bioactive peptides-
Novel opportunities for health promotion. International Dairy Federation 
Bulletin. 363:17-26. 
Korhonen H, Pilhanto-Leppala A, Rantamaki P, Tupasela T. (1998). Impact of 
processing on bioactive proteins and peptides. Trends in food science and 
Technology. 9:307-319. 
Korhonen H. (2002). Technology options for new nutritional concepts. International 
Journal of Dairy Technology. 55(2):79-88. 
Kussendrager KD, Kivitis MGC, Verver AB; (1994). Process for isolating milk 
lactoferrin and lactoperoxidase from milk and milk products and products 
obtained by such process. EP 0620709 A1. 
Ladisch MR. (2001). Bioseparations Engineering: Principles, Practice and 
Economics: John Wiley & Sons, New York, U.S.A. 
Laemmli UK. (1970). Cleavage of structural proteins during the assembly of the 
head of bacteriophage T4. Nature. 227:680-685  
Lang HJ. (1948). Simplified approach to preliminary cost estimates. Chemical 
Engineering. 55:112-113. 
Levison PR. (2003). Large-scale ion-exchange column chromatography of proteins: 
Comparison of different formats. Journal of Chromatography B. 790(1-2):17-
33. 
Lindsay M, Gil, G-C, Cadiz A, Velander WH, Zhang C, Van Cott KE. (2004). 
Purification of recombinant DNA-derived factor IX produced in transgenic 
pig milk and fractionation of active and inactive subpopulations. Journal of 
Chromatography A. 1026 (1-2):49-157. 
Lonnerdal B, Carlsson J. (1977). Isolation of lactoferrin from human milk by metal-
chelate affinity chromatography. FEBS Letters. 75(1):89-92. 
Mabrook MF, Petty MC. (2003). Effect of composition on the electrical conductance 
of milk. Journal of Food Engineering. 60:321-325. 
  
R-10 
Mackle TR, Bryant AM, Petch SF, Hooper RJ, Auldist MJ. (1999). Variation in the 
composition of milk protein from pasture-fed dairy cows in late lactation and 
the effect of grain and silage supplementation. New Zealand Journal of 
Agricultural Research. 42:147-154. 
MAF NZ. (2005). Situation and outlook for agriculture update: Dairy. In: Fisheries 
MoA, (ed). MAF Policy, Wellington, New Zealand. 
Marshall AD, Munro PA, Tragardh G. (1993). The effect of protein fouling in 
microfiltration and ultrafiltration on permeate flux, protein retention and 
selectivity: A literature review. Desalination. 91(1):65-108. 
Marshall KR, Fenwick RM. (1998). What are the future trends in dairy technology, 
In Dairy Science and Technology. The Danish National Committee on the 
IDF, Aarhus C, Denmark. p 40-50. 
Martin AA, Faust MA, Rowe LJ, Lonergan EJ. (2004). Associations of lactoferrin 
concentrations in milk with indicators of mastitis in dairy cows. Journal of 
Dairy Science. 86(S1):130. 
Maubois JL, Pierre A, Fauquant J, Piot M. (1987). Industrial fractionation of main 
whey proteins. International Dairy Federation Bulletins. 212:154-159. 
Mein GA. (1998). Design of milk harvesting systems for cows producing 100 pounds 
of milk daily. Stoneleigh, U.K. 
Meindersma GW, Kuczynski M. 1996. Implementing membrane technology in the 
process industry: problems and opportunities. Journal of Membrane Science. 
113(2):285-292. 
Meisel H. (2001). Bioactive peptides from milk proteins: a perspective for consumers 
and producers. Australian Journal of Dairy Technology. 56:83-92. 
Michalski M-C, Briard V, Juaneda P. (2005). CLA profile in native fat globules of 
different sizes selected from raw milk. International Dairy Journal. 
15(11):1089-1094. 
Mirabel B; (1978). Process for extracting proteins from milk using silica and anion-
exchange resins. US 4229342. 
Morison KR, Joyce L. (2005). Column-based ion exchange of whey proteins. Food 
New Zealand. 5(1):22-30. 
Morr CV, Ha EYW. (1993). Whey protein concentrates and isolates: processing and 
functional properties. Critical Reviews in Food Science and Nutrition. 
33(6):431-476. 
Mulvihill DM. (1992). Production, functional properties and utilization of milk 
protein products. In: Advanced Dairy Chemistry. Fox PF (ed). Applied 
Science: Elsevier, London, U.K. p 365-404. 
Naidu SA. (2002). Activated lactoferrin - A new approach to meat safety. Food 
Technology. 56(3):40-45. 
Nakano T, Silva-Hernandez ER, Ikawa N, Ozimek L. (2002). Purification of casein 
glycomacropeptide from sweet whey with undetectable level of 
phenylalanine. Biotechnology Progress. 18 (2):409-412. 
  
R-11 
NBR. (2004). Fonterra: Lactoferrin is the new aspirin. The National Business 
Review. Auckland, New Zealand. 
Neyestani TR, Djalali M, Pezeshki M. (2003). Isolation of α-lactalbumin, β-
lactoglobulin, and bovine serum albumin from cows milk using gel filtration 
and anion-exchange chromatography including evaluation of their 
antigenicity. Protein Expression and Purification. 29(2):202-208. 
Nicholas GD, Auldist MJ, Molan PC, Stelwagen K, Prosser CG. (2002). Effects of 
stage of lactation and time of year on plasmin-derived proteolytic activity in 
bovine milk in New Zealand. Journal of Dairy Research. 69(4):533-540. 
Nikolov ZL, Woodard SL. (2004). Downstream processing of recombinant proteins 
from transgenic feedstock. Current Opinion in Biotechnology. 15(5):479-486. 
Nimmo-Bell. (2003). Economic evaluation of the food processing sector: A strategic 
review for New Zealand Trade and Enterprise. Nimmo-Bell, Wellington, 
New Zealand. 
Noh KH, Rhee MS, Imm JY. (2005). Separation of lactoferrin by reverse micelles 
formed by cationic surfactants. Food Science and Biotechnology. 14(1):131-
136. 
Noppe W, Haezebrouck P, Hanssens I, De Cuyper M. (1999). A simplified 
purification procedure of alpha-lactalbumin from milk using Ca2+-dependent 
adsorption in hydrophobic expanded bed chromatography. Bioseparation. 
8(1-5 ):153-158. 
Noppe W, Plieva FM, Galaev IY, Vanhoorelbeke K, Mattiasson B, Deckmyn H. 
2006. Immobilised peptide displaying phages as affinity ligands: Purification 
of lactoferrin from defatted milk. Journal of Chromatography A. 1101(1-
2):79-85. 
Norberg E. (2005). Electrical conductivity of milk as a phenotypic and genetic 
indicator of bovine mastitis: A review. Livestock Production Science. 96:129-
139. 
Nuyens JH, Van Veen HH; (1999). Isolation of lactoferrin from milk. US 6 183 803. 
Ohashi A, Murata E, Yamamoto K, Majima E, Sano E, Le QT, Katunuma N. (2003). 
New functions of lactoferrin and β-casein in mammalian milk as cysteine 
protease inhibitors. Biochemical and Biophysical Research Communications. 
306:98-103. 
Okonogi S, Tomita M, Tomimura T, Tamura Y, Mizoto T; (1988). A process for 
producing bovine lactoferrin in high purity. EP 0253395 A1. 
Orthner CL, Madurawe RD, Velander WH, Drohan WN, Battey FD, Strickland DK. 
(1989). Conformational changes in an epitope localized to the NH2- terminal 
region of protein C. Journal of Biological Chemistry. 264:18781-18788. 
Owen RO, Chase HA. (1997). Direct purification of lysozyme using continuous 
counter-current expanded bed adsorption. Journal of Chromatography A. 
757:41-49. 
  
R-12 
Pakkamen R, Aalto J. (1997). Growth factors and anti-microbial factors in bovine 
colostrum. International Dairy Journal. 7:285-297. 
Palmano KP, Elgar DF. (2002). Detection and quantitation of lactoferrin in bovine 
whey samples by reversed-phase HPLC on polystyrene-divinylbenzene. 
Journal of Chromatography A. 947:307-311. 
Paramasivam M, Saravanan K, Uma K, Sharma S, Singh TP, Srinivasan A. (2002). 
Expression, purification, and characterisation of equine lactoferrin in Pischia 
pastoris. Protein Expression and Purification. 26:28-34. 
Parker MH, Birck-Wilson E, Allard G, Masiello N, Day M, Murphy KP, Paragas V, 
Silver S, Moody MD. (2004). Purification and characterization of a 
recombinant version of human alpha-fetoprotein expressed in the milk of 
transgenic goats. Protein Expression and Purification. 38(2):177-183. 
Parodi PW. (1999). Conjugated linoleic acid and other anticarcinogenic agents of 
bovine milk fat. Journal of Dairy Science 82:1339-1349. 
Parodi PW. (2001). Cow's milk components with anticancer potential. Australian 
Journal of Dairy Technology. 56:65-73. 
Pearce RJ. 1983. Thermal stabilization of beta-lactoglobulin and alpha-lactalbumin 
in bovine cheddar cheese whey. Australian Journal of Dairy Technology. 
38:144-149. 
Pedersen L, Mollerup J, Hansen E, Jungbauer A. (2003). Whey proteins as a model 
system for chromatographic separation of proteins. Journal of 
Chromatography B. 790(1-2):161-173. 
Playne MJ, Bennett LE, Smithers GW. 2003. Functional dairy foods and ingredients. 
Australian Journal of Dairy Technology. 58(3):242. 
Pollock DP, Kutzko JP, Birck-Wilson E, Williams JL, Echelard Y, Meade HM. 
(1999). Transgenic milk as a method for the production of recombinant 
antibodies. Journal of Immunological Methods. 231(1-2):147-157. 
Przybycien TM. 1998. Protein-protein interactions as a means of purification. 
Current Opinion in Biotechnology. 9:164-170. 
Punidadas P, Rizvi SSH. (1998). Separation of milk proteins into fractions rich in 
casein or whey proteins by cross flow filtration. Food Research International. 
31(4):265-272. 
Reiter B. (1985). The biological significance of the non-immunoglobulin protective 
proteins in milk. In Developments in Dairy Chemistry - 3. 281-336 p. 
Rejman J, Hegarty H, Hurley W. (1989). Purification and characterisation of bovine 
lactoferrin from secretions of the involuting mammary gland: identification of 
multiple molecular weight forms. Comparative Biochemistry and Physiology. 
93B(5):929-934. 
Renner E. (1989). Micronutrients in milk and milk-based food products. Renner E, 
(ed). Elsevier Science Direct, London, U.K. 1-70, 134-138 and 275-276 p. 
Rosenberg M. (1995). Current and future applications for membrane processes in the 
dairy industry. Trends in Food Science & Technology. 6(1):12-19. 
  
R-13 
Roupas P. (2001). On-farm practices and post farmgate processing parameters 
affecting composition of milk for cheesemaking. Australian Journal of Dairy 
Technology. 56(3):219-232. 
Rowe GE, Margaritis A, Ian Q, Bassi AS, Xiu J-Z. (1999). A new kinetic model of 
protein adsorption on suspended anion-exchange resin particles. 
Biotechnology and Bioengineering. 65(6):613-621. 
Saleh ZS, Hossain MM. (2001). A study of the separation of proteins from 
multicomponent mixtures by a semi-batch foaming process. Chemical 
Engineering and Processing. 40(4):371-378. 
Samsam SZ, Naieri SH. (2004). A rapid chromatography procedure for the isolation 
of lactoperoxidase from acid whey. Asia Pacific Journal of Clinical 
Nutrition. 13(S114). 
Sarfert FT, Etzel MR. (1997). Mass transfer limitations in protein separations using 
ion-exchange membranes. Journal of Chromatography A. 764(1):3-20. 
Satue´-Gracia MT, Frankel EN, Rangavajhyala N, German JB. (2000). Lactoferrin in 
Infant formulas: Effect on oxidation. Journal of Agricultural Food Chemistry. 
48(10):4984-4990. 
Seifu E, Buys EM, Donkin EF. (2005). Significance of the lactoperoxidase system in 
the dairy industry and its potential applications: A review. Trends in Food 
Science and Technology. 16:137-154. 
Severin S, Xia WS. (2005). Milk biologically active components as nutraceuticals: 
Review. Critical Reviews in Food Science and Nutrition. 45(7-8):645-656. 
Shiozawa M, Okabe H, Nakagawa Y, Morita H, Uchida T. (2001). Purification of 
lactoferrin by expanded-bed column chromatography. Kagaku Kogaku 
Ronbunshu. 27(2):145 - 148  
Sievers G. (1981). Structure of milk lactoperoxidase. FEBS Letters. 127(2):253-256. 
Skidmore GL, Horstmann BJ, Chase HA. (1990). Modelling single-component 
protein adsorption to the cation exchanger Sepharose Fast Flow. Journal of 
Chromatography. (498):113-128. 
Smithers GW, Ballard JF, Copeland AD, De Silva KJ, Dionysius DA, Francis GL, 
Goddard C, Grieve PA, McIntosh GH, Mitchell IR and others. (1996). New 
opportunities from the isolation and utilization of whey proteins. Journal of 
Dairy Science. 79:1454-1459. 
Splitt H, Mackenstedt I, Freitag R. (1996). Preparative membrane adsorber 
chromatography for the isolation of cow milk components. Journal of 
Chromatography A. 729(1-2):87-97. 
Spring F, Peyrouset A; (1982). Process of extraction of lactoferrin and 
immunoglobulins of milk. GB 2 098 998 A (U.K.). 
Steijns JM. (2001). Milk ingredients as nutraceuticals. International Journal of Dairy 
Technology. 54:81-88. 
  
R-14 
Strange ED, Malin EL, Van Hekken DL, Basch JJ. (1992). Chromatographic and 
electrophoretic methods used for analysis of milk proteins. Journal of 
Chromatography A. 624(1-2):81-102. 
Takeuchi T, Kitagawa H, Harada E. (2004). Evidence of lactoferrin transportation 
into blood circulation from intestine via lymphatic pathway in adult rats. 
Experimental Physiology. 89(3):263-270. 
Taylor S, Brock J, Kruger C, Berner T, Murphy M. (2004). Safety determination for 
the use of bovine milk-derived lactoferrin as a component of an antimicrobial 
beef carcass spray. Regulatory Toxicology and Pharmacology. 39(1):12-24. 
Thiersch G. (2004). Export Profile. US Dairy Export Council. 15(1):1-7. 
Tomasula PM, Craig JC, Boswell RT. (1997). A continuous process for casein 
production using high-pressure carbon dioxide. Journal of Food Engineering. 
33(3-4):405-419. 
Tome D, Debabbi H. (1998). Physiological effects of milk protein components. 
International Dairy Journal. 8:383-392. 
Tomita M, Wakabayashi H, Yamauchi K, Teraguchi S, Hayasawa H. (2002). Bovine 
lactoferrin and lactoferricin derived from milk: production and applications. 
Biochemistry and Cell Biology. 80(1):109-112. 
Torre M, Cohen ME. 1996. Perfusion liquid chromatography of whey proteins. 
Journal of Chromatography A. 729:99-111. 
Treloar T, Grieve PA, Nixon PF. (2000). One-step affinity purification of folate-
binding protein, a minor whey protein. Australian Journal of Dairy 
Technology. 55(2):96. 
Tsuda H, Sekine K, Ushida Y, Kuhara T, Takasuka N, Iigo M, Han BS, Moore MA. 
(2000). Milk and dairy products in cancer prevention: focus on bovine 
lactoferrin. Mutation Research. 462(2000):227-233. 
Tsuji S, Hirata Y, Mukai F. (1990). Comparison of lactoferrin content in colostrum 
between different cattle breeds. Journal of Dairy Science. 73:125-128. 
Turner S-A, Thomson NA, Auldist MJ. (2003a). Time of year and stage of lactation 
effects on lactoferrin concentrations in the milk of pasture fed dairy cows. 
Sixth International Conference on Lactoferrin: Structure, Function and 
Applications, Capri, Italy. 
Turner S-A, Williamson JH, Thomson NA, Roche JR, Kolver ES. (2003b). Diet and 
genotype affect milk lactoferrin concentration in late lactation; Proceedings 
of the New Zealand Society of Animal Production, Queenstown, New 
Zealand. 63:87-90. 
Turner S-A. (2002) Lactowhat?? Proceedings of the Ruakura Farmers' Conference, 
Hamilton, New Zealand. p 41-42. 
Uchida T, Dosako S, Sato K, Kawakami H. (2003). Sequential separation of 
lactoferrin, lactoperoxidase, and secretory component by sulphate-linked ion-
exchange chromatography. Milchwissenschaft. 58(9-10):482-486. 
  
R-15 
Uchida T, Sato K, Kawasaki Y, Dosako S; (1996). Separation of lactoperoxidase, 
secretory component and lactoferrin from milk or whey with a cation 
exchange resin. US 5 516 675. 
Ulber R, Plate K, Weiss T, Demmer W, Buchholz H, Scheper T. (2001). 
Downstream processing of bovine lactoferrin from sweet whey. Acta 
Biotechnology. 21(1):27-34. 
van Berkel HCP, Welling MM, Geerts M, Van Veen HA, Ravensbergen B, 
Salaheddine M, Pauwels EKJP, Pieper F, Nuijens JH, Nibbering PH. (2002). 
Large scale production of recombinant human lactoferrin in the milk of 
transgenic cows. Nature Biotechnology. 20:484-487. 
Varman AH, Sutherland JP. (1994). In Milk and Milk Products; Technology, 
chemistry and microbiology. Food Product Series, Chapman and Hall, 
London, U.K. 
Vervaeck V, Decatelle J, van Coillie Y; (1992). A method for isolating proteins from 
milk and a method for processing milk. EP 0518448 A1. 
Visser S, Slangen CJ, Rollema HS. (1991). Penotyping of bovine milk proteins by 
reverse-phase high-performance liquid chromatography. Journal of 
Chromatography. 548(1-2):361-370. 
Vivekanand V, Kentish SE, O'Connor AJ, Barber AR, Stevens GW. (2004). 
Microfiltration offers environmentally friendly fractionation of milk proteins. 
Australian Journal of Dairy Technology. 59:186-188. 
Walsh D, FitzGerald D. (2005). Health-related functional value of dairy proteins and 
peptides. Food Science and Technology. 19(1):22-24. 
Watanbe S, Murata S, Kumura H, Nakamura S, Bollen A, Moguilevsky N, 
Shimazaki K-I. (2000). Bovine lactoperoxidase and its recombinant: 
Comparison of structure and some biochemical properties. Biochemical and 
Biophysical Research Communications. 274:756-761. 
Werner RG. (1999). Transgenic manufactured biopharmaceuticals: a new method of 
drug manufacturing. Expert Opinion on Investigational Drugs. 8(6):731-736. 
Wheelwright SM. (1991). Protein purification: Design and scale up of downstream 
Processing. New York: Oxford University Press, NY, U.S.A. 
Wilcox CP, G. JV, Swaisgood HE. (2002). Isolation and partial characterization of 
CD36 from skim milk. Journal of Dairy Science. 85:1903-1908. 
Wolf E, Jehle PM, Weber MM, Sauerwein H, Daxenberger A, Breier BH, 
Besenfelder U, Frenyo L, Brem G. (1997). Human insulin-like growth factor 
I (IGF-I) produced in the mammary glands of transgenic rabbits: yield, 
receptor binding, mitogenic activity, and effects on IGF-binding proteins. 
Endocrinology. 138(1):307-313. 
Woolford M, Davis K, Jago J, Claycomb RW. (2003). The Greenfield Project: New 
Zealand's first automatic dairy farm, Hamilton, New Zealand. p 37-39. 
  
R-16 
Wright G, Carver A, Cottom D, Reeves D, Scott A, Simons P, Wilmut I, Garner I, 
Colman A. (1991). High level expression of active human alpha-1-antitrypsin 
in the milk of transgenic sheep. BioTechnology. 9:830-834. 
Wright G, Noble J. (1999). Production of transgenic protein, in Bioseparation and 
Bioprocessing. Subramanian G, (ed). Wiley-VCH: NY, U.S.A. 67-79 p. 
Wright PR, Muzzio FJ, Glasser BJ. 1999. Effect of resin characteristics on fluidized 
bed adsorption of proteins. Biotechnology Progress 15:932-940. 
Xu Y, Sleigh R, Hourigan J, Johnson R. (2000). Separation of bovine 
immunoglobulin G and glycomacropeptide from dairy whey. Process 
Biochemistry. 36:393-399. 
Yamauchi K. (1991) Biologically functional proteins of milk and peptides derived 
from milk proteins, 75th Annual Session of the IDF, Tokyo, Japan. 
Yang TS, Wu SC, Wang SR. (2000). Serum and milk lactoferrin concentrations and 
correlations with some blood components in lactating sows. Research in 
Veterinary Science. 69:95-97. 
Ye X, Yoshida S, Ng TB. (2000a). Isolation of lactoperoxidase, lactoferrin, alpha-
lactalbumin, beta-lactoglobulin B and beta-lactoglobulin A from bovine 
rennet whey using ion exchange chromatography. The International Journal 
of Biochemistry and Cell Biology. 32(11-12):1143-1150. 
Ye XY, Ng TB. (2000). Purification and characterization of glycolactin, a novel 
glycoprotein from bovine milk. Life Sciences. 66(13):1177-1186. 
Yoshida S, Wei Z, Shinmura Y, Fukunaga N. (2000). Separation of lactoferrin-a and 
-b from bovine colostrum. Journal of Dairy Science. 83:2211-2215. 
Yoshida S, Xiuyun Y. (1988). Isolation of some minor milk proteins, distributed in 
acid whey from approximately 100,000 to 250,000 Daltons of particle size. 
Journal of Dairy Science. 71:1-9. 
Yoshida S, Xiuyun Y. (1991a). Isolation of lactoperoxidase and lactoferrins from 
bovine milk acid whey by carboxymethyl cation exchange chromatography. 
Journal of Dairy Science. 74:1439-1444. 
Yoshida S, Xiuyun Y. (1991b). Isolation of lactoperoxidase and lactoferrins from 
bovine milk rennet whey and acid whey by sulphopropyl cation exchange 
chromatography. Netherlands Milk Dairy Journal. 45:273-280. 
Yoshida S. (1988). Isolation of lactoperoxidase 89 000 Daltons and a globulin 81 000 
Daltons from milk acid whey. Journal of Dairy Science. 71:2021-2027. 
Yoshida S. (1989). Preparation of lactoferrin by hydrophobic interaction 
chromatography from milk acid whey. Journal of Dairy Science. 72:1446-
1450. 
Zhang NT, Nakano T, Ozimek L. (2002). Isolation of lactoferrin from bovine 
colostrum by SP Sepharose cation-exchange chromatography. 
Milchwissenschaft. 57:614-617. 
Zydney AL. 1998. Protein separations using membrane filtration: new opportunities 
for whey fractionation. International Dairy Journal. 8:243-250. 
 Appendix A 
 
 
 
 
 
Detailed Engineering Drawings  
By Florian Kern 
The University of Waikato 
2005 
A
1
A
2
A
3
A
4
A
5
A
6
A
7
A
8
A
9
A
10
A
11
A
12
A
13
A
14
A
15
A
16
A
17
A
18
A
19
A
20
A
21
A
22
A
23
A
24
A
25
A
26
A
27
A
28
A
29
A
30
A
31
A
32
A
33
A
34
 Appendix B 
 
 
 
 
 
Retail (end-user) prices for LF 
 
2005 
  
Table B1: Some of the lactoferrin products that are available through internet with respective prices.  
Product name Company price  Retail 
prices 
    NZ$/g NZ$/kg  
60 caps, 250 mg Immunecare ImmuneCare UK 75.59 NZD 5.04 5039.33 
60 Capsules 250 mg each EINC.inc USA 16.99 USD 1.62 1619.71 
60 Capsules 300 mg each Health-n-Energy  24.95 USD 1.98 1982.14 
300 mg 60 capsules, Code 513 Healthmarketplace.com 39.95 USD 3.17 3173.81 
Lactoferrin 60 Caps (250 mg) Herbal Nutrition 19.50 USD 1.86 1859.00 
Denta Shield 60 Chewable Tabs Herbal Nutrition 20.12 USD 1.92 1918.11 
Laktoferrin, 120 Caps (350 mg) Herbal Nutrition 50.00 USD 1.70 1702.38 
Laktoferrin, 90 Caps (350 mg) Herbal Nutrition 39.00 USD 1.77 1770.48 
Lactoferrin 250mg - 60 Caps  Worldwidehealthcenter.net 31.95 USD 3.05 3045.90 
Symbiotics New Life 
100% Lactoferrin 60 Capsules Rite Care Pharmacy 21.88 USD 2.09 2085.89 
Lactoferrin 60 capsules, 250 mg Jarrow Formulae 19.29 USD 1.84 1838.98 
Lactoferrin 250 mg, 60 capsules Vitamin Research Products 29.95 USD 2.86 2855.23 
Average retail price (excluding ImmuneCare)    2.17 2168.33 
 
Source: internet (prices valid as at December, 2005). 
 
Retail prices ranged from $1.62 - $5.04 per g for capsule form of lactoferrin. These are generally marketed as nutraceuticals and/or 
functional food. 
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SuperPro Designer®  
Process layout and input, output 
summary of economic analysis  
from Case 19 
(section 8.4.3) 
 
 
  
SuperPro Designer® 
Figure C1: A simple process layout from SuperPro Designer, showing the capture and elution process of on-farm 
fractionation that was used in feasibility studies. 
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 C-3 
Example of economic feasibility report based on Case 19. 
 
EXECUTIVE SUMMARY (2005 prices) 
TOTAL CAPITAL INVESTMENT              125000  $ 
CAPITAL INV. CHARGED TO THIS PROJECT  125000  $ 
OPERATING COST                        29000  $/year 
PRODUCTION RATE                  109.1  kg/year of LF (in Product Line) 
UNIT PRODUCTION COST             261.3  $/kg of LF (in Product Line) 
TOTAL REVENUES  93000  $/year 
GROSS MARGIN  69.31  % 
RETURN ON INVESTMENT  38.98  % 
PAYBACK TIME  2.57  years 
IRR AFTER TAXES  46.64%  
NPV (at 7.0 % interest)  345000  $ 
 
 
MAJOR EQUIPMENT SPECIFICATION AND FOB COST (2005 prices) 
********************************************************************************** 
 Quantity/    Description   Unit Cost   Cost  
 Stand-by                     ($)       ($) 
********************************************************************************** 
   3/0    C-101      Chromatography Column     6000 18000 
   Column Diameter = 0.04 m   
   Column Height   = 0.25 m   
   1/0    CSP-101    Component Splitter            0 0 
   Throughput = 2881.63 kg/h   
   Cost of Unlisted Equipment   4000 
 TOTAL EQUIPMENT PURCHASE COST                             22000 
********************************************************************************** 
 
OVERALL PROCESS DATA 
*********************************************************************** 
 Annual Operating Time     1932.3  h 
 Annual Throughput     109.08  kg MP 
 Batch Throughput    0.01  kg MP 
 Recipe Batch Time   0.19  h 
 Recipe Cycle Time   0.19  h 
 Number of Batches Per Year   10000  
*********************************************************************** 
 MP = Main Product   Flow of   LF (in Product Line) 
 C-4 
FIXED CAPITAL ESTIMATE SUMMARY (2005 prices in $) 
***************************************************************** 
 A. TOTAL PLANT DIRECT COST (TPDC)  (physical cost)    
  1. Equipment Purchase Cost   22000 
  2. Installation   3000 
  3. Process Piping   8000 
  4. Instrumentation   9000 
  5. Insulation   1000 
  6. Electricals   2000 
  7. Buildings   10000 
  8. Yard Improvement   3000 
  9. Auxiliary Facilities   9000 
   
****************************** 
  TPDC =  65000 
 B. TOTAL PLANT INDIRECT COST (TPIC)    
  10. Engineering   16000 
  11. Construction   23000 
   
****************************** 
  TPIC =  39000 
 C. TOTAL PLANT COST (TPDC+TPIC)         TPC =   104000 
  12. Contractor's fee   5000 
  13. Contingency   10000 
    
  (12+13) =  16000 
********************************************************************************** 
 D. DIRECT FIXED CAPITAL (DFC) TPC+12+13   120000 
********************************************************************************** 
 
 
LABOR REQUIREMENT AND COST SUMMARY 
********************************************************************************* 
 Section    Labor Hours     Labor Cost   
 Name       Per Year        $/year        % 
********************************************************************************** 
 Main Section              183 5000 100 
********************************************************************************** 
 TOTAL  183 5000 100 
********************************************************************************** 
 
 
RAW MATERIALS COST SUMMARY  
********************************************************************************** 
 Raw        Unit Cost   Annual Amount   Cost  
 Material   ($/kg)         (kg)         ($/yr)   %  
********************************************************************************** 
 LP                0 1.5 0 0 
 Milk              0 149845.5 0 0 
 LF                0 151.5 0 0 
 Water             0 97480.3 0 0 
 Sodium Chloride   0.042 3623.79 152 1.75 
 Isopropanol       0.868 5479.58 4756 54.77 
 HCl (1 M)         0.065 15420.82 1004 11.56 
 NaOH (1 M)        0.056 15924.67 892 10.27 
 NaCI (2 M)        0.042 16413.25 689 7.94 
 Phosphate Buffer   0.078 15187.28 1191 13.71 
********************************************************************************** 
 TOTAL              319528.19 9000 100 
********************************************************************************** 
 C-5 
VARIOUS CONSUMABLES (2005 prices)     
********************************************************************************** 
 CHROMATOGRAPHY RESINS   
********************************************************************************** 
Procedure     Equipment     Unit Cost     Annual Amount      Cost   
 Name          Name           ( $/L )          ( L )         ( $/yr ) 
 P-1             C-101       1000 7.63 8000 
 TOTAL                8000 
********************************************************************************** 
 
WASTE TREATMENT / DISPOSAL (2005 prices) 
********************************************************************************** 
Stream   Unit Cost   Annual Amount     Cost  
 Name     ( $/kg )       ( kg )       ( $/yr )  
 a. SOLID WASTE    
 a. Subtotal (Solid Waste)    0 
b. LIQUID WASTE    
Waste             0.00E+00 138317.46 0 
 b. Subtotal (Liquid Waste)    0 
c. EMISSIONS    
 c. Subtotal (Emissions)    0 
WASTE TREATMENT/DISPOSAL TOTAL COST (a+b+c)         0 
********************************************************************************** 
 
 
UTILITY REQUIREMENTS (2005 prices) 
********************************************************************************** 
TOTAL               0 
 
 
ANNUAL OPERATING COST - SUMMARY  (2005 prices)   
********************************************************************************** 
 Cost Item   $/Year        %  
********************************************************************************** 
 Raw Materials  9000 30.47 
 Labor-Dependent  5000 18.33 
 Facility-Dependent  7000 24.23 
 Laboratory/QC/QA  0 0.18 
 Consumables  8000 26.79 
 Waste Treatment/Disposal  0 0 
 Utilities  0 0 
 Transportation  0 0 
 Miscellaneous  0 0 
 Advertising and Selling  0 0 
 Running Royalties  0 0 
 Failed Product Disposal  0 0 
********************************************************************************** 
 TOTAL  29000 100 
********************************************************************************** 
 C-6 
PROFITABILITY ANALYSIS  (2005 prices) $ 
********************************************************************************** 
 A. DIRECT FIXED CAPITAL                                120000  
 B. WORKING CAPITAL                                     5000  
 C. STARTUP COST                                        0  
 D. UP-FRONT R&D                                        0  
 E. UP-FRONT ROYALTIES                                  0  
 F. TOTAL INVESTMENT (A+B+C+D+E)                        125000  
 G. INVESTMENT CHARGED TO THIS PROJECT                  125000 
 H. REVENUE STREAM FLOWRATES                         
     kg/year of LF (in Product Line)                 109.079 
     kg/year of total flow (in Residual Milk)        149846 
 I. PRODUCTION (UNIT) COST                           
     $/kg of LF (in Product Line)                261.289 
 J. SELLING/PROCESSING PRICE                         
     $/kg of LF (in Product Line)                        401.485 
     $/kg of total flow (in  Residual Milk)              0.328 
 K. REVENUES   ($/year)                             
     Product Line                           44000 
     Residual Milk                          49000 
    Total Revenues    93000 
 L. ANNUAL OPERATING COST                                  29000 
 M. GROSS PROFIT  (K-L)                                64000 
 N. TAXES (33 %)  21000 
 O. NET PROFIT    (M-N + Depreciation )                49000 
    GROSS MARGIN                                          69.31  % 
    RETURN ON INVESTMENT                                  38.98  % 
    PAYBACK TIME (years)                                  2.57  
********************************************************************************** 
 
LOAN INFORMATION ($’000) 
          Direct Fixed    Working   Up Front   Up Front  
              Capital      Capital   R&D        Royalties  
  Amount  120 5 0 0 
  Equity    (%)  100 100 100 100 
  Debt      (%)  0 0 0 0 
  Interest  (%)  9 12 12 12 
  Loan Time (yrs)  10 6 6 6 
********************************************************************************** 
 
 
 BREAKDOWN OF CAPITAL OUTLAY ($) 
 YEAR   DIRECT FIXED WORKING  START-UP   UP FRONT  UP FRONT           TOTAL   
            CAPITAL      CAPITAL      COST          R&D         ROYALTIES   
********************************************************************************** 
1 -36029 -5183 0 0 0 -41212 
2 -48039 0 0 0 0 -48039 
3 -36029 0 0 0 0 -36029 
4-19 0 0 0 0 0  0 
20 6005 5183 0 0 0 11188 
********************************************************************************** 
 
BREAKDOWN OF LOAN PAYMENT ($)       
**********************************************************************************  
YEAR     DIRECT FIXED       WORKING     UP FRONT    UP FRONT   TOTAL   
            CAPITAL            CAPITAL        R&D        ROYALTIES   
********************************************************************************** 
1-20 0 0 0 0 0 
********************************************************************************** 
 
 C-7 
CASH FLOW ANALYSIS ($’000)  
YR CAPITAL DEBT SALES OPERAT GROSS LOAN DEPREC. TAXABLE TAXES NET NET 
 INVESTM FINANCE   COST PROFIT PAYMENT  INCOME  PROFIT CASH 
           FLOW 
****************************************************************************************************** 
1 -41 0 8 13 -6 0 6 0 0 -6 -47 
2 -48 0 93 29 64 0 6 59 19 45 -3 
3 -36 0 93 29 64 0 6 59 19 45 9 
4-19 0 0 93 29 64 0 6 59 19 45 45 
20 11 0 93 29 64 0 6 59 19 45 56 
 
IRR BEFORE TAXES  74.609  %   INTEREST  7.00% 9.00% 11.00% 
 IRR AFTER  TAXES  46.641  %   NPV           345 284 235  
 Depreciation Method:  Straight-Line 
 DFC Salvage Factor  0.05 
